Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.163322869789261,0.00294949869649687,0.157541852344127,0.169103887234395,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.175157357406322,0.00290663329689987,0.169460356144398,0.180854358668245,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42568,-0.138999076194296,0.00397868626740655,-0.146797301278413,-0.131200851110179,5.61910337398555e-256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42663,0.0868012804902688,0.00269300060106748,0.0815229993121766,0.0920795616683611,1.22947759656702e-219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.087094870703846,0.00271555496433233,0.0817723829737546,0.0924173584339374,1.42529386437479e-217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.123346767445171,0.00394260584413191,-0.13107427489967,-0.115619259990673,3.67015693837513e-206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42611,-0.126034232566572,0.00416882979064022,-0.134205138956227,-0.117863326176918,2.68984084933452e-194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,40532,0.0691356169591324,0.00228120910203188,0.0646644471191499,0.0736067867991149,4.53814728949475e-194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,42346,-0.350487050360336,0.0120967991630397,-0.374196776719894,-0.326777324000778,5.5772880372809e-179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42618,-0.156153136710697,0.00544023864952525,-0.166816004463767,-0.145490268957628,6.72569501358905e-176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.331051439261893,0.0115414601841594,0.308430177300941,0.353672701222846,1.00563158658893e-175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,40539,0.184144642497468,0.00664299885478156,0.171124364742096,0.197164920252839,1.05615442735667e-163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.207256649934795,0.00798342484444337,-0.222904162629904,-0.191609137239686,2.19634261606129e-144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0876646640642508,0.0033902822646868,-0.0943096173030369,-0.0810197108254646,6.24490103153966e-144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.072429197950142,0.00299808175177728,0.0665529577166585,0.0783054381836254,2.95511222454537e-126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.0796788522768579,0.00333473325042645,-0.0862149294476937,-0.073142775106022,1.27679665518227e-123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.0841797285247526,0.00357964658866319,0.0771636212109728,0.0911958358385325,1.97536035644382e-119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,40116,-0.232895333350281,0.00993046183180906,-0.252359038540627,-0.213431628159936,1.0356570135879e-118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.145579360375354,0.00624087906674802,-0.15781148334618,-0.133347237404528,4.99672505020968e-118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,40033,0.0973435005140691,0.00422557618956159,0.0890613711825283,0.10562562984561,1.10453023811968e-114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0484111170855371,0.00211626629973438,0.0442632351380577,0.0525589990330165,1.15227781142069e-113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.0665203142855963,0.00295750103635572,-0.0723170163168535,-0.0607236122543391,5.51373623032264e-110
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.085766217026767,0.00382670994058755,0.0782658655432154,0.0932665685103186,2.99026862682963e-109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0676710413608119,0.00303133608479175,0.0617296226346201,0.0736124600870038,5.09265858181557e-108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.0882733409661682,0.00397882617538207,-0.096071840269917,-0.0804748416624193,3.93459394567326e-107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42636,0.100259943230519,0.00453103094387444,0.0913791225805254,0.109140763880513,1.36272745216491e-106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,42370,-0.168019319859733,0.00775643099460222,-0.183221924609154,-0.152816715110313,2.82666728434187e-102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9,Complement component C9,40532,0.111924929164146,0.00517257266079115,0.101786686748995,0.122063171579296,8.85788316410697e-102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.191533936939613,0.00887464066652353,-0.208928232645999,-0.174139641233227,1.40757556787888e-101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0566632873309006,0.00263941739924955,0.0514900292283715,0.0618365454334297,1.49710605485123e-100
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42659,0.112031057802276,0.00524482086950743,0.101751208898041,0.12231090670651,1.39289688938863e-99
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0746559297852014,0.00350604526198017,0.0677840810717203,0.0815277784986825,5.45414166824236e-99
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.185759045844804,0.008731316357683,-0.202872425905863,-0.168645665783746,1.62005313130685e-98
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.285226776930953,0.0134547051479202,-0.311597999020877,-0.258855554841029,3.82922087560082e-98
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0405368671038307,0.00193837812945399,0.0367376459701008,0.0443360882375605,1.34779510682926e-95
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.110402934547654,0.00535158836295373,-0.120892047739044,-0.0999138213562651,7.62119279252163e-93
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0711965789525479,0.00348418726552065,0.0643675719121274,0.0780255859929684,2.01421644448092e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REN,Renin,42636,-0.17038086869055,0.00835847352592972,-0.186763476801372,-0.153998260579728,5.45170068675145e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42636,-0.119717208038925,0.00589229570601485,-0.131266107622714,-0.108168308455136,2.03778730543045e-90
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0670924541018154,0.0033199095597363,-0.0735994768388986,-0.0605854313647323,1.78399520552775e-89
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0501101245001214,0.00248872652937728,0.0452322205025419,0.0549880284977009,7.23714251391619e-89
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.0992993027130069,0.00493565936055261,0.0896254103663237,0.10897319505969,1.75380981064286e-88
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.0752546076139529,0.00374632866954607,0.0679118034216426,0.0825974118062632,1.88367396678303e-88
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0587590633616186,0.00294090321650778,0.0529948930572634,0.0645232336659738,1.51927120704153e-87
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.065261790316275,0.00327947261863615,0.0588340239837481,0.0716895566488018,7.12243278542184e-87
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0716565672290027,0.00360072592690951,0.0645991444122601,0.0787139900457453,1.2189089653962e-86
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42655,-0.0652605752139346,0.00328540923494102,-0.071699977314419,-0.0588211731134502,1.44947741363074e-86
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.106429511042079,0.00542714905411128,-0.117066723188137,-0.0957922988960207,1.99872917074979e-84
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42754,-0.0551148834559041,0.00283344635213151,-0.0606684383060818,-0.0495613286057263,3.8270302156177e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0626360683750492,0.00322233043153202,-0.0689518360208519,-0.0563203007292464,5.02588342598393e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.151598134110179,0.00794121776612397,-0.167162920931782,-0.136033347288576,3.53526612791378e-80
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.0982437166876737,0.00520048311210452,0.0880507697879488,0.108436663587399,1.45261749880388e-78
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.149897900487367,0.00794659764755237,-0.16547323187657,-0.134322569098164,2.46448868811328e-78
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42754,-0.09208082332519,0.00505021681267591,-0.101979248278035,-0.0821823983723452,2.12068805946119e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.0794415183262452,0.00439252351847535,0.0708321722300335,0.0880508644224569,2.97308084683624e-72
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.0624784755337368,0.00349916055551226,0.0556201208449328,0.0693368302225408,1.68410048727997e-70
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0283966829410502,0.00160499373741333,0.0252508952157201,0.0315424706663803,2.87276366384978e-69
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.0926628973346207,0.00526184216444762,-0.102976107976938,-0.0823496866923033,1.25374460311082e-68
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.117372501737962,0.00669185189301368,-0.130488531448269,-0.104256472027655,4.24085613524049e-68
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0550643211183261,0.00316167613027304,-0.0612612063336612,-0.0488674359029909,5.08331535359095e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.0885454429016293,0.00510592147395997,-0.0985530489905908,-0.0785378368126678,1.18552279201957e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.090922545065461,0.00525693889613755,-0.101226145301891,-0.0806189448290314,2.65428430693093e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,42311,-0.0883901675111471,0.00512246014869157,-0.0984301894025826,-0.0783501456197116,5.44378026177815e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0834678843924959,0.00484253475316796,0.0739765162762867,0.0929592525087051,9.75832924303823e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42600,-0.173810211980849,0.0101322412982934,-0.193669404925504,-0.153951019036194,2.90435381046428e-65
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42636,-0.0559350646616224,0.00335145644286523,-0.0625039192896383,-0.0493662100336066,6.52361121111099e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.188073075988303,0.0114567069081418,-0.210528221528262,-0.165617930448345,5.59987933672627e-60
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.1321762259197,0.00807073788551778,-0.147994872175315,-0.116357579664085,1.05467834960306e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.0747569334257178,0.00460408777200038,-0.0837809454588385,-0.065732921392597,9.9105647788766e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0542489276304797,0.0033424334888449,0.0476977579923437,0.0608000972686157,1.09417953710698e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.127673393429824,0.00790112742139735,-0.143159603175763,-0.112187183683885,3.48723630703897e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.0735863344908109,0.00457183504177003,-0.0825471311726802,-0.0646255378089416,9.45409888928904e-58
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.0724473082573303,0.00454266940124715,-0.0813509402837747,-0.0635436762308858,9.58214154815897e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0649622619030382,0.00407395398464193,-0.0729472117129364,-0.05697731209314,9.9890915947967e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41747,-0.0657328791151525,0.00413471098562082,-0.0738369126469693,-0.0576288455833357,2.32534164204966e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.0998505866056981,0.00630248029182905,-0.112203447977683,-0.0874977252337132,5.17056072665459e-56
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FURIN,Furin,42679,-0.0500387591370058,0.00319373418943783,-0.056298478148304,-0.0437790401257077,7.64241274589501e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.0831816093926679,0.00533799184213533,-0.0936440734032532,-0.0727191453820827,2.84684547925946e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0518556280198823,0.00332817544815679,0.045332404141495,0.0583788518982696,2.94001376218983e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0856291434335236,0.00549148245408854,-0.0963924490435371,-0.0748658378235101,3.1118768075184e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42676,0.0644117784107288,0.00415251955848819,0.056272840076092,0.0725507167453657,8.45381659833577e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,42488,0.0423355799838508,0.0027343353424634,0.0369762827126225,0.047694877255079,1.32743687712388e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.100258276708823,0.00647908061506556,-0.112957274714352,-0.0875592787032948,1.49668168217935e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.143030894785143,0.0092668095189543,-0.161193841442293,-0.124867948127992,2.7403062603237e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,40527,0.0913114226269756,0.00591409983912313,0.0797197869422942,0.102903058311657,3.08301695310184e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.129214220787177,0.00837297273474406,-0.145625247347276,-0.112803194227079,3.46961249264131e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0693833424628448,0.00450106385542615,0.0605612573062095,0.07820542761948,3.71508258661413e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0403168356451016,0.0026161354061728,-0.0454444610412003,-0.0351892102490029,4.86344713810215e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42706,-0.0313193688454263,0.00205388168239837,-0.0353449769429271,-0.0272937607479255,4.54248544417601e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.082997453682077,0.00547191554580632,-0.0937224081518574,-0.0722724992122966,1.54550881076006e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0505207425609933,0.0033523746483436,-0.0570913968717468,-0.0439500882502399,7.90261039707862e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42587,-0.119794987588671,0.00796651211735504,-0.135409351338686,-0.104180623838655,1.08354686600469e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0550123160918018,0.00366536279039725,-0.0621964271609804,-0.0478282050226232,2.01444377577949e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42663,-0.0264894501302898,0.0017707698473666,-0.0299601590311283,-0.0230187412294512,3.42520889175331e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.118769682127742,0.00794088708937651,-0.13433382082292,-0.103205543432564,3.55762660504537e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42668,0.0569151991563349,0.00382079705699039,0.0494264369246338,0.0644039613880361,8.68798100933361e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFM,Afamin,40539,-0.0291914772958807,0.00195984668796176,-0.0330327768042857,-0.0253501777874756,1.04976423933454e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0456488731020421,0.00308329852412423,-0.0516921382093255,-0.0396056079947586,3.28721462325539e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.0852452112869878,0.005763492121881,-0.0965416558458746,-0.0739487667281011,4.96615517361895e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42611,0.0393183641302941,0.00266906506357878,0.0340869966056797,0.0445497316549085,9.76959767099527e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.0502441299605305,0.00341480691878576,-0.0569371515213506,-0.0435511083997104,1.24947666930551e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42764,0.0790410227989254,0.00542286990226174,0.0684121977904924,0.0896698478073584,9.22945894693974e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0345733153324048,0.00238196445246008,-0.0392419656592265,-0.029904665005583,2.22562104320022e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.0385739056131063,0.00267082765884641,0.0333390834017673,0.0438087278244453,6.26775041932061e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.0877280867744831,0.00608569734195705,0.0758001199842473,0.0996560535647189,9.15874075638333e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0564901186645721,0.00393517549519552,-0.0642030626351553,-0.0487771746939888,2.16266078252806e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42754,-0.0374401069714,0.00261224898101952,-0.0425601149741983,-0.0323200989686018,2.98306804817813e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0429634978298764,0.00301220716649975,-0.0488674238762159,-0.0370595717835369,8.01816452554814e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POSTN,Periostin,40527,0.0539708194440282,0.00379086811374522,0.0465407179410876,0.0614009209469688,1.33289703812801e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42754,-0.0428267133744181,0.00301682891720056,-0.0487396980521312,-0.036913728696705,2.05266093253401e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0227048872906795,0.00160282354460389,0.0195633531432559,0.0258464214381031,3.13801219280311e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.062037638612654,0.0043980195058281,-0.0706577568440771,-0.0534175203812309,7.24278219092218e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.0707350278088186,0.00502086349429585,-0.0805759202576384,-0.0608941353599987,9.33395425353804e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.104766267042651,0.00747960520283499,-0.119426293240207,-0.0901062408450942,2.9395704486874e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.139393928162437,0.00999814306703411,-0.158990288573824,-0.11979756775105,7.2733603576701e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,40283,-0.0530748016334891,0.00381736315857628,-0.0605568334242986,-0.0455927698426796,1.39868677042024e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD248,Endosialin,40527,0.055333704617412,0.0040123044545787,0.0474695878864377,0.0631978213483862,6.40905221046847e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0531471724148067,0.00388048203763992,-0.0607529172085809,-0.0455414276210325,2.04960370462573e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0495461071304083,0.00362400389552704,-0.0566491547656413,-0.0424430594951753,2.86862348456012e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.0643549955425977,0.00471076594956529,-0.0735880968037457,-0.0551218942814498,3.34596568914402e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0409210870438812,0.00300311525852205,0.035034981137178,0.0468071929505844,5.30844183840461e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.0968321623240777,0.00711852039106755,-0.11078446229057,-0.0828798623575853,8.2386403925045e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0470555366662393,0.00347317553459661,-0.0538629607140487,-0.04024811261843,1.52304466036117e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FST,Follistatin,42654,0.0653929448984961,0.00483613665682635,0.0559141170511165,0.0748717727458758,2.16830877666638e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0614586793483224,0.00457838575193739,-0.0704323154221197,-0.0524850432745251,9.14357373939164e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0369554379198576,0.00276662581044872,-0.0423780245083371,-0.0315328513313781,2.16176104852138e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.092269251406238,0.00693522212910781,-0.105862286779289,-0.0786762160331867,3.92457780344757e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0437426298778046,0.00329753499037796,-0.0502057984589454,-0.0372794612966638,6.57257817686455e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42594,0.0574630811121478,0.00434847312179042,0.0489400737934385,0.065986088430857,1.27950396250631e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42588,0.0501215115926326,0.00379944575689216,0.042674597909124,0.0575684252761413,1.7243933734266e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.0759074465162876,0.00579438876360057,-0.0872644484929447,-0.0645504445396305,5.76019720516708e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.0701455049176701,0.00535732968069102,-0.0806458710918246,-0.0596451387435157,6.19847244097556e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.0705328908199195,0.00539538947657425,-0.081107854194005,-0.059957927445834,8.23080917535817e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0960336698832743,0.00736410418798596,0.0816000256748218,0.110467314091727,1.36027274013371e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,40283,-0.0363724435262077,0.00279614612431159,-0.0418528899298584,-0.030891997122557,2.10173628661004e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0308398861506156,0.00237682806570197,-0.0354984691593915,-0.0261813031418398,2.85801893430194e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.067308035978559,0.00518815986346002,-0.0774768293109406,-0.0571392426461773,2.93835015772828e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,40488,0.0248867942323807,0.00191975044029168,0.021124083369409,0.0286495050953524,3.6837027575018e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.104776557973184,0.00811957531537043,-0.12069092559131,-0.088862190355058,7.21419280549984e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,40283,0.0295372186619486,0.00228779487644714,0.0250531407041122,0.034021296619785,7.3299891394892e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.04376340574248,0.00339615848850688,0.0371069351050066,0.0504198763799535,8.98434861682479e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.157915527958918,0.0122800888585979,-0.18198450212177,-0.133846553796067,1.2637802306268e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.0357538672108173,0.00278014712423494,-0.0412029555743178,-0.0303047788473168,1.37738481217033e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0416688449589293,0.00324208293076304,-0.0480233275032249,-0.0353143624146337,1.38007605280949e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0502063175171347,0.00391394040960779,-0.057877640719966,-0.0425349943143034,1.90880222851128e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42611,-0.0391317006241878,0.00306408624585946,-0.0451373096660724,-0.0331260915823033,3.91206694604149e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.0931984360338455,0.0072984869874594,-0.107503470529266,-0.0788934015384251,4.37057987338266e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0647647160478565,0.0050987485372273,-0.074758263180822,-0.054771168914891,9.37759589131263e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0311784709789609,0.00246281371419777,0.0263513560991333,0.0360055858587886,1.6005769852298e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.0756420477190964,0.00597366657685116,0.0639336612284681,0.0873504342097247,1.70975281686963e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42587,-0.0529153538000655,0.00419800232213005,-0.0611434383514404,-0.0446872692486906,3.18602358854985e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0566323483099498,0.00449505476584162,-0.0654426556509994,-0.0478220409689002,3.43527073983292e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,40223,-0.0775814099297378,0.00617173090384168,-0.0896780025012675,-0.0654848173582081,5.41604546444658e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0285574186886567,0.00228282282986416,-0.0330317514351905,-0.024083085942123,1.04761769836454e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0402491768239856,0.00322127534417405,-0.0465628764985667,-0.0339354771494045,1.25339223976158e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEP,Leptin,42636,-0.0814573196867634,0.00653036398582495,-0.0942568330989803,-0.0686578062745465,1.63493421027261e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42594,-0.0906997346291611,0.00727212487332035,-0.104953099380869,-0.0764463698774532,1.6655062581697e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42794,-0.0619513392098955,0.00498972805215625,-0.0717312061921217,-0.0521714722276692,3.32930097400699e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.102240717972824,0.00826024301235944,-0.118430794277049,-0.0860506416685998,5.82607762184432e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0632130948680808,0.00511012933341525,-0.0732289483615747,-0.053197241374587,6.38963027018254e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0605743030754919,0.00489947972536074,-0.0701772833371989,-0.0509713228137848,6.99548822325757e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0341969203113121,0.00277984699509145,0.0287484202009329,0.0396454204216914,1.36917705228199e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,40424,-0.0306193931381182,0.00248803556709649,-0.0354959428496273,-0.025742843426609,1.39288209388354e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.0669289809182409,0.00544783315253149,-0.0776067338972026,-0.0562512279392792,1.66220204687883e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42638,0.0258998179503081,0.00210818712033013,0.021767771194461,0.0300318647061551,1.66243109605174e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0468011901367494,0.0038236328024229,-0.0542955104294983,-0.0393068698440005,2.9054246765889e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.0333564939451728,0.00272680489115531,0.0280119563585084,0.0387010315318372,3.40836229206512e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPN,Asporin,40511,0.0337187024111586,0.00277484407985332,0.0282800080146461,0.0391573968076711,9.13092036281145e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0447466507428627,0.00369384768604079,-0.0519865922075026,-0.0375067092782227,1.34695089872653e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.072263996864486,0.00597109655019702,-0.0839673461028722,-0.0605606476260999,1.52722971267815e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0282491120546491,0.00234257258743892,0.0236576697832688,0.0328405543260294,2.58658147116387e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0367032490205125,0.00304596924070287,-0.0426733487322902,-0.0307331493087349,2.89134572441771e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0294497905337469,0.00244688144590696,0.0246539028997692,0.0342456781677245,3.4034787593004e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.0655495346831398,0.00546233969385908,-0.0762557204831036,-0.054843348883176,5.26455081540366e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0403400300690083,0.00337153918957355,0.0337318132574442,0.0469482468805725,7.96700742574394e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,42188,-0.0469301344371058,0.0039281696463238,-0.0546293469439004,-0.0392309219303111,9.97827230411999e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.0522620036348715,0.00437507697972932,0.043686852754602,0.0608371545151409,1.00332427779288e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.0930842520136596,0.00780539010426328,-0.108382816618016,-0.0777856874093035,1.27263573824631e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42495,0.0403848603535043,0.00341110309486356,0.0336990982875717,0.0470706224194369,3.54895000824409e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.0663097454811747,0.00560183400279856,-0.0772893401266599,-0.0553301508356895,3.88927231742105e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.050835356947509,0.00431244277309817,0.0423829691122366,0.0592877447827814,6.4506411778851e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0412269355430981,0.00349848312914461,-0.0480839624762215,-0.0343699086099747,6.74211294860079e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.172817877681171,0.0147548707625086,-0.201737424375688,-0.143898330986654,1.56979413997015e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,40511,0.040387007987911,0.00345243563614741,0.0336202341410621,0.0471537818347599,1.97605137080137e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.106196823270443,0.00910202186212216,-0.124036786120203,-0.0883568604206838,2.6671911937063e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0278785068251194,0.00239118295387838,0.0231917882355178,0.032565225414721,2.92044221948972e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,40511,-0.0303925951733983,0.0026135627173087,-0.0355151780993233,-0.0252700122474732,4.41856631419327e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.0669203621596645,0.00576639902769817,-0.0782225042539529,-0.0556182200653761,5.46649011387303e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0253228361810361,0.00220141277203266,-0.0296376052142201,-0.0210080671478521,1.76765343911553e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42640,0.0431857131281793,0.00375647227605743,0.0358230274671067,0.0505483987892519,1.90948156171446e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42613,-0.048769792103094,0.00425008797471123,-0.057099964533528,-0.04043961967266,2.44006108757324e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.0544167454452444,0.00474989079215412,-0.0637265313978665,-0.0451069594926223,3.03066055587694e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.057771662626089,0.00504605520442684,-0.0676619308267656,-0.0478813944254124,3.27588559284655e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0502788711743807,0.00441558379381691,-0.0589334154102618,-0.0416243269384996,7.15762391238286e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.0619727748482904,0.00544633420599143,-0.0726475898920336,-0.0512979598045472,7.37168101494481e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,40182,-0.0915269577828073,0.00806831268954395,-0.107340850654313,-0.0757130649113012,1.16105686438647e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42636,-0.0709629699858689,0.00626100946274023,-0.0832345485328397,-0.058691391438898,1.21217159706145e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42636,-0.0776592789311777,0.00686628292353939,-0.0911171934613149,-0.0642013644010405,1.58760227251528e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.0636913598322506,0.00563303045938597,-0.0747320995326471,-0.0526506201318541,1.76472196485796e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.076774894342695,0.00683499048466053,-0.0901714756926296,-0.0633783129927603,3.80551565475393e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.0736604857658968,0.00656789857840213,-0.0865335669795649,-0.0607874045522286,4.61820108286733e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,40283,-0.0700945005877368,0.00625001441268696,-0.0823445288366032,-0.0578444723388703,4.9261418530502e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42711,0.0419787249420278,0.00374857534540419,0.0346315172650356,0.04932593261902,5.55751572835753e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42636,0.0343114451801392,0.00307435078024068,0.0282857176508675,0.040337172709411,8.51095023344137e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0414869176892722,0.00373687860415741,-0.0488111997534208,-0.0341626356251237,1.73242237314105e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.121743652165389,0.0109830504215705,-0.143270430991668,-0.100216873339111,2.08810724295986e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.0381682283027961,0.00346203894834144,0.0313826319640468,0.0449538246415453,3.8340632896277e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.0299076668952763,0.00272369615272214,-0.0352461113546117,-0.0245692224359409,6.21592137757139e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00945288399811665,0.000861786899347876,0.00776378167539481,0.0111419863208385,7.05927455117904e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,40379,0.117984729104341,0.0107686037561998,0.0968782657421897,0.139091192466493,8.57353157943688e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.063386863366862,0.00579598030100415,-0.0747469847568302,-0.0520267419768939,1.01367819374207e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42618,-0.0361323899921053,0.00330750761765961,-0.0426151049227181,-0.0296496750614924,1.15270790342373e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.0310971458055436,0.00284682988074284,-0.0366769323717995,-0.0255173592392876,1.16206214651697e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.0851964049262684,0.00781166688998733,-0.100507272030644,-0.0698855378218932,1.47700608188417e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OCLN,Occludin,40482,-0.0482385047115597,0.00444091435003565,-0.0569426968376296,-0.0395343125854899,2.3799821782626e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0429651671480275,0.00395731098941609,-0.050721496687283,-0.0352088376087719,2.39530390941101e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0332236382708857,0.00307085139858943,-0.0392425070121209,-0.0272047695296504,3.62086877577479e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42611,0.0274099986499064,0.00254609754113266,0.0224196474692864,0.0324003498305264,6.45208922431895e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREH,Trehalase,40527,-0.0785883369630639,0.00732115704208379,-0.0929378047655482,-0.0642388691605797,9.43269755607291e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.0596265887726177,0.00559279824526752,-0.070588473333342,-0.0486647042118933,1.96478427772219e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.05256602210465,0.00493418873110886,-0.0622370320176233,-0.0428950121916766,2.14326031868903e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0432045099828721,0.00406617184919392,0.035234813158452,0.0511742068072921,2.88866396937072e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0482488273544375,0.00456158115025751,-0.0571895264089422,-0.0393081282999327,4.80369831296719e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.0650146886236404,0.00615448648165991,-0.0770774821276938,-0.052951895119587,5.52983113675195e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42689,-0.0581573596431837,0.00550694382347364,-0.068950969537192,-0.0473637497491753,5.72154925368209e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.054707888460527,0.00518969978531075,0.0445360768813179,0.064879700039736,7.00945074231307e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,40346,-0.0290260367245426,0.00275383260678831,-0.0344235486338477,-0.0236285248152375,7.45555084066256e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42754,-0.0460471829569921,0.00437488712339801,-0.0546219617188522,-0.037472404195132,8.30192520320078e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0334460543988681,0.00318626109774633,-0.039691126150451,-0.0272009826472853,1.12171126548016e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0230199110779713,0.00219372898496792,-0.0273196198885084,-0.0187202022674342,1.21263405252774e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0304859648015424,0.00290737875957175,0.0247875024327818,0.0361844271703031,1.26218063112647e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.0838704841989054,0.00801970522906941,-0.0995891064478814,-0.0681518619499293,1.69444948991199e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0339074205122644,0.00324897531478323,0.0275394288952892,0.0402754121292395,2.11027583536105e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0326909938491449,0.00313341533233348,0.0265494997977712,0.0388324879005185,2.2597275666341e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0273476788399845,0.0026249504085355,0.0222027760392549,0.032492581640714,2.55460289953724e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0300239130431549,0.0028902785569383,0.0243589670715559,0.035688859014754,3.50306437031487e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,42370,-0.0463491954642855,0.00446435474692666,-0.0550993307682617,-0.0375990601603092,3.74121030069343e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.0279291511590842,0.00270534395512707,-0.0332316253111333,-0.0226266770070352,6.82512852781996e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.0349478440239312,0.00339129535305514,0.0283009051319431,0.0415947829159193,8.26199627027039e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.074282549162829,0.00723371947180069,-0.0884606393275583,-0.0601044589980996,1.20267859242003e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.036234178993948,0.00353031922729932,-0.0431536046794547,-0.0293147533084413,1.26918276674052e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAST,Gastrin,40483,-0.147163166690573,0.0143618920276704,-0.175312475064807,-0.119013858316339,1.56668018974973e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.0702349402214738,0.00686323237859242,-0.0836868756835149,-0.0567830047594326,1.72711171525581e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0241369491155193,0.00236738945612991,0.0194968657815047,0.028777032449534,2.54349174395188e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.0823608627531598,0.0080863019042533,-0.0982100144854963,-0.0665117110208234,2.82952874598038e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0341031800066481,0.00334832613287394,-0.040665899227081,-0.0275404607862151,2.83695361314067e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,40482,-0.0442855622753825,0.00434975961114461,-0.052811091113226,-0.0357600334375391,3.0631075473724e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42613,-0.0316939728713455,0.00311442682580641,-0.0377982494499261,-0.025589696292765,3.09177688284718e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0503906295768181,0.00497210918731313,-0.0601359635839518,-0.0406452955696843,4.7224037501375e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.050087940988818,0.00495066094323449,-0.0597912364375576,-0.0403846455400784,5.63866921975616e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0359358010808056,0.00356039770821389,-0.0429141805889048,-0.0289574215727064,7.22209501188261e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0324083834167814,0.00322756939115152,-0.0387344194234384,-0.0260823474101244,1.21936999628216e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0271138633787849,0.00270217738100091,-0.0324101310455467,-0.0218175957120231,1.30756785139637e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0265293511861961,0.00264678868918392,-0.0317170570169966,-0.0213416453553957,1.45623512716723e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0284326458008903,0.00285084950166184,0.0228449807776331,0.0340203108241475,2.49881044436616e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42659,-0.0296258682843418,0.00298080374579294,-0.035468243626096,-0.0237834929425877,3.38898666568738e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.0574370968548755,0.0057839771283805,-0.0687736920265013,-0.0461005016832497,3.68190792458865e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42495,0.0251859227716715,0.00253979719829128,0.0202079202630206,0.0301639252803224,4.24395040402721e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.0583316104544409,0.00588956667408511,-0.0698751611356477,-0.0467880597732341,4.80604448133746e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42569,-0.0715475568528051,0.0072491500217084,-0.0857558908953536,-0.0573392228102566,6.73934015859129e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.101349875420662,0.0102870398261258,-0.121512473479868,-0.081187277361455,8.01819335222732e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0433375113982152,0.00439824723912666,-0.0519580759869034,-0.0347169468095269,8.23763616589046e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0446714580871404,0.00454652974871816,-0.053582656394628,-0.0357602597796528,1.04749482226564e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0266578414818626,0.00271259814776014,0.0213411491122527,0.0319745338514725,1.05700381307199e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0308247467990401,0.00314179947470261,-0.0369826737694572,-0.024666819828623,1.20066826149443e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0422397215510667,0.00432142255309424,-0.0507097097551314,-0.033769733347002,1.72252841039394e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42676,-0.0349117665411927,0.00358840258622602,-0.0419450356101957,-0.0278784974721897,2.68385232256817e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0323955639644767,0.00332994327907487,0.0258688751374899,0.0389222527914634,2.70238751754985e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0327843729659401,0.00337967628419588,-0.039408538482964,-0.0261602074489162,3.67076070277913e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,40539,-0.0187481316110126,0.00193389692499233,-0.0225385695839976,-0.0149576936380276,3.87802466214657e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,40199,-0.0447580231902158,0.00462118675586595,-0.053815549231713,-0.0357004971487185,4.26150385322779e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42721,0.0450607621525818,0.00465697117346642,0.0359330986525876,0.054188425652576,4.49701861184059e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.119991516595112,0.0124201108029252,-0.144334933768845,-0.0956480994213786,5.39473997173124e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.0347363012418274,0.0036037022391307,-0.0417995576305236,-0.0276730448531313,6.44947114059654e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.0651954805932581,0.00676890434325975,-0.0784625331060472,-0.051928428080469,7.17144320384305e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0630535575264941,0.00654780108899808,-0.0758872476609303,-0.0502198673920579,7.2708972309367e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0393308832760445,0.0040966068473045,0.0313015338553276,0.0473602326967613,9.31703811868531e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.058880850246953,0.00613770399841921,-0.0709107500838547,-0.0468509504100514,1.03223883360731e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42613,0.162139035334609,0.0169317786600763,0.128952749160859,0.195325321508358,1.18279345251303e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0313672829479092,0.0032757426182654,0.024946827416109,0.0377877384797093,1.22242217929052e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.0711253830783566,0.00743818179855726,-0.0857042194035289,-0.0565465467531844,1.35033413396941e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0400222521837757,0.00419245778268984,0.0318050349297036,0.0482394694378477,1.62388163763213e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.0761963875995747,0.00799255320038138,-0.0918617918723222,-0.0605309833268272,1.78536873338104e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.028197378587595,0.00296691606273527,-0.0340125340705561,-0.0223822231046339,2.3591311445418e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0356151806089473,0.00375148076361604,0.0282622783122599,0.0429680829056348,2.60251163062078e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0376341010649641,0.00397633857232828,0.0298404774632007,0.0454277246667276,3.43146912834856e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.0343787832983221,0.00365271531098999,-0.0415381053078625,-0.0272194612887818,5.66581717943044e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0407680545831882,0.00433721003393086,-0.0492689862496926,-0.0322671229166837,6.35274543305567e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,40342,-0.0223588608943448,0.00238215385121768,-0.0270278824427314,-0.0176898393459581,7.44037852285983e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42754,-0.0327844736149173,0.00350384632899468,-0.0396520124197468,-0.0259169348100877,9.49897915926213e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,40482,-0.05059282075506,0.00542718162232909,-0.061230096734825,-0.039955544775295,1.35203834974423e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0329160730115609,0.00354330666433229,0.0259711919494696,0.0398609540736522,1.78257091268859e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0268545101929586,0.00290363424898544,-0.0325456333209701,-0.0211633870649471,2.69545163788394e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELL,L-selectin,40539,0.0218497199921959,0.00236501193148596,0.0172142966064834,0.0264851433779084,2.93722167345638e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.0782653122305618,0.0085197903261447,-0.0949641012698054,-0.0615665231913182,4.65603661255191e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42689,0.0436132068192701,0.0047748483079906,0.0342545041356086,0.0529719095029317,7.5327522818221e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.035704067431528,0.00391598520980304,0.028028736420314,0.0433793984427419,8.78592125845713e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42721,-0.0504298144033057,0.00553869539636989,-0.0612856573801907,-0.0395739714264207,9.81984026422847e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0402777359329441,0.00442883746522695,0.0315972145010992,0.0489582573647889,1.08242918220283e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42663,-0.0288285168086084,0.00317084886616844,-0.0350433805862986,-0.0226136530309183,1.10930553048004e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0276078871339915,0.00304443341878192,-0.0335749766348041,-0.021640797633179,1.37353818223071e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0339782337567444,0.00374960636034145,-0.0413274622230136,-0.0266290052904751,1.45593281469116e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,40269,0.0188534339237715,0.00208020133993715,0.0147762392974947,0.0229306285500484,1.47852496670635e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0241962778394497,0.00266990314711155,-0.0294292880077884,-0.0189632676711111,1.48726038078694e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42794,0.0249105694716346,0.00275027976963484,0.0195200211231503,0.0303011178201189,1.51475038958735e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42711,0.0272780553709627,0.00302041359448743,0.0213580447257673,0.033198066016158,1.92455687866864e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0386797956972266,0.00428703364401978,-0.0470823816395054,-0.0302772097549478,2.08465879989925e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.0604205535039435,0.00669703812721778,-0.0735467482332903,-0.0472943587745966,2.15599263348297e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.0303683298099064,0.00337860382024159,-0.0369903932975799,-0.0237462663222329,2.90687121218884e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0190409213602456,0.00211929820884867,0.0148870968709023,0.023194745849589,2.94791832390309e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.0593137579361372,0.00661350165619696,-0.0722762211822832,-0.0463512946899911,3.47479022890794e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0318614376838133,0.00357186012651312,-0.0388622835317791,-0.0248605918358476,5.25493260971067e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,40283,0.0458811144375821,0.00515528385574713,0.0357767580803177,0.0559854707948465,6.46192562453175e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42692,-0.054708252117889,0.00615463686928465,-0.066771340381687,-0.0426451638540911,6.94217518847818e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0205215149566396,0.00231025129063424,-0.0250496074862827,-0.0159934224269965,7.50029638751867e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,42346,-0.0414770068601742,0.00467529276959206,-0.0506405806885747,-0.0323134330317738,8.13650450933443e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0521065248775592,0.00587595866231072,-0.0636234038556883,-0.0405896458994302,8.41409804471893e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0543553770547293,0.00613858974619531,-0.0663870129572721,-0.0423237411521865,9.43368399906507e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.0314845066353258,0.00355885382912124,-0.0384598601404035,-0.0245091531302482,1.01109203115449e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0510168306347793,0.00577060587481313,-0.0623272181494131,-0.0397064431201456,1.0664850958642e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42620,-0.0280031326579006,0.00318381090704474,-0.0342434020357082,-0.0217628632800929,1.59621770460776e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0239060267714203,0.00273712514497998,0.0185412614872596,0.0292707920555811,2.74581105275867e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0451341160188818,0.00517768368309572,-0.0552823760377494,-0.0349858560000142,3.18573576355465e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.0367562650235305,0.00422028212240476,-0.0450280179834439,-0.0284845120636172,3.4056190377568e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0312133042124516,0.0035890773655515,-0.0382478958489325,-0.0241787125759706,3.80517337731844e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.0734538121898536,0.00844557952486928,-0.0900071480585974,-0.0569004763211098,3.86823402970301e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0205987094786312,0.00237183335995103,0.0159499160931272,0.0252475028641352,4.22911385726541e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.0972712275004324,0.011210994431789,-0.119244776586739,-0.0752976784141259,4.55010884439347e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.036140551242745,0.00417410314048259,-0.0443217933980909,-0.0279593090873991,5.32804064145715e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.0532899070129699,0.00617023262514886,0.0411962510676781,0.0653835629582616,6.44016053477887e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0245047020237065,0.00285074775642348,0.0189172364211165,0.0300921676262965,9.16886679405984e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,40515,-0.047418873792439,0.00552551498402914,-0.0582488831611361,-0.0365888644237419,1.0556818736561e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.0835380488437457,0.00974696560695625,-0.10264210143338,-0.0644339962541115,1.16298049139016e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.056122874273314,0.00655278819336038,-0.0689663391323003,-0.0432794094143276,1.19942391827672e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0319482545471608,0.00373408633322925,-0.0392670637602901,-0.0246294453340315,1.29493266549755e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42495,0.0289999140832559,0.00339889241539905,0.0223380849490737,0.035661743217438,1.59049932467432e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0327886480243549,0.00384832983887073,-0.0403313745085416,-0.0252459215401683,1.79349997554719e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0293221140196771,0.00344939827355138,-0.0360829346358377,-0.0225612934035164,2.08775069499508e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0252237205352678,0.00297509294924487,-0.0310549027157877,-0.0193925383547478,2.52072225728502e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.0210667507504874,0.0024888722860473,0.0161885610698347,0.0259449404311401,2.83890334824377e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0577529784783336,0.00682569901718374,-0.0711313485520137,-0.0443746084046535,2.92581546532388e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.0727665608618425,0.00862251536914426,-0.0896666909853652,-0.0558664307383197,3.52490899644168e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.0533763192425399,0.00633069713104783,-0.0657844856193937,-0.0409681528656862,3.76348778579423e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0291068719823701,0.00345336880202966,-0.0358754748343483,-0.022338269130392,3.85314514743423e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42594,-0.0732681549703087,0.00874255367395829,-0.090403560171267,-0.0561327497693504,5.78490914712911e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0464674026901934,0.00554458977078451,-0.0573347986409311,-0.0356000067394558,5.90093798887245e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0679297996131119,0.00810667516809068,-0.0838188829425696,-0.0520407162836542,5.94464913790542e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.0496893539774995,0.00593210681635342,-0.0613162833375522,-0.0380624246174468,5.99627531543857e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.0616772792740826,0.0073638533065907,-0.0761104317550004,-0.0472441267931649,6.15123499582451e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,40223,-0.0487730803881898,0.00582663383474518,-0.0601932827042903,-0.0373528780720892,6.41839625715183e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0424466166395786,0.00510310494884571,0.032444530939841,0.0524487023393162,9.81731065576178e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXN,Paxillin,42311,-0.0420402588964726,0.00505607639768922,-0.0519501686359435,-0.0321303491570018,1.00904896325259e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0218074580513206,0.00262651067760334,-0.0269554189794231,-0.016659497123218,1.13188613933787e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0428219249352813,0.00516511666844806,-0.0529455536054395,-0.0326982962651231,1.23351240475733e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.0613267137449134,0.007427534338579,-0.0758846810485282,-0.0467687464412985,1.66456966624e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.032292127641721,0.0039148175477333,-0.0399651700352782,-0.0246190852481637,1.74971464133311e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0294017782979358,0.00356570344586658,0.0224129995440373,0.0363905570518343,1.79197142395109e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.0703878838547317,0.00853814435914326,-0.0871226467986525,-0.0536531209108109,1.8199248558635e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.0600071962658891,0.00729462932917848,-0.0743046697510789,-0.0457097227806992,2.14337471971016e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASN,Vasorin,42449,0.0223630373711483,0.0027242501991819,0.0170235069807517,0.0277025677615448,2.43771854717311e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0412502426722132,0.00503137614391032,-0.0511117399142775,-0.031388745430149,2.65606261291828e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0292506053682943,0.00357782553405618,-0.0362631434150444,-0.0222380673215442,3.2714967530746e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0306208173360743,0.00375143843670002,-0.0379736366720063,-0.0232679980001422,3.57172078209512e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.038140425139274,0.0046780104189406,-0.0473093255603975,-0.0289715247181504,3.85941796551852e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0430530306329297,0.00528124536286543,-0.0534042715441459,-0.0327017897217134,3.89311982952729e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0313091090876911,0.00384454537061624,-0.0388444180140989,-0.0237738001612833,4.16819591040838e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0272589129603335,0.00334884828997241,-0.0338226556086794,-0.0206951703119876,4.30760322142454e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0239761721552223,0.00295378422430978,0.0181867550755751,0.0297655892348694,5.18212743212466e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0582730125822197,0.00718048164345087,-0.0723467566033834,-0.0441992685610559,5.25820009229338e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.0611838848234532,0.00754139398715198,-0.0759650170382711,-0.0464027526086353,5.3574119354596e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.0122034476282523,0.00150666651938535,0.00925038125025705,0.0151565140062476,6.07796906883367e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0306220309570508,0.00378506941930621,-0.038040767018891,-0.0232032948952106,6.4647164586671e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42711,-0.0293495221152475,0.00362837540245249,-0.0364611379040544,-0.0222379063264406,6.53131699667103e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.0169967623312702,0.00210157336221925,0.0128776785413204,0.0211158461212199,6.70216722719777e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0460559040506959,0.00569607705161035,-0.0572202150718522,-0.0348915930295397,6.72853261593347e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.0183405769995287,0.00227954345396769,-0.0228084821693054,-0.0138726718297521,9.28984680009005e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0459063105781956,0.00572510730661696,-0.0571275208991648,-0.0346851002572263,1.15937924649689e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,42437,-0.0337019762344444,0.00420522247077981,-0.0419442122771729,-0.025459740191716,1.19980711993594e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.0761326709637368,0.00955183247842684,-0.0948542626214535,-0.0574110793060202,1.70789782494683e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.012409458822659,0.00155752713132926,0.00935670564525368,0.0154622120000644,1.77512152340679e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0213982068399247,0.00268746176114797,0.0161307817880747,0.0266656318917747,1.85071992577587e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0354944508120487,0.00445825258517862,-0.0442326258789988,-0.0267562757450987,1.86650940584474e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.0242186757117714,0.00304353574632337,-0.0301840057745652,-0.0182533456489776,1.89696817870689e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0458541447311448,0.00578286148133735,0.0345197362277235,0.057188553234566,2.37548112956088e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0236988042844057,0.00299119146363896,0.0178360690156733,0.029561539553138,2.50196139237658e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0240268912432933,0.00303481211353975,-0.0299751229858312,-0.0180786595007554,2.65755741687598e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0257580260321899,0.00325486123440894,0.0193784980127484,0.0321375540516315,2.73790674196468e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,40223,-0.0468143987982695,0.0059168829429914,-0.0584114893665326,-0.0352173082300063,2.77492945744514e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0360975978723788,0.00457706692274082,-0.0450686490409509,-0.0271265467038068,3.34624862961764e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,42357,0.0182676366474542,0.00232299997796659,0.0137145566906397,0.0228207166042688,4.01527136463147e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.0305705201740269,0.00388663435275742,-0.0381883235054314,-0.0229527168426223,4.01936885224716e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.0402053799369748,0.00513939224576626,-0.0502785887386767,-0.030132171135273,5.5462551379695e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.023454641414872,0.00300596081272737,0.0175629582219263,0.0293463246078176,6.5948274405032e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0292143235375799,0.00374561230640868,-0.0365557236581409,-0.0218729234170188,6.66725360271371e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42611,0.0221187552197716,0.00283701878295467,0.0165581984051804,0.0276793120343627,6.83348452914853e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0489498675456222,0.00629418042269624,-0.0612864611741068,-0.0366132739171375,7.97894028989737e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.039568171197836,0.00508699755935217,-0.0495386864141662,-0.0295976559815057,8.00605025147668e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,40527,0.0383077708471673,0.00493277675776013,0.0286395284019575,0.0479760132923772,8.8001919826795e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0619590592211015,0.00801001579409274,-0.0776586901775233,-0.0462594282646797,1.10585050822407e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.0800627913653356,0.0103547431324645,-0.100358087904966,-0.0597674948257052,1.13419051128437e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0514836852053836,0.00666481103273045,-0.0645467148295353,-0.0384206555812319,1.20005069732611e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.0606327301922346,0.00786293445857492,-0.0760440817310415,-0.0452213786534278,1.35377912386298e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,40449,-0.0654493675722014,0.0084907055092909,-0.0820911503704115,-0.0488075847739912,1.38170416458185e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0214343941098652,0.00278212623362732,0.0159814266919557,0.0268873615277748,1.40646573333607e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0518930549353034,0.00674760403751261,-0.0651183588488281,-0.0386677510217787,1.56657023951298e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.0424651986350575,0.00552769849524969,-0.0532994876857469,-0.0316309095843681,1.6713722228129e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42679,-0.0336376463916265,0.00437930302459092,-0.0422210803198247,-0.0250542124634283,1.68641129751506e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0448776241302219,0.00584431432118665,-0.0563324801997477,-0.033422768060696,1.71625258705593e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0362852199066027,0.00473505985685267,-0.0455659372260339,-0.0270045025871715,1.93796893219391e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.0794165727245112,0.0103993700856065,-0.0997993380922999,-0.0590338073567224,2.3798068898653e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.085230663872152,0.0111655537865554,-0.107115149293801,-0.0633461784505035,2.44162606535801e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.0282668210110318,0.00370395455230663,0.0210070700885108,0.0355265719335528,2.47522468623062e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42534,-0.0525680568110164,0.00690963458252723,-0.0661109405927698,-0.039025173029263,2.97138472909578e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.0469689033214622,0.00617661037482307,0.034862746986809,0.0590750596561154,3.05465622840497e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0413280336979786,0.00545980220677886,-0.0520292460232651,-0.030626821372692,3.99069427785087e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.030073324217112,0.00397550949228861,0.0222813256122263,0.0378653228219976,4.14667699958969e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39956,-0.0172100137585481,0.00227452584420934,-0.0216680844131984,-0.0127519431038978,4.14987280045008e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0202460590446981,0.00268111058618176,-0.0255010357936143,-0.0149910822957818,4.58436558978793e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0431940802123947,0.0057349242258979,-0.0544345316951546,-0.0319536287296348,5.33197864438155e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39872,-0.0181582489548403,0.0024162869827222,-0.0228941714409759,-0.0134223264687048,6.14965139923185e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,42317,-0.0367479262740657,0.00489130817089582,-0.0463348902890215,-0.0271609622591099,6.15690392318302e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.042545876236587,0.00566717866820982,-0.0536535464262782,-0.0314382060468957,6.410993669341e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42556,-0.0614361218392687,0.00819708973329535,-0.0775024177165276,-0.0453698259620098,7.05350504726662e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0295174226069095,0.00394853486015635,-0.037256550932816,-0.0217782942810031,8.16932986524352e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.028019194007064,0.00376421820536895,0.0206413263245409,0.0353970616895872,1.04051207397717e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,42136,-0.0673015001777267,0.00904171224495916,-0.0850232561778466,-0.0495797441776067,1.04287637918529e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0296888848046094,0.00399287169778181,-0.0375149133322617,-0.021862856276957,1.10445335858282e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.066512689412794,0.00894544025155495,-0.0840457523058417,-0.0489796265197463,1.1059999999946e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0376165691456929,0.00506151716803354,-0.0475371427950386,-0.0276959954963472,1.13696051120523e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.0488351098367657,0.00658661660216143,-0.0617448783770021,-0.0359253412965293,1.29613392445745e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,40539,0.022329715003037,0.00301377180871886,0.016422722257948,0.0282367077481259,1.36058493908942e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0280345623654145,0.00378724099030892,0.020611570024409,0.03545755470642,1.4190120818609e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0548757321013602,0.00741768810807986,-0.0694144007931967,-0.0403370634095237,1.46419074425859e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42754,-0.0267721075733185,0.00362205209784991,-0.0338713296851044,-0.0196728854615327,1.53770999289956e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0357361211329409,0.00483485216966308,0.0262598108804013,0.0452124313854806,1.54127365729219e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0235558496460404,0.00318735651884992,0.0173086308690945,0.0298030684229862,1.56696601212908e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0465278041344056,0.00629695332589482,-0.0588698326531594,-0.0341857756156517,1.56930747646333e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,42357,-0.0398166045597069,0.00539642126714321,-0.0503935902433076,-0.0292396188761062,1.69883008015287e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0329496715652454,0.00447286897246121,-0.0417164947512694,-0.0241828483792214,1.87323348916657e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,40539,-0.0155683640103622,0.0021137341231913,-0.0197112828918172,-0.0114254451289073,1.88946277039372e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.069827527275325,0.00948894984461189,-0.0884258689707643,-0.0512291855798857,1.96332230786618e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42671,-0.0225254542885911,0.00306128604178803,-0.0285255749304957,-0.0165253336466866,1.97235470907569e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,42475,0.0237759297419687,0.00323582621336832,0.0174337103637668,0.0301181491201706,2.13392517440736e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42648,-0.0233709155361137,0.00318397856856819,-0.0296115135305074,-0.0171303175417201,2.25574714832286e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0448983500808167,0.00612198205239691,-0.0568974349035146,-0.0328992652581187,2.36566931223216e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0268966630350764,0.00366904715691554,-0.0340879954626309,-0.019705330607522,2.44991202613975e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0324406592777762,0.0044330640530708,0.0237518537337574,0.041129464821795,2.66221457353047e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0583574660823241,0.00803488073318857,-0.0741058323193737,-0.0426090998452745,4.04283963654573e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.0127448887158797,0.00175676601133588,0.00930162733366141,0.016188150098098,4.24521495815536e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42587,0.0211866478316543,0.00292207714211877,0.0154593766331015,0.0269139190302071,4.37869098971885e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.0484442988326913,0.00668628161869148,-0.0615494108053266,-0.035339186860056,4.55431247305608e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0352395685262206,0.00486395772984217,-0.0447729256767112,-0.0257062113757299,4.55890406278776e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42679,-0.0283514143878643,0.00391476010637877,-0.0360243441963667,-0.0206784845793619,4.65450137769821e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0339919593075043,0.00469400143802028,-0.043192202126024,-0.0247917164889845,4.72351244093081e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0256580791044728,0.00354808394650145,-0.0326123236396156,-0.0187038345693299,5.03316053563251e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0288467524209234,0.00399021715861488,-0.0366675780518086,-0.0210259267900382,5.11367727211577e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0409355351893423,0.00566791067089964,-0.0520446401043056,-0.029826430274379,5.39220127687795e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0219296361296381,0.0030452528247798,-0.0278983316662065,-0.0159609405930697,6.2849208747815e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,42370,-0.0333399688791859,0.0046454787257219,-0.0424451071816008,-0.024234830576771,7.51464421788474e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42618,-0.0198721600738524,0.00276967123430702,-0.0253007156930941,-0.0144436044546106,7.61465240085798e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42636,-0.0298663356876474,0.00416294921873702,-0.038025716156372,-0.0217069552189229,7.6472005573497e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42666,0.0197014450869976,0.00274638605123773,0.0143185284265717,0.0250843617474236,7.68720867772044e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.0597472381797878,0.00833053775881495,-0.0760750921870651,-0.0434193841725105,7.77475515607723e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,40283,-0.0322482147608317,0.00450180710323971,-0.0410717566831815,-0.0234246728384819,8.36938982353856e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,40199,-0.0581048561419795,0.00812533558061264,-0.0740305138799803,-0.0421791984039787,9.15666250970984e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0418395701676853,0.00585828029042066,-0.0533217995369097,-0.0303573407984608,9.67624732483614e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0231011160015462,0.00323604438252626,-0.0294437629912977,-0.0167584690117948,1.00148808226567e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0189703780689162,0.00266015557059127,-0.024184282987275,-0.0137564731505573,1.05555602701669e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.026975580497142,0.00379435730762785,-0.0344125208200926,-0.0195386401741914,1.23590305488275e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0345180480724403,0.00485834433632559,-0.0440404029716385,-0.0249956931732422,1.26605351896735e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0227073361509008,0.00320416902329046,-0.0289875074365501,-0.0164271648652515,1.44101093238174e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.0861474667325468,0.0121578885518799,-0.109976928294231,-0.0623180051708622,1.45233372550535e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0193107053638174,0.00274279488521196,-0.0246865833388328,-0.0139348273888019,2.00855691618012e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0457450408111372,0.00650928579136428,-0.0585032409622112,-0.0329868406600632,2.20030081282441e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0199993281263008,0.0028499014930418,-0.0255851350526627,-0.0144135211999389,2.36885024882322e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.04548361194621,0.00648489580680492,-0.0581940077275477,-0.0327732161648724,2.45171121072997e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0395602864287783,0.00564197706380884,0.028502011383713,0.0506185614738437,2.46577535362353e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0301455052030098,0.00430273028825395,-0.0385788565679875,-0.021712153838032,2.56700348924769e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.041516338493304,0.00592957389894695,-0.05313830333524,-0.029894373651368,2.65395401574924e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.0189267794955263,0.00271214446276407,0.0136109763485087,0.0242425826425439,3.12308576839704e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.027648935820118,0.00396738176814907,-0.0354250040856901,-0.0198728675545458,3.37262410825258e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.0286123353049483,0.00410753473721697,-0.0366631033898936,-0.020561567220003,3.44587288445999e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0399474502391313,0.00573718058890003,-0.0511923241933754,-0.0287025762848873,3.49138732786351e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0680498489123398,0.00978433999698717,-0.0872271553064347,-0.048872542518245,3.68948715478425e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,40199,-0.0645147431201996,0.00927623614710054,-0.0826961659685167,-0.0463333202718826,3.72980191484209e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.0583406531777884,0.00839188412775549,-0.0747887460681891,-0.0418925602873876,3.76730223011223e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0441972766242561,0.00636894688426233,-0.0566804125174102,-0.0317141407311019,4.11417689388812e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0356557974805876,0.0051433194405511,-0.0457367035840678,-0.0255748913771075,4.32385703072181e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0354211949772881,0.00511682186017612,-0.0454501658232333,-0.0253922241313429,4.6788324415069e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0238860877391541,0.00345681735554646,0.017110725722283,0.0306614497560251,5.11886949533421e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0348172440275977,0.00504506277667819,-0.0447055670698869,-0.0249289209853084,5.38641047515782e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0181580588748787,0.00263382442294444,0.0129957630059076,0.0233203547438498,5.65790583330527e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0211187889400626,0.0030664351760764,-0.0271290018851723,-0.0151085759949528,5.99739327243058e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0542527258632372,0.0078837565191295,-0.069704888640731,-0.0388005630857434,6.24052207359354e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.0334662502931408,0.0048677932959014,-0.0430071251531075,-0.023925375433174,6.53395664256783e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.0259421751109502,0.00377971092186286,-0.0333504085178014,-0.0185339417040989,7.01321934879013e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0395515175047656,0.0057662571959882,-0.0508533816089024,-0.0282496534006287,7.23059772140411e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.031880138675398,0.00466000447574914,0.0227465299029296,0.0410137474478663,8.18977268934496e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0197342697806325,0.00289311376126337,-0.0254047727527087,-0.0140637668085563,9.42384620966659e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNST,Consortin,42636,-0.0729784000119356,0.0107010525291843,-0.0939524629691368,-0.0520043370547343,9.5102961131753e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42611,-0.0261225166088592,0.00383826425749263,-0.0336455145535447,-0.0185995186641736,1.04745981362367e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.0608509413606475,0.00896230918434644,-0.0784170673619665,-0.0432848153593285,1.17140762667037e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.0717671423935708,0.0105695206977348,-0.0924834029611311,-0.0510508818260106,1.17770532995123e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0426085550758172,0.00627786384195521,-0.0549131682060494,-0.030303941945585,1.20329683909239e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0537341044510179,0.00793379307210332,-0.0692843388723405,-0.0381838700296954,1.31568877376486e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.0724533131235404,0.0107225160589708,-0.0934694445991232,-0.0514371816479576,1.47707523722621e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0458341741760718,0.00682002919397016,-0.0592014313962533,-0.0324669169558903,1.89791092624688e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0421978814413349,0.00628255319075075,-0.0545116856952063,-0.0298840771874634,1.93559671745061e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0248901118545032,0.00370645694248769,-0.0321547674617791,-0.0176254562472273,1.95170106624812e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.0586795525326286,0.00875803970430846,-0.0758453103530732,-0.0415137947121841,2.16704922989737e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.0601859893056271,0.00904329584956928,-0.0779108491707829,-0.0424611294404713,2.93690727649434e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.0213766331960674,0.00321251246811858,0.0150801087585549,0.0276731576335798,2.95892334309411e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.0165022306789073,0.00248128297843481,0.0116389160411751,0.0213655453166395,3.02878586234755e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0556850178790793,0.00838831282199179,-0.0721261110101832,-0.0392439247479753,3.29248791905758e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0130615561116877,0.00196792619350598,-0.0169186914509594,-0.00920442077241597,3.31950485786442e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.0232445648527368,0.00350330639557437,0.0163780843174111,0.0301110453880626,3.39622757529876e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.034550719445391,0.00521183466556276,0.024335523500888,0.044765915389894,3.5024101950536e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.0595459788863866,0.00898671039244493,-0.0771599312555787,-0.0419320265171946,3.57991727607291e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0264430512941291,0.00399442851251664,-0.0342721311786617,-0.0186139714095964,3.7329501427578e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0379794162885378,0.00574919191510139,-0.0492478324421365,-0.0267110001349391,4.0956511938539e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0175483354131935,0.00265765640691954,0.0123393288556312,0.0227573419707558,4.21183161633577e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0312556619836901,0.00474027078642246,-0.0405465927250782,-0.0219647312423021,4.45048583291898e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42754,-0.031992088514801,0.00485274465683099,-0.0415034680421898,-0.0224807089874123,4.48254872120973e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.0393631833600494,0.0059790412204353,-0.0510821041521025,-0.0276442625679962,4.76377283243282e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42495,-0.0447033435144825,0.00679374928728395,-0.0580190921175591,-0.031387594911406,4.87839101576057e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0239051786828733,0.00363306555373359,-0.0310259871681912,-0.0167843701975555,4.8826580717055e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.0382823979431145,0.00582365492046313,-0.0496967615872222,-0.0268680342990067,5.09245779455063e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.013932105051925,0.00212134840894403,0.00977426217039469,0.0180899479334553,5.30217028121251e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0344244554601793,0.00524472399704484,-0.0447041144943872,-0.0241447964259714,5.48126183996555e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.0136568525552116,0.00208426387914222,0.00957169535209283,0.0177420097583303,5.9157583140396e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.0455891441026889,0.00697142051250864,-0.0592531283072059,-0.031925159898172,6.39927969043547e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0270530316480094,0.004142617079654,-0.0351725611241312,-0.0189335021718875,6.84013812974419e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0502559932677249,0.00770547580474886,-0.0653587258450326,-0.0351532606904171,7.23861399089452e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0109788906020329,0.00168513950327581,-0.0142817640284535,-0.00767601717561237,7.57043026409771e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.019062612744295,0.00293437131212743,-0.0248139805160648,-0.0133112449725253,8.51956658726941e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42594,-0.0604974767604466,0.00931283359925184,-0.0787506306149802,-0.042244322905913,8.53172915454265e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.0465394000902068,0.00717541020398707,-0.0606032040900214,-0.0324755960903921,9.12887460052272e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42587,-0.0450576139334417,0.0069574272521237,-0.0586941713476042,-0.0314210565192793,9.73521259023055e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0341217937233757,0.00527039186637215,-0.0444517617814651,-0.0237918256652863,9.93457677182496e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0471229004462646,0.00728327347681844,-0.0613981164608288,-0.0328476844317005,1.02185438821567e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0382432756552598,0.00591605186290882,0.0266478140039585,0.0498387373065611,1.05319099043087e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,42476,0.031889517069957,0.00493320748247353,0.0222204304043089,0.0415586037356051,1.05356039727679e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,42476,-0.0402302556386854,0.00623598817653838,-0.0524527924647006,-0.0280077188126702,1.14736597222229e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0162117637150677,0.0025191535794192,-0.0211493047307294,-0.0112742226994061,1.27345955244611e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0228268503654475,0.00356257453553065,-0.0298094964550876,-0.0158442042758075,1.52953047882523e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,40527,-0.0176669783988889,0.00275732490519266,-0.0230713352130665,-0.0122626215847113,1.54002048242413e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.0660954655556066,0.010324024566416,-0.086330553705782,-0.0458603774054312,1.59350191596756e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42587,0.00967587412124241,0.00151236530000747,0.00671163813322776,0.0126401101092571,1.6283012871325e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.0651574325309442,0.0101931457400129,-0.0851359981813695,-0.0451788668805188,1.68845800753259e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0285968243731796,0.00447868106668562,-0.0373750392638834,-0.0198186094824758,1.76978239174129e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,40527,-0.0720305425271575,0.0113045184458707,-0.0941873986810641,-0.049873686373251,1.94020999494276e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42794,0.01898525743905,0.00298048444064478,0.0131435079353862,0.0248270069427138,1.95294976130466e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0269424746682461,0.00422926475502308,0.0186531157484009,0.0352318335880914,1.95934895000994e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42636,-0.0235012711361722,0.00368974449697215,-0.0307331703502376,-0.0162693719221068,1.96012532085763e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.0593537490609471,0.00932391653250643,-0.0776286254646597,-0.0410788726572345,2.00782744677235e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0426745985365365,0.00670888460586349,-0.055824012364029,-0.0295251847090441,2.07040595176855e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,42488,-0.0222733404230618,0.00350256867758781,-0.0291383750311339,-0.0154083058149896,2.09518084535376e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0182092814456502,0.00286541451807581,0.0125930689902216,0.0238254939010788,2.15281322414033e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.017618671994573,0.00277336625216045,0.0121828741403385,0.0230544698488075,2.19697954186474e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0128690101861884,0.00202700337122737,-0.016841936793794,-0.00889608357858272,2.24026315843078e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,40199,0.0193624333103413,0.00305183908090626,0.013380828711765,0.0253440379089176,2.31893708888516e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0183135709326232,0.00290018626036175,-0.0239979360029323,-0.0126292058623142,2.81031762980846e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0375456341337562,0.00594689738624542,0.0258897152567152,0.0492015530107973,2.81429720692975e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0527050914056402,0.0083618895487326,-0.0690943949211561,-0.0363157878901243,3.01262847460368e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0329568735414311,0.00526310591585724,-0.0432725611365113,-0.022641185946351,3.92013340219641e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0186122645534611,0.00297388189453324,-0.0244410730667463,-0.012783456040176,4.02852713035796e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0376499553482312,0.00601674258408503,-0.0494427708130379,-0.0258571398834245,4.03012378196507e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0410039629821361,0.00655587367845407,0.0281544505723661,0.0538534753919061,4.10816310985019e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.0281281127078062,0.00450589677599951,-0.0369596703887652,-0.0192965550268471,4.46013624375909e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42679,-0.0350429791035769,0.00561505269198691,-0.0460484823798713,-0.0240374758272826,4.48085975600466e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0242874607381756,0.00389536829073239,-0.0319223825880111,-0.0166525388883401,4.65377216209596e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0353970041829222,0.00569020072038024,-0.0465497975948675,-0.0242442107709769,5.09679039410219e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.0425453905816039,0.00684513598950755,-0.0559618571210387,-0.0291289240421691,5.29984688028438e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0193913905446104,0.00312072254095833,-0.0255080067248887,-0.013274774364332,5.35734418265072e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0169868702813078,0.00273453755653186,-0.0223465638921102,-0.0116271766705053,5.38666233429305e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0327437151319342,0.00528158035046421,-0.0430956126188441,-0.0223918176450243,5.82785439217831e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42711,-0.0145976221309769,0.00235632423913383,-0.0192160176396792,-0.00997922662227462,5.9944399895434e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0247520220444585,0.00400814799511551,-0.0326079921148849,-0.0168960519740321,6.78692448290463e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.0601731571938247,0.00974381420670063,-0.079271033038958,-0.0410752813486915,6.82183318310659e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.0626484070353934,0.0101509793813033,-0.0825443266227479,-0.0427524874480389,6.99009234834793e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.0335369986390694,0.00543591424628201,-0.0441913905617821,-0.0228826067163567,7.04387843681789e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0192103162426526,0.00311714320259094,-0.0253199169197308,-0.0131007155655744,7.38969373825913e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0224489553591646,0.00364470303082364,-0.0295925732995789,-0.0153053374187502,7.51253064650227e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0242161088726942,0.00393308616343597,-0.0319249577530287,-0.0165072599923597,7.62783871005728e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.0200971967338884,0.00327693416506858,0.013674405770354,0.0265199876974229,8.86953064122983e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0418825384873667,0.00682914894494662,-0.0552676704194621,-0.0284974065552713,8.87773846341622e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,40267,0.0183188685728744,0.00300613863569947,0.0124268368469034,0.0242109002988454,1.13914380677274e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.0505927950365397,0.00831407631720752,-0.0668883846182665,-0.034297205454813,1.20211713912219e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.0271075270256423,0.00445690733688055,-0.0358430654059282,-0.0183719886453564,1.218290358317e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0248954738856825,0.00410626237721295,-0.0329437481450199,-0.0168471996263451,1.38120519247237e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,42370,-0.0448166584479537,0.00739357601661849,-0.0593080674405259,-0.0303252494553815,1.38482997978047e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.029594376305935,0.00488354978549612,-0.0391661338855074,-0.0200226187263626,1.39830712932306e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,40283,-0.0307971803254731,0.00508888783753966,-0.0407714004870509,-0.0208229601638954,1.47820190385788e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0462279220791311,0.00765672364359765,-0.0612351004205825,-0.0312207437376797,1.61549671976794e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.0482413270809659,0.00799319874546615,-0.0639079966220795,-0.0325746575398522,1.62818729078818e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0409211187361491,0.00678242740299065,-0.0542146764460107,-0.0276275610262874,1.65696359533671e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0158679418146507,0.00263054676197848,0.0107120701611729,0.0210238134681286,1.66804264650313e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.0651001134768753,0.0108201745699555,-0.0863076556339881,-0.0438925713197624,1.82907992316621e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0387654776381327,0.00644621152660891,0.0261309030459792,0.0514000522302861,1.86050600912083e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0382049177474151,0.00635353380471425,-0.050657844004655,-0.0257519914901751,1.87552201236576e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0268237659681955,0.0044626837392814,-0.0355706260971871,-0.018076905839204,1.89538042349422e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,42141,0.0191820552009424,0.00319206550867387,0.0129256068039416,0.0254385035979432,1.91340637607748e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0164532675743137,0.00273854866391193,-0.0218208229555811,-0.0110857121930463,1.92636195640303e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0248795108739048,0.00414737604048312,-0.0330083679132517,-0.0167506538345579,2.03801975328169e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.0562684970821224,0.00938959389837762,-0.0746721011229425,-0.0378648930413022,2.11708256932168e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_E,,42594,-0.0182423942378607,0.00304487231450151,-0.0242103439742837,-0.0122744445014378,2.13658372006849e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,40511,-0.0191075628562942,0.00319107922322393,-0.0253620781338132,-0.0128530475787753,2.19146461599378e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.0119628410872405,0.00200079395250273,0.00804128494033515,0.0158843972341458,2.30108376524704e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42587,-0.0315413333075676,0.00529024818352401,-0.0419102197472747,-0.0211724468678606,2.55181952020598e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0250037796017815,0.00419428230967456,-0.0332245729287436,-0.0167829862748194,2.56385167603384e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0368739888398576,0.00618979521319753,-0.0490059874577248,-0.0247419902219905,2.63115518917198e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0341230103865381,0.00573612365921815,-0.0453658127586056,-0.0228802080144705,2.76862461446284e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0370538233954216,0.00623906374833075,-0.0492823883421499,-0.0248252584486933,2.93840124805533e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0421201210686473,0.007094225803071,-0.0560248036426665,-0.0282154384946281,2.97168696324622e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0185756380541128,0.00312878433075642,0.0124432207658302,0.0247080553423954,2.97430313513533e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0372243524167425,0.00627606020426873,-0.0495254304171092,-0.0249232744163758,3.09607264243361e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0347952544821383,0.00587806960365481,0.0232742380589749,0.0463162709053017,3.30735800432232e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.0726281859168456,0.0122712010700883,-0.0966797400142186,-0.0485766318194725,3.34703224797845e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42587,-0.0187507001984048,0.00317374704091048,-0.0249712443985894,-0.0125301559982203,3.54556277396628e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAYN,Layilin,42476,-0.0220674814441007,0.00373921262868711,-0.0293963381963274,-0.014738624691874,3.6868353384007e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.0534873227317577,0.00906394864972569,-0.0712526620852201,-0.0357219833782954,3.69690159999448e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42721,-0.0233497945779676,0.00395864007315615,-0.0311087291213536,-0.0155908600345815,3.75721944551231e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.0485769752043625,0.00824954337786788,-0.0647460802249835,-0.0324078701837414,4.01155481733732e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.0395084995605404,0.00671493446564377,-0.0526697711132022,-0.0263472280078786,4.12616974892786e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0202731310707117,0.00344710994826924,-0.0270294665693194,-0.013516795572104,4.16927510302191e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.025847785723503,0.0044015541649284,-0.0344748318867626,-0.0172207395602433,4.41795774546882e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.046659322721343,0.00794689535229635,-0.0622352376118438,-0.0310834078308421,4.44345229982067e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0291953183251439,0.00497996583582555,-0.038956051363362,-0.0194345852869259,4.66517036193285e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0163330264366954,0.0027880793591354,-0.0217976619806007,-0.01086839089279,4.78926432399735e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.0475200428043828,0.00811389314452469,-0.0634232733676512,-0.0316168122411144,4.83367888162245e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.0163751048467781,0.00279965360498651,-0.0218624259125517,-0.0108877837810045,5.06076702216725e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.0159267400488157,0.00272485045485134,0.0105860331573071,0.0212674469403243,5.18190132768735e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.0229183743072507,0.00392525976945467,-0.0306118834553818,-0.0152248651591195,5.3855841883962e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0374156515846685,0.00642096048516065,-0.0500007341355834,-0.0248305690337537,5.76798826256834e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42587,0.0267310562290894,0.00459021235347231,0.0177342400162837,0.0357278724418951,5.89533223440997e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0388099983579809,0.00667048461694524,-0.0518841482071936,-0.0257358485087682,6.08587326360053e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42611,0.0256732415738128,0.00442182237027628,0.0170064697280713,0.0343400134195543,6.54184826102037e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0174142907534879,0.0030000955825956,-0.0232944780953753,-0.0115341034116005,6.62703636661342e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0335555529736507,0.0057895196408948,-0.0449030114698045,-0.0222080944774969,6.98121733185993e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0193629251068042,0.00334542123628821,-0.0259199507299291,-0.0128058994836793,7.29304707172918e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0305103298914378,0.0052720301650593,-0.040843509014954,-0.0201771507679215,7.35455587548152e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0437378289086693,0.007561080334743,-0.0585575463647656,-0.0289181114525731,7.43089612364589e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42562,-0.0205383721763872,0.00355158758155816,-0.0274994838362412,-0.0135772605165332,7.50785110518152e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,42311,-0.0183833002119488,0.00317928692654554,-0.0246147025879781,-0.0121518978359196,7.54058309254783e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.0207893571986222,0.00360124492627652,0.0137309171431202,0.0278477972541241,7.969332065807e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,40483,-0.0215012184085871,0.0037342732914947,-0.0288203940599167,-0.0141820427572575,8.74365080295284e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0468988082368025,0.00815580186718102,-0.0628841798964773,-0.0309134365771277,9.13701610567371e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0406081355585951,0.00706196134082758,-0.0544495797866172,-0.0267666913305731,9.14227421724868e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0341226395035154,0.00594119013537536,-0.0457673721688511,-0.0224779068381797,9.48083655640742e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0156020458934759,0.00272189552339455,-0.0209369611193292,-0.0102671306676226,1.01837545093544e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.030972134434033,0.00541044322517811,-0.0415766031553821,-0.0203676657126839,1.06445669016728e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0785831729083932,0.0137610256283522,-0.105554783139963,-0.051611562676823,1.14996482230919e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0324338706988607,0.00568928956439925,-0.0435848782450832,-0.0212828631526381,1.22190375668886e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.014445152554259,0.00253497101894098,0.00947660935713466,0.0194136957513833,1.23511215462483e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,40483,0.0210724012572321,0.00369844432454058,0.0138234503811325,0.0283213521333316,1.24517095935564e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0373421068426211,0.00655422766454029,-0.0501883930651201,-0.0244958206201222,1.24741230238178e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0267565437685444,0.00470437470534315,-0.035977118191017,-0.0175359693460718,1.31590250624342e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.047419627338145,0.00834939442304851,-0.0637844404073201,-0.0310548142689699,1.38587183967813e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42677,0.0235182377189912,0.00414280089100642,0.0153983479726186,0.0316381274653638,1.39990785726614e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,42475,-0.0285458879095284,0.00503233690750261,-0.0384092682482335,-0.0186825075708233,1.43672430042669e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0132089861898193,0.00233357845084296,-0.0177827999534715,-0.00863517242616709,1.54072349231366e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,40054,-0.0406837467097153,0.0071882863484441,-0.0547727879526658,-0.0265947054667649,1.55455496944313e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.0224277856431407,0.00396495722830632,0.0146564694756603,0.0301991018106211,1.5764561228998e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.0520330641728711,0.00922700516439282,-0.070117994295081,-0.0339481340506612,1.74238551046034e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0433665266098017,0.00769103271479588,-0.0584409507308016,-0.0282921024888018,1.75562482060156e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.0632741672943015,0.0112278474624341,-0.0852807483206724,-0.0412675862679305,1.78779970867739e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0254641995146617,0.00452556279658971,-0.0343343025959775,-0.0165940964333458,1.87303969504872e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0322113465962181,0.0057274464308648,-0.0434371416007131,-0.0209855515917231,1.9099547934749e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0147681316809649,0.00262892187590296,-0.0199208185577347,-0.0096154448041951,1.9750154522714e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0216095597993698,0.0038468782208889,-0.0291494411123121,-0.0140696784864276,1.97745534813218e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42611,0.0133655899861662,0.00237949869795956,0.00870177253816543,0.0180294074341669,1.98188956697678e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.0360904450942489,0.00642770651129646,-0.04868874985639,-0.0234921403321079,2.00745433170473e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0282455384224581,0.00503147964976255,-0.0381072385359927,-0.0183838383089235,2.02730348164398e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.0176064322131472,0.00313766790525128,0.0114566031188547,0.0237562613074398,2.04719732977265e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0186093342437949,0.00331761107056403,-0.0251118519421003,-0.0121068165454894,2.08179663893076e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.0413143733672106,0.00736913878498428,-0.0557578853857798,-0.0268708613486414,2.10730684280413e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELN,Elastin,40511,-0.0203564353207781,0.00363133363379687,-0.02747384924302,-0.0132390213985363,2.12180653406416e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0223184970287624,0.00398483872097137,-0.0301287809218663,-0.0145082131356585,2.17575872771348e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0343201411371664,0.006128587986697,-0.0463321735910926,-0.0223081086832403,2.19522846230747e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,42311,-0.03724842142904,0.00665318360325348,-0.0502886612914168,-0.0242081815666631,2.20444753865333e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.0244789279803731,0.00437292086413147,-0.0330498528740708,-0.0159080030866754,2.22189122848849e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.016032579066194,0.00286488256175022,-0.0216477488872245,-0.0104174092451636,2.24168476954048e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.0458148694877436,0.00820548437108938,-0.0618976188550788,-0.0297321201204084,2.40383927232412e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42636,-0.0195636520757822,0.00351327562622786,-0.0264496723031888,-0.0126776318483756,2.61878125673461e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42754,-0.0190599476666374,0.00342624353433383,-0.0257753849939317,-0.0123445103393431,2.70306874719576e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0175909520188745,0.00316540652151784,0.0113867552366995,0.0237951488010494,2.80390003058336e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.0536286063914976,0.009660606887797,-0.0725633958915798,-0.0346938168914155,2.8893199181502e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,40483,-0.015749592897251,0.00284039017335694,-0.0213167576370306,-0.0101824281574714,3.00788663034352e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.0186449844772495,0.00336796699912935,0.012043769158956,0.0252461997955431,3.15299749922822e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0264565800784789,0.00478439698051853,0.0170791619966626,0.0358339981602952,3.26708512509577e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RETN,Resistin,42598,-0.0236876299822392,0.00428413239614916,-0.0320845294786916,-0.0152907304857869,3.27795836794439e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0324758069457195,0.00587430316858076,-0.0439894411561377,-0.0209621727353012,3.30270496265715e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0332029799134038,0.00600722340433219,-0.0449771377858949,-0.0214288220409127,3.31638568346418e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.0519664428022952,0.00940264086821481,-0.0703956189039962,-0.0335372667005942,3.32284492021673e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0414292959249048,0.00749766197902533,-0.0561247134037945,-0.0267338784460152,3.3561297748904e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0169111909481667,0.00306473540695313,-0.0229180723457949,-0.0109043095505386,3.50479914449926e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,40532,-0.0155244816034326,0.00281819296215436,-0.0210481398092552,-0.0100008233976101,3.69454782280376e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42754,-0.0314042823201708,0.00570313709059329,-0.0425824310177337,-0.020226133622608,3.72712141013916e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.040535512399579,0.00736092857129772,-0.0549629323993225,-0.0261080923998355,3.73502820308076e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0260748738575581,0.00474425031995543,-0.0353736044846707,-0.0167761432304454,3.9674111487816e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,40283,-0.038747735323159,0.00705007965686301,-0.0525658914506105,-0.0249295791957075,3.96936305942563e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0223515177524055,0.00406761890365292,-0.0303240508035652,-0.0143789847012457,3.97820781735323e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0126584501403958,0.00230436773509292,-0.0171750109011779,-0.00814188937961364,4.03331282527329e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0152874835203472,0.0027840001632896,-0.0207441238403948,-0.00983084320029955,4.06522652278619e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0280746330720425,0.00511528248900394,-0.0381005867504902,-0.0180486793935948,4.12935838630099e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.029778584907608,0.00543773855587338,-0.0404365524771199,-0.0191206173380962,4.42329367095809e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0302903539077849,0.00553528808750024,-0.0411395185592854,-0.0194411892562844,4.53881463936403e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0620477824671732,0.0113415960728795,-0.0842773107700171,-0.0398182541643293,4.56101177767154e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0289169960558922,0.00528677439101403,-0.0392790738622797,-0.0185549182495048,4.58841941292892e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0441254289778348,0.00806947503344061,-0.0599416000433784,-0.0283092579122912,4.62797073128649e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,0.0157262757491544,0.00287829461637947,0.0100848183010507,0.0213677331972582,4.74608815824694e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0209021866732522,0.00383133172423529,-0.0284115968527534,-0.013392776493751,4.96734743383168e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0151444988231603,0.00277741690015409,-0.0205882359474623,-0.00970076169885829,5.04763468678091e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0277390328461664,0.00509150964022042,0.0177596739513344,0.0377183917409984,5.19763039900219e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0187002654498103,0.00343369775928633,-0.0254303130580115,-0.0119702178416091,5.23908439401945e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0238714914913664,0.00438285636344429,0.0152810930190156,0.0324618899637172,5.24554625001023e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42669,-0.0161115332132771,0.00296022325350647,-0.0219135707901498,-0.0103094956364044,5.3404383544929e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0177254784823773,0.00325948331339537,-0.0241140657766322,-0.0113368911881223,5.48060629859653e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0231308736169253,0.00425608296382505,-0.0314727962260223,-0.0147889510078282,5.60048155216881e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0174740785093331,0.00321682643608634,-0.0237790583240623,-0.0111690986946039,5.68821601115368e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0153629840402343,0.0028317537543759,-0.0209132213988111,-0.00981274668165759,5.88636747704508e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0194480706113562,0.00358464581298908,-0.0264739764048148,-0.0124221648178976,5.90191103745055e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0348186639612536,0.00642005766658802,-0.0474019769877661,-0.0222353509347411,5.96967481563313e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0244966692210146,0.00451737987655382,-0.0333507337790601,-0.0156426046629691,5.99149586093e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0417591929341382,0.00771896320572656,-0.0568883608173622,-0.0266300250509141,6.41495171469119e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0151726677478386,0.00281465691718384,-0.0206893953055189,-0.00965594019015825,7.14052060885208e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0258630910191928,0.00480572196985171,0.0164438759582835,0.0352823060801021,7.50157925559987e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0361889384003433,0.00673214830668431,-0.0493839490814446,-0.0229939277192421,7.79253622339061e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.029971353014742,0.00558633411914233,-0.040920567888261,-0.0190221381412231,8.25360181311768e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,40440,-0.0153872011901715,0.00286899418151627,-0.0210104297859434,-0.00976397259439965,8.3346484447573e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0442720229770865,0.00827774586884135,-0.0604964048800156,-0.0280476410741575,9.02342732184078e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0186298905848854,0.00349250518759451,-0.0254752007525706,-0.0117845804172001,9.75019532839264e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0260695818042029,0.00489188469010615,-0.0356576757968109,-0.0164814878115948,1.00662689149965e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42676,-0.0240516080235992,0.00452877441453602,-0.0329280058760898,-0.0151752101711087,1.10853076820026e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0562518957702539,0.0106050289534942,-0.0770377525191025,-0.0354660390214053,1.14940209036355e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42594,0.0226972365411436,0.00428119392387049,0.0143060964503574,0.0310883766319298,1.16605836223441e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0278764286471874,0.00526260257211924,-0.0381911296885411,-0.0175617276058336,1.1954480811473e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDK,Midkine,42638,-0.0267130029945076,0.00504326689579317,-0.0365978061102622,-0.0168281998787529,1.19730359711746e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.0327699229048852,0.0061888162068518,-0.0449000026703148,-0.0206398431394557,1.20865352039764e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0157898509345578,0.00298248098144524,-0.0216355136581905,-0.00994418821092512,1.21409589156964e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0408874360080649,0.00773959255047066,-0.0560570374069874,-0.0257178346091424,1.29569343715439e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0326260711376011,0.00618166705236274,-0.0447421385602321,-0.0205100037149701,1.33170596288877e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.0566010798162852,0.0107545212040512,-0.0776799413762257,-0.0355222182563448,1.44353027261911e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0210085032130513,0.00399308599331396,-0.0288349517599467,-0.0131820546661559,1.45304081695107e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42587,-0.0528319951094197,0.0100526704566213,-0.0725352292043974,-0.033128761014442,1.49874313754048e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0199597816088229,0.00380326224586243,-0.0274141756107132,-0.0125053876069325,1.5654008019738e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0251887334878753,0.00481102059485474,0.0157591331219601,0.0346183338537906,1.67436997015607e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0227078556900679,0.00434447561175774,-0.0312230278891131,-0.0141926834910228,1.75594776188059e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.037745648668265,0.00722250778450238,-0.0519017639258897,-0.0235895334106403,1.76204029686539e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,40223,-0.0270793817324991,0.00518194184523759,-0.0372359877491648,-0.0169227757158334,1.76645561456831e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.0349714838465255,0.00669874583232976,-0.0481010256778918,-0.0218419420151591,1.81586831967005e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,0.0124953365101362,0.00239547817034443,0.00780019929626107,0.0171904737240112,1.85331229953094e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,40499,-0.0227001884695803,0.00435187879094759,-0.0312298708998376,-0.014170506039323,1.85879527964998e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0393503051955745,0.00754411066469353,-0.0541367620983738,-0.0245638482927752,1.86112702793322e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.0373452720276576,0.00716789382619063,-0.0513943439269912,-0.0232962001283239,1.91546817739785e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0219676637867264,0.0042181939558251,-0.0302353239401436,-0.0137000036333092,1.93854830073181e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0221779905542433,0.00425942152323885,-0.0305264567397915,-0.0138295243686952,1.94956051432685e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0423740482338497,0.00814074499983897,-0.0583299084335341,-0.0264181880341653,1.97203661009263e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.0558704790572383,0.010763077849946,-0.0769661116431325,-0.0347748464713441,2.12896948892589e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42636,-0.0280944020545951,0.00541374443077254,-0.0387053411389093,-0.017483462970281,2.13977714976505e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.042079955670415,0.00812310149901562,-0.0580012346084856,-0.0261586767323444,2.25370262727423e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0287201915956586,0.00554800752757617,-0.0395942863497079,-0.0178460968416093,2.29152619459436e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0198019668792348,0.00382655167424364,-0.0273020081607524,-0.0123019255977173,2.31352793023594e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0216056346172238,0.00417732919480622,0.0134180693954037,0.029793199839044,2.35422561771569e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,40539,0.0373291121820913,0.0072190565545124,0.023179761335247,0.0514784630289356,2.36921193229522e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0335746293412632,0.00650187548851573,-0.046318305298754,-0.0208309533837724,2.45470146656734e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0215982548817926,0.00418325255914995,-0.0297974298977265,-0.0133990798658587,2.46528017862241e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0295354319764095,0.00572403427263865,-0.0407545391507813,-0.0183163248020378,2.51355572381071e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0321999652649024,0.00624114879850377,-0.0444326169099698,-0.019967313619835,2.52079751584815e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0423934831968569,0.0082238967347568,-0.0585123207969802,-0.0262746455967335,2.57359643803709e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0251142825277498,0.00487495374100205,0.0155593731953858,0.0346691918601139,2.61789567741519e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0398733270756962,0.0077431613024092,-0.0550499232284183,-0.0246967309229742,2.65596508868682e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42585,-0.0444721069339336,0.0086412350589686,-0.061408927649512,-0.0275352862183551,2.69149026890748e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0354517174841313,0.00689282903558039,-0.0489616623938689,-0.0219417725743938,2.74529636849296e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2,Brorin,42456,-0.0209197681218615,0.00406785532146191,-0.0288927645519269,-0.0129467716917962,2.74674041988464e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.0144793375018027,0.00281633883027403,-0.0199993616091398,-0.00895931339446561,2.76920088833606e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.0175352549041075,0.0034145442320339,-0.0242277615988939,-0.0108427482093211,2.86267562033675e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42711,-0.0303066472337476,0.00590285734931302,-0.0418762476384011,-0.0187370468290941,2.87231554746472e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.0567883491431054,0.0110597751834839,-0.0784655085027338,-0.035111189783477,2.87417074041307e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0428550047428871,0.00835268768470731,-0.0592262726049134,-0.0264837368808607,2.92724981004695e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0419722248044382,0.00818240095147673,-0.0580097306693326,-0.0259347189395438,2.94459600675124e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42711,-0.0116723669050534,0.00227946946455132,-0.016140127055574,-0.00720460675453281,3.08669333969729e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.0492057595251656,0.00961177285565487,-0.0680448343222491,-0.030366684728082,3.11684819737894e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0302174142304955,0.00590992227697411,-0.0418008618933648,-0.0186339665676263,3.21492477539272e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.0200730993250807,0.00392609423180913,0.0123779546307348,0.0277682440194266,3.21844453729869e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0290120829681989,0.00568155293431699,-0.0401479267194602,-0.0178762392169376,3.32954440363275e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0286491763864108,0.00562161466360682,-0.0396675411270801,-0.0176308116457414,3.51246105495182e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42566,-0.023355415970756,0.00458966235056188,-0.0323511541778572,-0.0143596777636547,3.6541627553834e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0140269232086269,0.00275790244768609,-0.0194324120060916,-0.00862143441116214,3.70440180163049e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.0520214440146837,0.0102535228266614,-0.07211834875494,-0.0319245392744273,3.96734287273929e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0359359456947643,0.00708670836595101,-0.0498258940920283,-0.0220459972975003,4.0127832868258e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0192406887819353,0.00379456744948962,-0.026678040982935,-0.0118033365809357,4.01997389433908e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0383053110939884,0.00755457560743053,-0.0531122792845523,-0.0234983429034246,4.02124276910748e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.0333616042668225,0.00658762603558327,-0.0462733512965657,-0.0204498572370793,4.15504130275224e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0342416710312303,0.00676775268893052,-0.0475064663015341,-0.0209768757609264,4.25826989725139e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0105909089107471,0.00209308546674606,-0.0146933564255693,-0.00648846139592477,4.25982114973196e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0117958931539427,0.00233315805163628,-0.0163688829351498,-0.00722290337273556,4.34374770803966e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.0484601884568936,0.00958953015981606,-0.067255667570133,-0.0296647093436541,4.39730640203967e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0161795403460677,0.0032020900316187,-0.0224556368080403,-0.00990344388409502,4.4105837703038e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.0421592794508227,0.00836315545638548,-0.0585510641453383,-0.0257674947563072,4.69072976540499e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,40483,-0.0115618071059054,0.0022935058231704,-0.0160570785193194,-0.00706653569249142,4.70025071854687e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,42370,0.0155735045355677,0.00309040335140343,0.00951631396681695,0.0216306951043184,4.73403261668965e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42494,-0.0347441156787936,0.00689570876981424,-0.0482597048676295,-0.0212285264899577,4.75320548638436e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.0454886817113147,0.00903497469854296,-0.0631972321204589,-0.0277801313021705,4.85881806565001e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42771,0.0235489654926129,0.00467982735752789,0.0143765038718583,0.0327214271133676,4.91556800040028e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.0359760458954792,0.00715818801690704,-0.050006094408617,-0.0219459973823414,5.09046282899969e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.0156088828812277,0.00310998116848862,0.00951331979098997,0.0217044459714654,5.27428763847615e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.0170641881836101,0.00340120366042136,-0.023730547358036,-0.0103978290091843,5.31289284568861e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.00980696551615444,0.00195690548107216,-0.0136425002590559,-0.005971430773253,5.47248341496108e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0254857666316797,0.00509433271362454,-0.0354706587503838,-0.0155008745129756,5.7244386243198e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0332603743569887,0.00665685678311174,-0.0463078136518877,-0.0202129350620897,5.93124509320275e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0232423520406535,0.00465415527031813,-0.032364496370477,-0.0141202077108299,5.99100620227242e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42642,-0.0463794242206777,0.00928805323502652,-0.0645840085613297,-0.0281748398800257,6.00537067910142e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0192021669757087,0.00384585590772356,-0.0267400445548468,-0.0116642893965705,6.02106531720311e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0152911382855015,0.00306542012638702,-0.02129936173322,-0.00928291483778289,6.18300704826738e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42794,0.0201790503617396,0.00404762507206029,0.0122457052205014,0.0281123955029777,6.25936662713576e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.013303258747484,0.00267336940388794,-0.0185430627791044,-0.00806345471586366,6.57918815425683e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.0132528303635464,0.002663920239049,0.00803154669501033,0.0184741140320824,6.60668250114525e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.0301932814245853,0.00607345599487272,0.0182893076746347,0.0420972551745358,6.7318275281919e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,40509,0.0178615243306122,0.00359714872659009,0.0108111128264956,0.0249119358347287,6.95357274271124e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.0135086089422265,0.00272705468549218,0.00816358175866188,0.0188536361257912,7.37535859104146e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,40494,-0.0229146162181577,0.00464738471275688,-0.0320234902551612,-0.0138057421811542,8.31225311716944e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,42333,-0.0246684247328415,0.00500514256604748,-0.0344785041622946,-0.0148583453033885,8.38242974498314e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.0249355714056367,0.00506582126414844,0.0150065617279057,0.0348645810833676,8.67388114749586e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.0313520899099497,0.00638519840485389,-0.0438670787834633,-0.0188371010364361,9.23253194112174e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,40482,0.0234359177916722,0.00478999709963031,0.0140475234763968,0.0328243121069476,1.00846405630201e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0338215450188854,0.0069167614071935,-0.0473783973769847,-0.0202646926607862,1.02336054651535e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0230237257999068,0.00473593496692142,-0.0323061583350728,-0.0137412932647408,1.17838978640032e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,40283,-0.0158256069059344,0.00325560171659132,-0.0222065862704534,-0.00944462754141539,1.18372302583148e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0193583753625084,0.00398738180348324,-0.0271736436973356,-0.0115431070276813,1.22056324415799e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.044945853837438,0.00925939139664843,-0.0630942609748689,-0.0267974467000071,1.22309266834744e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0350833033719703,0.00723667184686671,-0.049267180191829,-0.0208994265521115,1.26114285019678e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.0250177416432502,0.00517415395160858,-0.035159083388403,-0.0148763998980974,1.34559593338773e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.0214665874568539,0.00444074301997939,0.0127627311376943,0.0301704437760136,1.35286285638151e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0253235463898974,0.00523959559902654,-0.0355931537639894,-0.0150539390158054,1.35898693134887e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0351742868236142,0.00729249273226795,-0.0494675725788594,-0.020881001068369,1.43002899213249e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,40451,-0.0292237229235944,0.00606329607993018,-0.0411077832402576,-0.0173396626069312,1.45598218874445e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0440981893706636,0.00915229039180796,-0.0620366785386072,-0.02615970020272,1.46424750650071e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0106293720941078,0.00220741843078195,0.00630283196977515,0.0149559122184404,1.48587002140211e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0195968665689696,0.00407152661584268,-0.0275770587360213,-0.0116166744019179,1.5017565127546e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.0169556767065683,0.0035318526214285,0.0100332455685684,0.0238781078445681,1.59786495581734e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.0142202910195818,0.00296356076867562,-0.020028870126186,-0.00841171191297756,1.61711199955824e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0143806783389043,0.00299729876615258,-0.0202553839205634,-0.00850597275724523,1.6241850985628e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0204843517855672,0.00427605506282338,-0.0288654197087011,-0.0121032838624334,1.68501123060177e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0147783474721459,0.00308719067810556,-0.0208292412012328,-0.00872745374305901,1.7109166152344e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0298825940476041,0.0062499249208023,-0.0421324468923766,-0.0176327412028316,1.76383956871655e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0302319609493694,0.00632299644801258,-0.0426250339874741,-0.0178388879112647,1.76397213341802e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0398557419040625,0.0083360839851878,-0.0561944665150306,-0.0235170172930944,1.76537691322064e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42636,-0.0177724386396558,0.00371765674310596,-0.0250590458561434,-0.0104858314231681,1.76669553690743e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0315277868780765,0.00659726357766657,-0.044458423490303,-0.0185971502658501,1.78537441116233e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0210099227182965,0.00439776593856775,-0.0296295439578893,-0.0123903014787038,1.79449075175545e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0207004493529938,0.00433595586496728,-0.0291989228483296,-0.0122019758576579,1.82484271137914e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42538,-0.0339066200958243,0.00710254880803761,-0.047827615759578,-0.0199856244320706,1.8264049581748e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0270975498917509,0.00568002775299222,-0.0382304042876156,-0.0159646954958861,1.85531227288395e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,40532,-0.0382879865174897,0.00803626751676266,-0.0540390708503445,-0.0225369021846349,1.91767185072163e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0710034244456741,0.014919254069974,-0.100245162422823,-0.0417616864685251,1.96410814992454e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0227063741422472,0.00477339502783884,-0.0320622283968114,-0.0133505198876831,1.98676006314043e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.0641479486168692,0.0135051245133244,-0.0906179926629851,-0.0376779045707533,2.05631386678544e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.0125823978649938,0.00265341526372328,0.00738170394809614,0.0177830917818914,2.1423383176771e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0223011758037685,0.00470348445256987,-0.0315200053308054,-0.0130823462767315,2.14832784659904e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0455991919513239,0.00961839714363535,-0.0644512503528492,-0.0267471335497986,2.15031314605152e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0237673121085843,0.00501479849440236,-0.0335963171576129,-0.0139383070595556,2.16559496529695e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.0103925477017761,0.00219318518757608,0.00609390473412697,0.0146911906694252,2.17912240821584e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0186869795576876,0.00394371292503297,-0.0264166568907522,-0.0109573022246229,2.18023264077865e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0370098751214595,0.00781795367164344,-0.0523330643178806,-0.0216866859250383,2.22865972029159e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.0141408977670933,0.00298822310156217,0.00828398048803142,0.0199978150461551,2.24324962487358e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42611,-0.0207580441787716,0.00438656786453772,-0.0293557171932655,-0.0121603711642776,2.24384259707331e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0331834127634496,0.00701558792583589,-0.0469339650980879,-0.0194328604288112,2.27290946263741e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,40483,-0.0261710887824831,0.00553578469607772,-0.0370212267867954,-0.0153209507781708,2.29913512843755e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0355700414808264,0.00753152573527689,-0.0503318319219691,-0.0208082510396837,2.3496089147745e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,40449,-0.0486016667151338,0.0102900032765901,-0.0687700731372504,-0.0284332602930171,2.34976897226068e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0239161122346565,0.00506372153883052,-0.0338410064507643,-0.0139912180185487,2.35163678720338e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,40532,0.0273151651955406,0.00578645218353214,0.0159737189158176,0.0386566114752636,2.38037998426181e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42711,-0.0210343940249597,0.00446529856245306,-0.0297863792073677,-0.0122824088425517,2.49403355323534e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,40269,-0.027415861792126,0.00581984554214457,-0.0388227590547294,-0.0160089645295226,2.49802648630896e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0326993041705017,0.00694626789131149,-0.0463139892374722,-0.0190846191035311,2.53801470390811e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0221179485418101,0.00469936141649674,-0.0313286969181437,-0.0129072001654765,2.54964993298317e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.0280180391073456,0.00595508232321054,-0.0396900004608382,-0.0163460777538529,2.56582468901751e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.0559821929794846,0.011909225534661,-0.0793242750274202,-0.032640110931549,2.62369201245885e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,42445,0.0178827409649052,0.0038060205334898,0.0104229407192651,0.0253425412105452,2.64661710565217e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0202006945381905,0.00430043499398494,-0.028629547126401,-0.01177184194998,2.66181699610066e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.0129491400251629,0.00275702782756108,0.00754536548314314,0.0183529145671826,2.66926037260743e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0101421428931861,0.00216200372805671,0.0059046155861949,0.0143796702001772,2.74475068295636e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0342774692552798,0.00730842440490702,-0.0486019810888975,-0.019952957421662,2.75722058064544e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0245071598215636,0.00523353221461136,-0.0347648829622019,-0.0142494366809253,2.86517193163303e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42563,-0.0168631162171331,0.0036048505211585,-0.0239286232386038,-0.00979760919566245,2.92672698459941e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLU,Clusterin,40539,0.0146598517567979,0.00313417369935006,0.00851687130607183,0.0208028322075241,2.93859238195938e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0140439525155896,0.00300402895813358,-0.0199318492735314,-0.00815605575764774,2.96762238621699e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0281069224973262,0.00602201939834162,-0.0399100805180757,-0.0163037644765766,3.08018109380814e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.021665332710216,0.00464360943295991,-0.0307668071988174,-0.0125638582216146,3.11229663530883e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42636,-0.0114572950170275,0.00245734470352921,-0.0162736906359448,-0.00664089939811029,3.15442861064676e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.0166987321683678,0.00358363523253688,0.00967480711259546,0.02372265722414,3.20263461781887e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0136026777326802,0.00292277602748335,-0.0193313187465476,-0.00787403671881285,3.29210714509035e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0311062786177254,0.00668812400534694,-0.0442150016682054,-0.0179975555672454,3.34135765505455e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0400400423491909,0.00861169158982215,0.0231611268331395,0.0569189578652424,3.35906566451353e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0471263257843582,0.0101472527160795,-0.0670149411078741,-0.0272377104608423,3.44551928980865e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.015016177788846,0.00323814225529653,-0.0213629366092272,-0.00866941896846478,3.5705594833955e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00804357769384434,0.00173475544621186,0.0046434570192691,0.0114436983684196,3.5731242508229e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42594,-0.0151643045584895,0.00328180810061437,-0.0215966484356937,-0.00873196068128537,3.85981970334029e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,42261,-0.03318862002126,0.00718453106942833,-0.0472703009173396,-0.0191069391251805,3.8842315748958e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.0106946111042927,0.00231809178626348,0.00615115120321629,0.0152380710053691,3.9950272164376e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42638,0.0134904988724325,0.00293029661408281,0.00774711750883023,0.0192338802360349,4.186517267131e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.0196248703426025,0.00426345209130475,-0.0279812364415599,-0.0112685042436452,4.20243793005846e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0180204098474879,0.00391494338006211,-0.0256936988724097,-0.0103471208225662,4.21042926858508e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0408040964360641,0.0088766326212474,-0.058202296373709,-0.0234058964984192,4.33687367135442e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0166081776854766,0.00361914903424286,0.00951464557836061,0.0237017097925926,4.49427352088486e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.0155071656560739,0.00338368446690959,-0.0221391872112167,-0.00887514410093111,4.62711229864835e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0105275659634287,0.00230157915473344,-0.0150386611067062,-0.00601647082015116,4.82640878769311e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0300639121408061,0.00658827393359632,-0.0429769290506549,-0.0171508952309573,5.08109849821016e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42636,-0.0541551088621681,0.0118719940665506,-0.0774242172326073,-0.0308860004917289,5.12179038700638e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0163163523666295,0.00357843089678184,-0.0233300769243219,-0.00930262780893712,5.18007477834691e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0158853404788186,0.00348929332275033,-0.0227243553914093,-0.009046325566228,5.34546490498921e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42652,0.0206258712668098,0.00453397230460174,0.0117392855497904,0.0295124569838292,5.43252382617809e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0424312618901567,0.00933517177398231,-0.0607281985671621,-0.0241343252131514,5.53376787861891e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.017866333757748,0.00393375563015611,-0.025576494792854,-0.010156172722642,5.62715800680351e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0171219270609679,0.00377203397380077,-0.0245151136496174,-0.00972874047231835,5.69748923653056e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.00884435620890777,0.00194910681809302,0.00502410684544545,0.0126646055723701,5.73805163854023e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0342596541058986,0.00755111554684143,-0.0490598405777078,-0.0194594676340894,5.76419754684631e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0185023006908192,0.00407858844151844,-0.0264963340361953,-0.010508267345443,5.77007986113763e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.039709658385726,0.00875770305776235,-0.0568747563789402,-0.0225445603925118,5.84023509130931e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.0120272739072165,0.00265272694603348,-0.0172266187214422,-0.00682792909299091,5.84911300022809e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,40302,-0.0245206467965015,0.00541221625076754,-0.0351285906480059,-0.0139127029449972,5.9426871856819e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.03271994046924,0.00722743233784381,-0.0468857078514138,-0.0185541730870661,6.0285658548725e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.0495038380396442,0.0109361276638351,-0.0709386482607609,-0.0280690278185274,6.04516111781682e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0349379910164409,0.00772143094288344,-0.0500719956644925,-0.0198039863683894,6.09816654403949e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.0166050519674506,0.00367190616584524,0.00940811588239396,0.0238019880525073,6.18256819660636e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42636,0.0355211989696806,0.00785878950298685,0.0201179715438264,0.0509244263955348,6.23874108245619e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.00950487138362298,0.00210329329078185,-0.0136273262335554,-0.00538241653369055,6.26518411675126e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.0304153314828754,0.00673249018127755,-0.0436110122381794,-0.0172196507275714,6.30493882560984e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0250347712788203,0.00554408233983273,-0.0359011726648925,-0.0141683698927482,6.36831048183315e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42636,0.0181516939010475,0.00402053222456133,0.0102714507409073,0.0260319370611877,6.39305917470122e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42636,0.0379249836266347,0.00840833685451375,0.0214446433917878,0.0544053238614817,6.52526580894033e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0135505953465221,0.00301548831856624,-0.019460952450912,-0.00764023824213229,7.07204060769607e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.0126596559242898,0.00281981671236111,0.00713281516806201,0.0181864966805176,7.19704727870111e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.0185324881719728,0.00413753601027413,0.0104229175918356,0.0266420587521101,7.55824111400514e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0162579694267214,0.00363150977329599,-0.0233757285823816,-0.0091402102710613,7.64902383181762e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.00821582890984423,0.00183532091115489,-0.0118130578957078,-0.00461859992398064,7.66137582157103e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.026045786225546,0.00581869225007833,0.0146411494153925,0.0374504230356995,7.67149953160041e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0126303109947238,0.00282569606422538,-0.0181686752806056,-0.00709194670884205,7.90795358285468e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0289651229785898,0.00648116875896357,-0.0416682137461584,-0.0162620322110212,7.9306944856094e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42495,0.0187312510135541,0.00419340287350656,0.0105121813814812,0.026950320645627,8.00387582096117e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0241999067141059,0.00543036828360507,-0.0348434285499718,-0.01355638487824,8.40228603662494e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0143025404828977,0.00321186418082037,-0.0205977942773057,-0.00800728668848982,8.53399589345728e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.024953894766226,0.00560638823872642,-0.0359424157141298,-0.0139653738183222,8.61843860545061e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.0120246070745481,0.00270344196355282,0.00672586082598461,0.0173233533231117,8.74066539955775e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0209284260435451,0.00470778895896309,-0.0301556924031127,-0.0117011596839774,8.83956013842923e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.021413652271384,0.00481750041023192,-0.0308559530754385,-0.0119713514673294,8.87702652529734e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0326003262745255,0.0073381565211036,-0.0469831130558885,-0.0182175394931624,8.97317804069344e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COCH,Cochlin,40511,-0.0205630640807547,0.00464365671806446,-0.0296646312481611,-0.0114614969133484,9.59116599359767e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0230653663412459,0.00521495045608069,-0.0332866692351641,-0.0128440634473277,9.81546895421785e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0227278651041461,0.00514620906022252,0.0126412953461099,0.0328144348621822,1.01137130475977e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,40539,-0.0181755720449089,0.00411783383965105,-0.0262465263706249,-0.0101046177191928,1.02478374823017e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.0189344934048786,0.00429256933060965,-0.0273479292928735,-0.0105210575168836,1.0388281182972e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0281263690446122,0.00638037885201736,-0.0406319115945663,-0.0156208264946582,1.05193718761708e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0252497712216357,0.00573228786130275,-0.0364850554297891,-0.0140144870134823,1.06702088249259e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42779,-0.0154591894180199,0.00351392564593943,-0.0223464836840611,-0.00857189515197856,1.09373621287874e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.0422414654718676,0.00960582951481744,-0.0610688913209098,-0.0234140396228254,1.10539979767484e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0261985462821042,0.00596101775300961,0.0145149514862054,0.037882141078003,1.11795471244468e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,40199,-0.0217830449279193,0.00496123532222643,-0.0315070661594831,-0.0120590236963555,1.14067604478343e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.016012293581545,0.00364863273242756,-0.023163613737103,-0.00886097342598696,1.15167750500605e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0301198128063529,0.00686778968062888,-0.0435806805803855,-0.0166589450323203,1.16509422900796e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0386129112147286,0.00880700469687179,-0.0558746404205973,-0.0213511820088599,1.17417494316176e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,40483,-0.0269598649316138,0.00615050248377079,-0.0390148497998045,-0.014904880063423,1.17919530010042e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,42311,-0.0375548212440102,0.00857229406239946,-0.0543565176063131,-0.0207531248817072,1.19078227280356e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,42311,-0.0313855784794332,0.00717068305841119,-0.0454401172739191,-0.0173310396849472,1.21293472974994e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,40527,-0.0121440146089207,0.00277471298060396,-0.0175824520509044,-0.00670557716693689,1.21582884974943e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0166887270193913,0.00381464615549212,-0.0241654334841559,-0.00921202055462677,1.2241947442132e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.046324404864992,0.0105889117378969,-0.0670786718712699,-0.0255701378587141,1.22632823430744e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0182561292116014,0.00417442026075974,-0.0264379929226905,-0.0100742655005123,1.23280868376084e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,42134,-0.02621773993707,0.00600512303420288,-0.0379877810841077,-0.0144476987900324,1.27586038002875e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0272134107199819,0.00624029000966842,0.0149824423010318,0.039444379138932,1.30703937576316e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0244154095767307,0.00560120465937501,-0.0353937707091057,-0.0134370484443557,1.318671597165e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0166609952947095,0.00382292293091769,-0.0241539242393081,-0.00916806635011079,1.32124261743428e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42676,0.0277384278652412,0.00636855476805987,0.0152560605198439,0.0402207952106386,1.33725917034964e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0285445941296059,0.00655732494902678,-0.0413969510296984,-0.0156922372295134,1.35221876848719e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0325414546612276,0.00748380724327806,-0.0472097168580526,-0.0178731924644026,1.38237519489059e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0157313104342138,0.00361866462611805,-0.0228238931014052,-0.00863872776702244,1.39081531645153e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.0563686777439196,0.0129694818119588,-0.0817888620953589,-0.0309484933924803,1.39493110463411e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,40223,-0.0312074937395875,0.00719621248127734,-0.0453120702028911,-0.0171029172762839,1.45952298083185e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.0179246794345473,0.0041338144617756,-0.0260269557796275,-0.00982240308946716,1.46069176884715e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.0145846810079,0.00336636133627825,-0.0211827492270054,-0.00798661278879466,1.48515476283812e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.0120424860153908,0.00278061947176873,0.00659247185072403,0.0174925001800575,1.49598058467513e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,40302,-0.0551185460228001,0.0127602855158976,-0.0801287056339594,-0.0301083864116407,1.57714098820958e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.016850845919924,0.00390420376179265,-0.0245030852930376,-0.00919860654681042,1.59955196639412e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.0353207053433346,0.00819176609562282,-0.0513765668907553,-0.0192648437959139,1.63359168647104e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42552,-0.0104657880355059,0.00242830595058702,-0.0152252676986565,-0.00570630837235539,1.64487780669264e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0338465503700216,0.00786254890418414,-0.0492571462222225,-0.0184359545178207,1.68561398327381e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0143126790658055,0.00332630727161308,-0.0208322413181672,-0.00779311681344391,1.70053947466972e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0129036882151813,0.00299947586574275,-0.0187826609120371,-0.00702471551832554,1.70477752509511e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0160320078293709,0.00372861455597435,0.00872392329966119,0.0233400923590806,1.72217854142058e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.024064105562355,0.00560484600844609,-0.0350496037389094,-0.0130786073858007,1.77414158638223e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0240946829840381,0.00561715770872062,-0.0351043120931305,-0.0130850538749457,1.80338546756955e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.0342942174701302,0.00800900328075538,-0.0499918639004107,-0.0185965710398497,1.86853851434023e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0274546092294959,0.00641294429518158,-0.0400239800480518,-0.01488523841094,1.87269703356137e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0293269536150462,0.00686249797793141,-0.0427774496517918,-0.0158764575783007,1.93751159299458e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0286831760238075,0.00671414870071404,-0.041842907477207,-0.015523444570408,1.95043685133938e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,42311,-0.0301918827387925,0.00707987403356341,-0.0440684358445768,-0.0163153296330082,2.01783723745456e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0184450519010687,0.00432547222269931,-0.0269229774575593,-0.00996712634457802,2.02212630715378e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0168163269806183,0.00394368723985413,-0.0245459539707324,-0.00908669999050418,2.02331269014986e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0144273467527923,0.00338468464472876,0.00779336484912388,0.0210613286564606,2.03503201792356e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.025058090462737,0.00589079453690299,-0.0366040477550669,-0.0135121331704072,2.1190993482301e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42587,-0.0192285540652301,0.00452166029914031,-0.0280910082515451,-0.0103660998789151,2.1279059659529e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0296480073317989,0.00699291102062153,0.0159419017313807,0.0433541129322171,2.25582272168186e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0244786588089926,0.00577413905530125,-0.035795971357383,-0.0131613462606021,2.25654375965692e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGN,Biglycan,42328,0.0503398642713829,0.0118825002580669,0.0270501637655717,0.073629564777194,2.286087857867e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0114287170443298,0.00269884226488828,-0.0167184478835108,-0.00613898620514875,2.30689252884685e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0295612878413125,0.00698480611283275,0.0158710678601603,0.0432515078224647,2.32923921214107e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42711,-0.0156988109167964,0.00371375182048194,-0.022977764484941,-0.00841985734865175,2.38160724220221e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.010720417877665,0.00254173320497821,0.0057386207959077,0.0157022149594223,2.4865831816153e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0244396206872881,0.00580687417640194,-0.0358210940730359,-0.0130581473015403,2.58504612139799e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0218916228776257,0.00520764844400267,-0.0320986138278709,-0.0116846319273805,2.64553202201973e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0239260844953247,0.00569359325448245,-0.0350855272741103,-0.0127666417165391,2.65988986770618e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0250768563999013,0.005977131115134,-0.0367920333855639,-0.0133616794142386,2.74441556541566e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0267978499608381,0.00639927273025831,-0.0393404245121444,-0.0142552754095318,2.83656871217352e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0242310674607064,0.00579292988718269,-0.0355852100395845,-0.0128769248818284,2.89669777545222e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,40470,-0.0134392832729302,0.00321531729107598,-0.0197413051634392,-0.0071372613824213,2.94007820036983e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42495,0.0140140700890024,0.0033561286608157,0.00743605791380359,0.0205920822642011,2.99009512941472e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00758394218974962,0.00181840516037234,0.00401986807541984,0.0111480163040794,3.05988254188713e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.0223784830311199,0.00536746163876353,-0.0328987078430964,-0.0118582582191434,3.07890726667177e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42594,-0.0145434905229932,0.00349164931383594,-0.0213871231781117,-0.00769985786787477,3.12999881887677e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0232926376197864,0.00559663548230698,-0.0342620431651081,-0.0123232320744647,3.1757909753611e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0223077397064458,0.00536030793994087,-0.0328139432687299,-0.0118015361441617,3.1796112420359e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,42201,0.0112477934945164,0.00270360315615006,0.00594873130846223,0.0165468556805705,3.1987542786094e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,40482,-0.0225964920934149,0.00543256968082294,-0.0332443286678279,-0.0119486555190019,3.21378274103774e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0186657118473408,0.0044929110235988,-0.0274718174535944,-0.00985960624108713,3.2849478845086e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0427119953846824,0.0102847525838014,-0.0628701104489332,-0.0225538803204317,3.30246718942429e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00890408615210751,0.00214440929334533,0.00470104393715066,0.0131071283670644,3.31290896833015e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.0133876931032987,0.00322432450781945,-0.0197073691386248,-0.0070680170679726,3.31870756035729e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42611,-0.0269340880606738,0.0065035011877064,-0.0396809503885784,-0.0141872257327693,3.47191872139187e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0164581479052779,0.00397404083552998,-0.0242472679429166,-0.0086690278676391,3.47763632896159e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0182946489720646,0.00441919857627332,-0.0269562781815603,-0.00963301976256889,3.50125179136515e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.0108188223212311,0.00261412979786833,-0.015942516725053,-0.00569512791740912,3.51545210528083e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0283013780193757,0.00684287781361492,-0.041713418534061,-0.0148893375046905,3.55740424049194e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42689,-0.0228455326972861,0.00552664738868833,-0.0336777615791152,-0.012013303815457,3.59117923811288e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0163693115546332,0.00396687629596486,-0.0241443890947243,-0.00859423401454205,3.70546531947355e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0118827698921518,0.00288192357914302,-0.0175313401072721,-0.00623419967703144,3.75877209896104e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0197631105628926,0.00479571948287617,-0.0291627207493299,-0.0103635003764553,3.79943078989259e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0247040843045426,0.00600530661372483,0.012933683341642,0.0364744852674433,3.91679692474062e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.0258813260531769,0.006309224298703,-0.0382474056786348,-0.013515246427719,4.11817066648523e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0135375170528904,0.00330211938715706,-0.0200096710517183,-0.00706536305406261,4.16194730683272e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0484962187272207,0.0118348719468252,0.0252998697114433,0.0716925677429981,4.19679290477155e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0190916136249254,0.00466787130137515,-0.0282406413756207,-0.00994258587423014,4.33944676202728e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0171871994563446,0.00420244909372552,-0.0254239996800466,-0.00895039923264261,4.34257953280081e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0160170862456129,0.0039166439635937,-0.0236937084142565,-0.00834046407696921,4.35418033416634e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0385226268210018,0.00942549869653267,-0.0569966042662059,-0.0200486493757978,4.39394843915137e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0197903323164053,0.00485073507614756,-0.0292977730656545,-0.0102828915671561,4.53801652409722e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.0221762549124599,0.00544428042658107,-0.0328470445485588,-0.011505465276361,4.66659334650758e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,40166,-0.0180804924681707,0.00443892303951593,-0.0267807816256219,-0.00938020331071945,4.67033975981886e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0095698404429629,0.00234969143019964,0.0049644452397716,0.0141752356461542,4.67166833323396e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0182919172767565,0.00450220816790201,-0.0271162452858445,-0.0094675892676686,4.87538056719441e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42794,-0.0213579732816684,0.00525814756917263,-0.0316639425172467,-0.01105200404609,4.89518135039906e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0258110078099291,0.00635576325316464,-0.0382683037861318,-0.0133537118337264,4.91838417376699e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0164897920182213,0.00406751060339074,-0.0244621128008672,-0.00851747123557547,5.06240428886599e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0379471871985234,0.00936535973436974,-0.0563032922778881,-0.0195910821191587,5.11026605293405e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.0434766687575931,0.0107420174183861,-0.0645310228976299,-0.0224223146175562,5.21480041357301e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.0321720004860335,0.0079650084327193,-0.0477834170141633,-0.0165605839579036,5.4006078990373e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0143807105379782,0.00356279905776268,-0.0213637966911931,-0.00739762438476337,5.46481406830153e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0288787321188682,0.00716201925414312,-0.0429162898569887,-0.0148411743807477,5.55673524697037e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.0242941030551819,0.00603840353794654,-0.0361293739895571,-0.0124588321208066,5.77080472829607e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42587,-0.0218260893244103,0.00542549866920986,-0.0324600667160616,-0.0111921119327589,5.78083420898131e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0297121079516902,0.00739227137131108,-0.0442009598394599,-0.0152232560639205,5.8738604689875e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0237984054779424,0.00592743154832417,-0.0354161713126578,-0.012180639643227,5.97850814149855e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0394594467838452,0.00983369871867359,-0.0587334962724454,-0.020185397295245,6.03583292585467e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0406926754005013,0.010144045194813,-0.0605750039823348,-0.0208103468186679,6.07284641729555e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0258931664808527,0.00647927332970186,-0.0385925422070683,-0.013193790754637,6.46775241020154e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42654,0.0327239198104367,0.00819542012101468,0.016660896373248,0.0487869432476255,6.56023614293618e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00630679507847596,0.00157967026180256,0.00321064136534295,0.00940294879160897,6.57306063690687e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBN,Nibrin,42370,-0.021113154411199,0.00529039313730563,-0.0314823249603181,-0.01074398386208,6.61940207394365e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0229620083607787,0.00575516129755035,-0.0342421245039774,-0.01168189221758,6.65435497033583e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,40344,-0.0128145085865221,0.00321326066784489,-0.0191124994954981,-0.00651651767754608,6.70558600384965e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0131972792888719,0.00331013652284944,-0.0196851468736568,-0.00670941170408698,6.73632837206985e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,42216,-0.030056519721518,0.00755164833697794,-0.0448577504619948,-0.0152552889810413,6.92520365551224e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.0135391200316091,0.00340337444018387,-0.0202097339343695,-0.00686850612884871,6.98166931027749e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0162304208512138,0.00408327559728068,-0.024233641021884,-0.00822720068054368,7.07947566769409e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0407350217007722,0.0102696579496263,-0.0608635512820397,-0.0206064921195047,7.33818051876978e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,40408,-0.0367169687479642,0.0092609963815803,-0.0548685216558616,-0.0185654158400668,7.39480008768307e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,40527,-0.0173237306371499,0.00437207808910753,-0.0258930036918006,-0.00875445758249912,7.46685749606728e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.0102902768409922,0.00260119832109841,0.00519192813163926,0.015388625550345,7.67011728153195e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,42311,-0.0136573727314142,0.00345981745387985,-0.0204386149410187,-0.00687613052180972,7.94082447136992e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.00752561489225864,0.00190783449330204,-0.0112649704991306,-0.00378625928538664,8.03406192373639e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0223277492902166,0.00566717300110709,-0.0334354083723865,-0.0112200902080467,8.19528795812518e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,42459,0.0260657966046292,0.00662352912589355,0.0130836795178778,0.0390479136913805,8.35049984652113e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0203215020452953,0.00516445967044121,0.0101991610912305,0.03044384299936,8.36681448097561e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.0113461245055611,0.00288412307065444,0.00569324328707841,0.0169990057240438,8.39759510917526e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0106237474326444,0.00270108587917848,-0.0159178757558342,-0.00532961910945453,8.42632933277734e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0223219285148361,0.0056822404617052,-0.0334591198197783,-0.0111847372098939,8.60338435305331e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0161517493812712,0.00411297794978536,0.00809031259969186,0.0242131861628505,8.64397905320401e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,40449,-0.0259896764058124,0.00665028347633845,-0.0390242320194358,-0.0129551207921891,9.35869437727684e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0135128900082257,0.00345811898762105,-0.020290803223963,-0.00673497679248848,9.37819002355769e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0208452138138255,0.00533975933815425,-0.0313111421166078,-0.0103792855110431,9.52649151846758e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42611,-0.0179425015580011,0.00459913488709392,-0.0269568059367052,-0.00892819717929705,9.61533002490717e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0204012265490665,0.00522970328473756,-0.0306514449871521,-0.0101510081109808,9.63491184685229e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.0373800169741803,0.00958404167592916,-0.0561647386590015,-0.0185952952893592,9.66706237666867e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI3,Elafin,42446,-0.0219697777070884,0.00563430048693806,-0.033013006661487,-0.0109265487526898,9.69504585714468e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,42476,-0.0308910536134606,0.00792830905077453,-0.0464305393529786,-0.0153515678739425,9.81534099531041e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.0203249665202515,0.00522337174037533,-0.0305627751313871,-0.0100871579091158,0.000100349284553334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.0090758086568737,0.00233272719666614,-0.0136479539623393,-0.00450366335140807,0.000100462567720282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.017037295870592,0.00438152649657554,0.00844950393730394,0.0256250878038801,0.000101484275711458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.0185270193058775,0.00477459779399649,-0.0278852309821106,-0.00916880762964437,0.000104907477385528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,40449,-0.0214632086013544,0.00555179285421743,-0.0323447225956206,-0.0105816946070882,0.000111258828240691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0154643246408984,0.00400217272688673,-0.0233085831855964,-0.00762006609620041,0.000112188656764824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,40527,-0.0374973745224136,0.00971182702605269,-0.0565325554934768,-0.0184621935513503,0.000113550861456667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0128354862679392,0.00333174242719759,-0.0193657014252465,-0.00630527111063197,0.000117470380734037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.0397621012466468,0.0103232961490159,-0.0599957616987179,-0.0195284407945756,0.000117849870902661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0104070179527308,0.0027041373248386,-0.0157071271094144,-0.00510690879604709,0.000119367937826432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0202521496636852,0.00526251510900534,-0.0305666792773357,-0.00993762005003476,0.000119572844123542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42587,-0.0225847457886154,0.00587226570348393,-0.0340943865674439,-0.0110751050097869,0.000120616867492402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.0420131925396479,0.010942339319948,-0.063460177606746,-0.0205662074725499,0.000123848510250148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00958816462781298,0.00250152468430824,0.00468517624656882,0.0144911530090571,0.000127311053977239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,40482,0.0135842667644564,0.00355007327726999,0.00662612314100719,0.0205424103879056,0.000130692304562407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0248861876520906,0.00650411583460591,-0.0376342546879182,-0.012138120616263,0.000130850306345528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,0.0153368025823056,0.00401157709289641,0.00747411148022869,0.0231994936843826,0.000132367112838576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0228050777879595,0.00596479725897767,-0.0344960804155557,-0.0111140751603633,0.000132395269943668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.0521802153255602,0.0136647049003192,-0.0789630369301858,-0.0253973937209346,0.000134924492085187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,42130,-0.00946797366775691,0.00248165186200888,-0.0143320113172943,-0.00460393601821951,0.000136711193741858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0251712237449232,0.00660731121706953,-0.0381215537303794,-0.0122208937594669,0.000139825949077645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0261232634163005,0.00686694907974201,-0.0395824836125948,-0.0126640432200061,0.000143032845083357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42771,-0.0115949778341148,0.00305680688869929,-0.0175863193359654,-0.0056036363322642,0.000149383293172083
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.0374559470550006,0.00989179063864756,-0.0568438567067498,-0.0180680374032514,0.000153408484039186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.0123445807623384,0.00326168572107459,-0.0187374847756446,-0.0059516767490322,0.000154545396870695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,40283,-0.0252651942457766,0.00667579369692007,-0.0383497498917399,-0.0121806385998133,0.000154768111572168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0243954145623662,0.00644929465919338,-0.0370360320943852,-0.0117547970303471,0.000155969636857331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.0246605208893985,0.00651940954900302,-0.0374385636054444,-0.0118824781733525,0.000156007447684969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,40284,0.0116342224414121,0.00307715347053775,0.00560300163915817,0.0176654432436661,0.000157120563689156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0214078302208943,0.00566286281240354,-0.0325070413332053,-0.0103086191085834,0.000157389424886056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0181656369529504,0.00481029668751942,-0.0275938184604884,-0.00873745544541233,0.000159921372304928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0105749829523502,0.00280713111599713,-0.0160769599397046,-0.00507300596499587,0.000165807962719097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0100748202713901,0.00267932572445293,0.0048233418514624,0.0153262986913179,0.000170495058749781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0353761733344582,0.00940850385740037,-0.0538168408949629,-0.0169355057739535,0.0001706212355439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0396178574517215,0.0105530378992088,-0.0603018117341709,-0.0189339031692722,0.000174792160174523
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0315914717498832,0.00841796441168491,-0.0480906819967856,-0.0150922615029807,0.000175719222008399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0383729872184111,0.010227066162127,-0.0584180368961799,-0.0183279375406422,0.000176098189467354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0286196965238492,0.00765497867769325,-0.043623454732128,-0.0136159383155704,0.000185885528617206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0202900429040069,0.0054289311037338,-0.0309307478673251,-0.00964933794068862,0.000186702543808686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0309669891579663,0.00828811967257886,-0.0472117037162209,-0.0147222745997117,0.000187517465725812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0238129166217595,0.00637641991432976,-0.0363106996538458,-0.0113151335896732,0.000188847525368598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.0143222019869502,0.00383899012891383,-0.0218466226396213,-0.00679778133427904,0.00019186809417439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0286814785030453,0.00769310749380713,-0.0437599691909073,-0.0136029878151833,0.000193648704263065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42611,0.00909403744728433,0.00244020923098521,0.00431122735455332,0.0138768475400153,0.000194764953609598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.0169309407839326,0.00455077374344347,-0.0258504573210818,-0.00801142424678339,0.000199695497330483
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0231384759855054,0.00623259852704362,-0.0353543690985109,-0.0109225828724999,0.000206077644793728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0205586175695151,0.00554085220979725,0.00969854723831247,0.0314186879007177,0.000207952088764726
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0145609407633545,0.00392858810885872,-0.0222609734567176,-0.00686090806999137,0.000211060242934497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0204746365644861,0.00553048397284922,-0.0313143851512706,-0.00963488797770167,0.000214640399743645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0287667161874219,0.00777186472004011,-0.0439995710387005,-0.0135338613361433,0.000215276560018618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0135769905583117,0.00366796464713593,-0.0207662012666981,-0.00638777984992527,0.00021538171150684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0180228424492068,0.00487157192098277,-0.0275711234143331,-0.00847456148408061,0.000216972445723086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0193835089476588,0.00524753720839849,-0.0296686818761198,-0.00909833601919771,0.000221785695839792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0193679417644684,0.00525056304360544,-0.029659045329935,-0.0090768381990017,0.000226277420882923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0163612800798771,0.00443887386614947,-0.0250614728575301,-0.00766108730222415,0.000228983552425354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2,Complement C2,42663,-0.00835395784080423,0.00226763044157145,-0.0127985135062843,-0.00390940217532419,0.0002304985277165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0251693939347942,0.00683335276286732,-0.0385627653500142,-0.0117760225195743,0.00023131462401222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.0197714390541283,0.00536837028949245,-0.0302934448215335,-0.00924943328672311,0.000231661018647031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFP,Properdin,40539,0.00814809716246845,0.00221331074553781,0.00381000810121433,0.0124861862237226,0.000233026477649748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42505,0.047160734846237,0.012832967730684,0.0220081180940963,0.0723133515983777,0.000238814051072119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0285030711898663,0.007762778950031,-0.043718117931927,-0.0132880244478055,0.000241821099447217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42636,0.00991955309806746,0.00270303637290848,0.00462160180716685,0.0152175043889681,0.000243696690357397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0105727852313542,0.00288424200749261,-0.0162258995660397,-0.00491967089666872,0.000247814664299474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0240331565650175,0.00655965359107541,-0.0368900776035253,-0.0111762355265097,0.000249474398330664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0170662425753998,0.00466137006379423,-0.0262025279004365,-0.00792995725036308,0.000252170688880914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42611,0.0182744306788888,0.00499572869044999,0.00848280244560686,0.0280660589121708,0.000255153195381546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.010861012066177,0.00297057118299765,-0.0166833315848524,-0.00503869254750156,0.000256956563228097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0146555718816705,0.00401235896148404,-0.0225197954461792,-0.00679134831716173,0.000260769229697355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42594,0.0335743982323582,0.00921840633110614,0.0155063218233902,0.0516424746413262,0.000271438110298088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.0102085684616654,0.0028029429709505,0.00471480023860245,0.0157023366847284,0.000271447634999865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0277449167413869,0.00762135228165135,-0.0426827672134236,-0.0128070662693503,0.000273238594438673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0143488388326149,0.00394791994364584,-0.0220867619221607,-0.00661091574306903,0.000279723530075693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0187978591829964,0.00517695666752047,-0.0289446942513365,-0.00865102411465627,0.000283534456864626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0113727487762112,0.00313815861162351,0.00522195789742912,0.0175235396549933,0.000291125462369343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.0361661563090771,0.00998945560414874,-0.0557454892932087,-0.0165868233249456,0.000295195334906221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,42476,-0.0225066284850665,0.00622249855964516,-0.034702725661971,-0.010310531308162,0.000299169766512238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0123249690259251,0.0034077096227503,-0.0190040798865156,-0.00564585816533447,0.000299584134389933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42580,-0.0103383436781692,0.00286444824692149,-0.0159526622421353,-0.00472402511420309,0.000308272905554725
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0210705325126594,0.00583871399201032,-0.0325144119369996,-0.00962665308831917,0.000308781884301361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.019938134395081,0.00552947633921042,0.00910036077022856,0.0307759080199334,0.000312334750963538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.0211584752513077,0.00587457843272693,-0.0326726489794525,-0.00964430152316294,0.000317278344080894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42794,0.00620048316936469,0.00172266993380273,0.00282405009911134,0.00957691623961803,0.000320153863625113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0249402087566955,0.00693274893281331,-0.0385283966650096,-0.0113520208483814,0.000322510879580147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0124163632074699,0.00345406103885957,-0.0191863228436347,-0.00564640357130517,0.00032590965407787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0172440927837874,0.00479953331465243,-0.0266511780805062,-0.00783700748706867,0.000328487080768255
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0240850620111088,0.0067339471372817,-0.037283598400181,-0.0108865256220367,0.000349503508205382
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42569,0.0101268321701079,0.00283227252556971,0.00457557801999123,0.0156780863202245,0.000350771813107739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.030551429933838,0.00858423002860431,-0.0473765207899025,-0.0137263390777736,0.000373531352667616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42594,-0.016768274614497,0.00471694208884415,-0.0260134811086316,-0.0075230681203625,0.000379419754297161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,42261,-0.0108473538927167,0.00305243884213708,-0.0168301340233054,-0.00486457376212807,0.000381238517754806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0203376938728929,0.00573323537206794,-0.0315748352021461,-0.00910055254363975,0.000390507251947177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0249294834456768,0.00703640479625786,-0.0387208368463422,-0.0111381300450114,0.000397335457662273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.013512886661898,0.00381507562637775,-0.0209904348895984,-0.0060353384341976,0.000398521463495499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0151609049736043,0.00428106091704354,-0.0235517843710096,-0.00677002557619894,0.000399368218757498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,40539,0.00731042286830156,0.0020652380574863,0.00326255627562842,0.0113582894609747,0.000402112389533468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.0431537115990127,0.0122008001935938,-0.0670672799784565,-0.019240143219569,0.000406124235588407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.0149946313710856,0.00424013723569111,-0.0233053003530402,-0.00668396238913098,0.000407323022938979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,40527,0.0114563798416104,0.00324065558261836,0.0051046948996784,0.0178080647835424,0.000409085144718946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,40283,0.019187063308521,0.00542958028115655,0.00854508595745422,0.0298290406595879,0.000411294802432012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,40451,0.040388577385656,0.0114493331802735,0.0179478843523199,0.062829270418992,0.000421028360495569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0113303426143998,0.00321483093541995,-0.0176314112478229,-0.00502927398097667,0.000425862796165244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0282136248780191,0.00802129626246785,-0.0439353655524561,-0.0124918842035821,0.000437648497493875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.015836962149965,0.00450267076048246,0.00701172745941936,0.0246621968405106,0.00043777690522226
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0160042762147114,0.00455641137272817,-0.0249348425052586,-0.00707370992416417,0.000445404609648014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0330576357450328,0.00943373315489948,-0.0515477527286358,-0.0145675187614298,0.000459496590460475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0148248713483068,0.00423225630898885,-0.0231200937139249,-0.00652964898268864,0.000462182210380873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.0242055624900753,0.00691402551603406,-0.037757052501502,-0.0106540724786485,0.000465127441224763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0135577176265206,0.00388010168095114,-0.0211627169211849,-0.00595271833185639,0.000477369163443767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0188524962909666,0.00539647428546981,-0.0294295858904874,-0.00827540669144576,0.000478651816232685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42654,0.011188995491466,0.003204552947798,0.00490807171378189,0.0174699192691501,0.000481687999127363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0178647859731409,0.00512374693419437,-0.0279073299641619,-0.00782224198211994,0.00049064429554331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.0127931613141186,0.00366977352285115,0.00560040520933034,0.0199859174189068,0.00049202893816676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.0215328177479897,0.00618222999061859,-0.0336499885296022,-0.00941564696637729,0.000497405610772637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIT,Vitrin,40511,0.0132978223866915,0.0038259422954229,0.00579897548766258,0.0207966692857204,0.000511434746548702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0148477263325532,0.004274323179804,-0.023225399764969,-0.00647005290013733,0.000514936520293936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0108300273933601,0.00311773668490412,-0.0169407912957722,-0.00471926349094807,0.000514979504058942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0236340860734162,0.0068232233759804,0.0102605682564946,0.0370076038903378,0.000534336088907845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0164332250522116,0.00474463307774505,-0.0257327058845919,-0.00713374421983133,0.000534812665824407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0119594441168705,0.00346120020573383,-0.0187433965201088,-0.00517549171363219,0.000551721046279499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.00854149987851874,0.00247317331793112,-0.0133889195816637,-0.00369408017537374,0.000554741559474296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0117542574303801,0.0034151260772582,-0.0184479045418061,-0.005060610318954,0.000579937357674976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0170592131501827,0.00496035926573726,-0.0267815173110277,-0.00733690898933763,0.000585785266802816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0223339082153994,0.00650296243800779,-0.0350797145938946,-0.00958810183690409,0.000596001589047843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.0205005638424486,0.00596958949655697,0.00880016842919696,0.0322009592557003,0.000596161388081864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0121520398847808,0.00354037077891326,-0.0190911666114508,-0.00521291315811076,0.000600359531001263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42624,-0.0186585719330917,0.0054491860759126,-0.0293389766418804,-0.00797816722430301,0.000618676101409577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.00857406621730641,0.00250826928668855,0.00365785841539685,0.013490274019216,0.000631948066759661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0161736449950561,0.00473497777921565,-0.0254542014423188,-0.00689308854779342,0.00063824185087767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.0096160442507772,0.00281576824246777,0.00409713849554038,0.015134950006014,0.000639541975864871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0136683425924964,0.00400504161441279,-0.0215182241567455,-0.00581846102824732,0.000645292588049287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,40199,-0.019295195388199,0.00565408256001016,-0.0303771972058189,-0.00821319357057906,0.000645749584383021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,40483,0.0264299562009936,0.00775755419456774,0.0112251499796409,0.0416347624223464,0.000659112447962292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0118858614566063,0.00349087545588777,-0.0187279773501463,-0.00504374556306628,0.000664399757604702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42721,0.0155270527686667,0.00456503618228497,0.00657958185138819,0.0244745236859453,0.000672604698214183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.00698862401224384,0.00205489380237015,0.00296103215959834,0.0110162158648893,0.000673430153631317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0221217010572738,0.00651830247407035,-0.0348975739064517,-0.00934582820809595,0.000691714847420433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.0434479049848681,0.0128071125406192,-0.0685498455644817,-0.0183459644052545,0.000695067238841385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,40539,0.00654475563662275,0.00193078493502406,0.0027604171639756,0.0103290941092699,0.000702109544963633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,42292,-0.0204451346149074,0.00603677784127419,-0.0322772191838048,-0.00861305004600999,0.000709304805628041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0254782440633465,0.00752636757626527,-0.0402299245128265,-0.0107265636138666,0.000713755018732534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.0993579407408113,0.0294079193052917,-0.156997462579183,-0.0417184189024395,0.000730599931279721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0134419286430382,0.00398013735920523,-0.0212429978670805,-0.00564085941899598,0.000734604490470761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0222239037944866,0.00660010095157616,-0.0351601016595759,-0.00928770592939735,0.00076145530547612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0160740831938167,0.00477884729978634,-0.025440623901398,-0.00670754248623551,0.000771986766117302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.0421600273465053,0.0125441781288077,-0.0667466164789684,-0.0175734382140422,0.000778985872004849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.00943575610793651,0.00281017137256437,-0.0149436919981627,-0.00392782021771033,0.000788068918663337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.017449817577494,0.0051997407829148,-0.0276413095120071,-0.00725832564298104,0.000793738316180194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0283986483966233,0.00847074030864613,-0.0450012994015697,-0.0117959973916769,0.000802969461421662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0174521692309326,0.00520604108229618,-0.0276560097522331,-0.0072483287096321,0.000804087656327777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,40532,-0.0242084469595558,0.00723764337354498,-0.0383942279717039,-0.0100226659474076,0.000826099614356659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0273657903366465,0.0081848265682782,-0.0434080504104718,-0.0113235302628212,0.000829618704367758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0114661955337852,0.00343008248697283,-0.0181891572082519,-0.00474323385931843,0.000831519640300128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0126583562508626,0.00379158073983756,-0.0200898545009442,-0.00522685800078099,0.000844533994563393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0132709554681759,0.00397756514108777,-0.0210669831447079,-0.00547492779164384,0.000851381746924532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0174776910805058,0.00524009312414648,0.00720710855717872,0.0277482736038329,0.000854192375567786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0165034185907984,0.00495843054907757,-0.0262219424669905,-0.00678489471460639,0.000876470540706282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.0185686754565197,0.00559233100860427,0.00760770667965529,0.029529644233384,0.000901399611329759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAT,Catalase,40361,-0.0179281301583297,0.00540009361039807,-0.0285123136347099,-0.0073439466819495,0.000903166664380118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.029251579832948,0.00881216202896233,-0.0465234174097142,-0.0119797422561818,0.000904393585659512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0103551671330094,0.00312335559428551,-0.016476944097809,-0.00423339016820982,0.000917536476905079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42613,-0.0120973584433532,0.00365298568644198,-0.0192572103887795,-0.00493750649792691,0.000929971435428328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0201292645731912,0.00608667111433193,-0.0320591399572817,-0.00819938918910058,0.000945187258960514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0100941742911496,0.00305422418822022,-0.0160804537000612,-0.00410789488223793,0.000952276414298353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,40449,-0.014348473561948,0.00434829058628071,-0.0228711231110582,-0.00582582401283781,0.000970556881238569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.014214810215301,0.00430889202716725,0.00576938184205317,0.0226602385885488,0.000973537546421702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0185928787591468,0.0056361219379783,-0.0296396777575842,-0.00754607976070932,0.000973802989273461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0194670759888482,0.00590239882745414,-0.0310357776906583,-0.00789837428703804,0.000975731301485317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0233253910684053,0.00708068159372333,-0.037203526992103,-0.00944725514470754,0.000989440398106033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00835698932059878,0.00253722202555833,0.00338403415050446,0.0133299444906931,0.000991614499581297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0201242509110487,0.00612344855715176,-0.0321262100830661,-0.0081222917390312,0.00101777715944252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00998638623423587,0.00304100650137321,0.00402601349154439,0.0159467589769273,0.00102645672462456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42721,0.0144913448722393,0.00441777211203721,0.00583251153264638,0.0231501782118323,0.00103981786859861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42754,-0.0159680087286944,0.00487565052946202,-0.0255242837664399,-0.0064117336909488,0.00105907518074473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,40532,0.00727002069152301,0.00222311860723841,0.00291270822133572,0.0116273331617103,0.00107795867116126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42636,-0.0337398152502365,0.0103301694176161,-0.053986947308764,-0.013492683191709,0.00109296088302122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0158391437046269,0.00485839565565368,-0.0253615991897081,-0.00631668821954566,0.00111687352927869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00952500020177206,0.00292720240377634,-0.0152623169131737,-0.00378768349037044,0.00114143068585653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0157456481596649,0.00484142613327692,-0.0252348433808877,-0.00625645293844218,0.0011482241240336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,0.00756292071373064,0.00232589187892514,0.00300417263103736,0.0121216687964239,0.0011503236713678
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42543,0.0161423694387182,0.0049661274558497,0.00640875962525274,0.0258759792521836,0.00115490006903897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42597,-0.0150340436418205,0.00462949758935925,-0.0241078589169646,-0.00596022836667636,0.00116732122796931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0256259965908534,0.0078925345117856,-0.0410953642339531,-0.0101566289477536,0.00116967949774948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0097499995496951,0.00300535424012434,-0.0156404938603388,-0.0038595052390514,0.00118067786185481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.0455650833305137,0.0140586494833751,-0.073120036317929,-0.0180101303430984,0.00119377507199225
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0312013562726271,0.00964816882795017,0.0122909453698447,0.0501117671754094,0.00122399769545343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0103915464844947,0.00321418340023534,-0.016691345948956,-0.00409174702003346,0.00122838212525367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.0100527914613289,0.00311564083065401,0.00394613543324701,0.0161594474894107,0.00125656510940435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42594,-0.0213930764959846,0.00663539627311714,-0.0343984531912942,-0.008387699800675,0.00126678915239156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0212565437695192,0.00660512070241623,-0.034202580346255,-0.00831050719278338,0.00129307569877979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0287686248709439,0.00894260203402748,-0.0462961248576378,-0.01124112488425,0.00129838302977213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0133888048848577,0.00416779838537412,-0.021557689720191,-0.00521992004952444,0.00131982663510284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0196473158013427,0.00613052384981093,-0.0316631425469721,-0.00763148905571327,0.00135515944578316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,42357,0.0123713819955533,0.00386386882419322,0.0047981991001346,0.019944564890972,0.00136890625849066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C3,Complement C3,39989,-0.0149921866868857,0.00468439163801022,-0.0241735942973857,-0.00581077907638562,0.00137607676672796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0197500727698471,0.00617786584488503,-0.0318586898258217,-0.00764145571387239,0.00139237475403404
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0294009307056576,0.00921296709874725,-0.0474583462192022,-0.011343515192113,0.00142043912147368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0276563958074969,0.00867234802935281,-0.0446541979450284,-0.0106585936699654,0.00143141014843331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.012549003479324,0.00394974051239746,-0.020290494883623,-0.00480751207502497,0.00149120827880518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.0131304940801317,0.00413296481766653,-0.0212311051227581,-0.00502988303750526,0.00149209199741598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0177858595168765,0.00559902365148393,-0.028759945873785,-0.00681177315996803,0.00149349566494973
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,42370,0.0148322930885843,0.00467092247983299,0.0056772850281116,0.0239873011490569,0.00149947500410194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.0202929829571948,0.00639306889177662,0.00776256792931266,0.032823397985077,0.00150657860602987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,40539,-0.0064835126044418,0.00204328056167326,-0.0104883425053214,-0.0024786827035622,0.00151228267561132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.00680910220646117,0.00214808717879954,-0.0110193530769083,-0.00259885133601408,0.00152935297763347
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.0102796972605994,0.00324309078326359,-0.0166361551957961,-0.00392323932540278,0.00152991158721564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.0159992123331324,0.00504863586138273,0.00610388604482221,0.0258945386214425,0.00153363687426489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0392235907935451,0.0124011071349419,-0.0635297607780312,-0.0149174208090589,0.00156628167872818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0139153509847477,0.00440141948159515,-0.0225421331686742,-0.00528856880082121,0.00157276844302839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0143345692593968,0.00453406919118889,-0.023221344874127,-0.00544779364466659,0.00157302115514106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0189235496900306,0.00600213562767782,-0.0306877355202791,-0.00715936385978208,0.00162073794680115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0224371594336235,0.0071208577647978,-0.0363940406526272,-0.00848027821461982,0.00163189687056288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0161055618851256,0.00511174155138059,-0.0261245753258316,-0.00608654844441966,0.00163237870237178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0259231538482965,0.00823017167191532,-0.0420542903252505,-0.00979201737134247,0.00163768260703771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,40479,0.0149306307542472,0.00474522776307347,0.00562998433862323,0.0242312771698712,0.00165694155184862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.0368191824950776,0.0117025369120421,0.0138822101474751,0.0597561548426802,0.00165735776907656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.0109249655011337,0.00347591421083967,0.00411217364788792,0.0177377573543794,0.00167645768375846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0149249450442472,0.00475697303509661,-0.0242486121930366,-0.00560127789545785,0.0017084065419183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0196313859122232,0.00626148115206077,-0.0319038889702623,-0.00735888285418412,0.00172142293577563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0117324731022631,0.00374947983986944,0.00438349261611904,0.0190814535884072,0.00175722856370111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,42347,-0.0133813380336928,0.00427807403871307,-0.0217663631495704,-0.00499631291781514,0.00176451310480852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0155213326106064,0.00496530974070684,-0.0252533397023918,-0.00578932551882097,0.00177679994871343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0205654094403624,0.00659113539132787,-0.033484034807365,-0.00764678407335978,0.0018120719444588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42594,-0.0118508065472883,0.00379848320174306,-0.0192958336227047,-0.00440577947187191,0.00181309532702937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.024613382774912,0.00790200379328747,-0.0401013102097555,-0.00912545534006858,0.00184443358739188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0107473113149226,0.00345258233680557,-0.0175143726950615,-0.00398024993478364,0.00185690763888235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0195754844213624,0.00629672102453763,0.0072339112132686,0.0319170576294561,0.00188304661800147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0199901060831827,0.00643765058733995,-0.032607901234369,-0.00737231093199638,0.0019055658197027
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.0446604188030342,0.0143921226779853,-0.0728689792518855,-0.016451858354183,0.00191969308404261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.0131810892404153,0.00425367805831055,-0.021518298234704,-0.00484388024612664,0.00194749202848984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.022505533582177,0.00728589134504798,-0.036785880618471,-0.00822518654588294,0.00201382404523465
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0165977536169216,0.00537826125433197,-0.0271391456754123,-0.00605636155843097,0.00203316686513326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00777177984017338,0.00251857157977347,-0.0127081801365294,-0.00283537954381738,0.0020350267181338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.010898134324133,0.00353417238736233,-0.0178251122033632,-0.00397115644490282,0.00204900010300592
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0218911835746442,0.00709920256711722,-0.0358056206061939,-0.00797674654309446,0.00205011464733756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0312396800558047,0.0101334562072186,-0.0511012542219531,-0.0113781058896563,0.0020555122456441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0128041003495712,0.00415890711686469,-0.020955558298626,-0.0046526424005164,0.00208313876005311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0147233477367624,0.00480211435507977,-0.0241354918727187,-0.00531120360080603,0.00217361293557958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0203436812292339,0.00663683659411533,-0.0333518809536999,-0.00733548150476785,0.00217988757743236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0272046227953674,0.00887769775107091,-0.0446049103874663,-0.00980433520326837,0.00218556648608387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.00652634759209396,0.00213603729685727,-0.0107129806939342,-0.0023397144902537,0.00225322016702267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.0119815944404985,0.00392391843293019,-0.0196724745690417,-0.00429071431195534,0.00226649966857015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,42357,-0.0149718770221903,0.00490901340295995,-0.0245935432919918,-0.00535021075238881,0.00229391763084853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0126701798023834,0.004160289387505,-0.0208243470018931,-0.00451601260287356,0.00232845839319906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0131806491706317,0.00433225758857242,-0.0216718740442336,-0.00468942429702971,0.00235218884748518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.00661815722755245,0.00217568292366547,-0.0108824957579368,-0.00235381869716813,0.00235559318335581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42495,0.0169066104372383,0.00556175015251292,0.00600558013831299,0.0278076407361636,0.00237195079658676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.011360198586813,0.00374027134185254,0.004029266756782,0.018691130416844,0.00239211031984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,40182,-0.0139793885388775,0.00461030674629155,-0.023015589761609,-0.00494318731614606,0.00243341454512702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.00904403726384067,0.00298887991956402,-0.0149022419061861,-0.00318583262149519,0.00248465635422198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0113743235697297,0.00376015596569301,-0.018744229262488,-0.0040044178769714,0.00249226209281037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42679,0.011122422852722,0.00368513594883287,0.00389955639300955,0.0183452893124344,0.00254768360353049
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.0240557394728517,0.00797853161448591,-0.039693661437244,-0.00841781750845926,0.00257516442795622
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.0228496620617207,0.00758962943453016,-0.0377253357533998,-0.00797398837004161,0.00261285417713066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0201006141041438,0.00667916814015626,-0.0331917836588501,-0.00700944454943756,0.00262209257677819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0199201118380354,0.00662406344093395,-0.0329032761822659,-0.00693694749380481,0.00264216846675496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0147518997739452,0.00490593795931735,-0.0243675381742072,-0.00513626137368315,0.00264384815743796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0158911382128405,0.00529548212560848,-0.0262702831790332,-0.00551199324664794,0.0026978199885609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.0269788979080898,0.00900518975310002,-0.0446290698241658,-0.00932872599201376,0.00274219450446178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0178330669023011,0.00596292056896607,-0.0295203912174746,-0.00614574258712759,0.00278890329966316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42651,0.0104071369514518,0.00348383588520607,0.00357881861644788,0.0172354552864557,0.00281994047499411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,40471,-0.0248918085680572,0.00834255769409208,-0.0412432216484777,-0.00854039548763671,0.0028538247069742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,0.0135723087494017,0.00454902861398257,0.00465621266599585,0.0224884048328075,0.00285426134509608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0125068101742809,0.00419336106378249,0.00428782248926725,0.0207257978592946,0.00286391328703185
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.016095175285726,0.00539788112890353,-0.0266750222983769,-0.00551532827307505,0.00287230715961034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.023111553739448,0.00775890593631995,-0.0383190093746351,-0.00790409810426084,0.00289989122533963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0255863977806216,0.00859315434030805,-0.0424289802876254,-0.00874381527361778,0.00291210234073796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0269757397862451,0.00906589035375639,-0.0447448848796076,-0.00920659469288253,0.00293126248220817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0253350747644488,0.00851835005863342,-0.0420310408793703,-0.00863910864952726,0.00294397532756731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.00892517712013851,0.00300113281885464,0.00304295679518342,0.0148073974450936,0.00294525371849299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0109031114532416,0.00366896049819718,0.00371194887677517,0.0180942740297081,0.00296761654511364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0223683571789954,0.00753447769743636,-0.0371359334659707,-0.00760078089202013,0.00299493530940002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.00936181800651991,0.00316014720925244,-0.0155557065366547,-0.00316792947638512,0.00305725021262254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0181039961962134,0.00611760572696447,-0.0300945034210638,-0.00611348897136306,0.00308844610216189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.019850865863064,0.00671208916788208,-0.0330065606321128,-0.00669517109401508,0.00310818454583746
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0154193271594816,0.00521516091553173,-0.0256410425539238,-0.0051976117650394,0.00311552202787393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.0154915431222607,0.00524131404669221,0.00521856759074401,0.0257645186537775,0.00312643075643531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0149903984292331,0.00507245797687083,-0.0249324160638999,-0.00504838079456624,0.00312953523515963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0249485115665523,0.00844300914329107,-0.0414968094874028,-0.00840021364570183,0.00313279495121833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0181923175382022,0.00616254608026127,-0.0302709078555142,-0.00611372722089008,0.00316314463717923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.0206901583487564,0.00702356907289918,-0.0344563537316388,-0.00692396296587405,0.0032265563849315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,40199,0.016498383304212,0.00560501715182952,0.00551254968662611,0.0274842169217978,0.00325198828015769
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42664,-0.0125129444326606,0.00425513350740333,-0.0208530061071711,-0.00417288275815007,0.00328059890520414
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0128469901866111,0.00437292076921924,-0.0214179148942809,-0.00427606547894144,0.00331179734851594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LXN,Latexin,42461,0.0196727933425641,0.00670113476341328,0.00653856920627409,0.0328070174788542,0.00333323448468541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0100811975847212,0.00343398500292891,-0.0168118081904619,-0.00335058697898055,0.00333352215118891
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0208088279706479,0.00711161812121935,-0.0347475994882378,-0.00687005645305802,0.00343903442427895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.0283577702090375,0.00971170124510364,-0.0473927046494406,-0.00932283576863432,0.00350767957996483
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0150931072611317,0.00517191924640826,-0.0252300689840918,-0.00495614553817147,0.00352566174542489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.00835509605897174,0.00286731932382032,-0.0139750419336596,-0.00273515018428392,0.00357523501923944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.020437314815428,0.00701398553556958,-0.0341847264651443,-0.00668990316571158,0.00357765220694106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.00866997250614593,0.00297624770497594,-0.0145034180078988,-0.00283652700439308,0.00358499180835389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.0220956835849922,0.00758926964902294,-0.0369706520970772,-0.00722071507290726,0.0036047607295687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,40511,0.00872275205534543,0.00299845455227688,0.00284578113288274,0.0145997229778081,0.00363196497531022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0117866443788727,0.00405433181250154,-0.0197331347313757,-0.00384015402636969,0.00365423311122179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00881371997487774,0.00303379861178028,0.0028674746957884,0.0147599652539671,0.00367653378370923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0180164971065793,0.00620261517113836,-0.0301736228420105,-0.00585937137114812,0.00368383421707383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0196228213034149,0.00675594869027285,-0.0328644807363497,-0.00638116187048011,0.00368411987890788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,40283,0.0100747442280767,0.00346940431504114,0.00327471177059604,0.0168747766855573,0.00369293153961531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0120758976151949,0.00416537931007722,-0.0202400410629462,-0.00391175416744353,0.00374956261142223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,42209,0.0198518589883548,0.00685037943583444,0.00642511529411933,0.0332786026825903,0.00376271925886724
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0231862307962929,0.00800515485446464,-0.0388763343110436,-0.00749612728154226,0.00378076829097813
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00991387090045908,0.00342555991297904,0.00319977347102016,0.016627968329898,0.00380866219796548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0197037258602541,0.00684243032999628,-0.0331148893070468,-0.00629256241346136,0.00398905119538319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0213742384165352,0.00744394592255066,-0.0359643724247345,-0.00678410440833595,0.00409350743454051
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,0.00606373926746924,0.00211208950225221,0.0019240438430549,0.0102034346918836,0.00409859687428744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.0277863976007584,0.00967883646755651,-0.0467569170771692,-0.00881587812434765,0.00410035143854768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0280796348310069,0.00981014215392184,-0.0473075134526937,-0.00885175620932005,0.00421226394248548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0136726741405352,0.00478847284673163,-0.0230580809201292,-0.00428726736094121,0.0043059177816663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0112285641991295,0.00393267345319809,0.00352052423086122,0.0189366041673977,0.00430773854651166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.012325214869075,0.0043219497107888,-0.0207962363022211,-0.00385419343592897,0.0043555434751507
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42626,0.0187165210354848,0.00656540728720965,0.00584832275255392,0.0315847193184157,0.00436788005548961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.00726202692950307,0.00254852158327943,0.00226692462627538,0.0122571292327308,0.00438683323170106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0206698385925522,0.00725527678204069,-0.034890181085352,-0.00644949609975247,0.00439465408003037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.0119458605429379,0.00419576528964326,0.00372216057523707,0.0201695605106386,0.00441988433310084
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0288831195133295,0.0101481061021282,-0.0487734074735007,-0.0089928315531582,0.00443173138828672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,40199,-0.0119625276180612,0.00420337884984744,-0.0202011501637622,-0.00372390507236023,0.0044363582813871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00781307045987879,0.00274579160661912,0.00243131891090532,0.0131948220088523,0.00444125863025454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.00791511409219251,0.00278255298640711,0.00246131023883458,0.0133689179455504,0.00445410119930021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0110594912276711,0.00388968050899847,0.00343571743003414,0.0186832650253081,0.00447179436901123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42679,-0.0196464312101146,0.00691283765725722,-0.0331955930183388,-0.00609726940189048,0.00448957835722058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,40418,-0.0128637724930532,0.00452704938449958,-0.0217367892866723,-0.003990755699434,0.00449777280990392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,40527,0.0253868964062055,0.00897110352032277,0.00780353350637286,0.0429702593060381,0.00466514038487396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.0127534416220982,0.00451297822037972,-0.0215988789340424,-0.00390800431015394,0.00472250660844839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0177311816799688,0.00629369730313966,-0.0300668283941226,-0.00539553496581508,0.00485143012912813
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0121090619706424,0.0043045166853313,-0.0205459146738917,-0.00367220926739302,0.00491382214933265
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42676,-0.0099369440924986,0.00353289085469731,-0.0168614101677053,-0.00301247801729187,0.00491992690043013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0135856133936405,0.00484365129883527,-0.0230791699393576,-0.00409205684792339,0.00504293431592164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.0110228198692612,0.00392995371446039,0.00332011058891881,0.0187255291496035,0.00504301262452264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0189068843515301,0.00674238828789783,-0.0321219653958099,-0.00569180330725036,0.00505182961851123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0245350645811944,0.0087612529605649,-0.0417071203839016,-0.0073630087784872,0.00511271772668472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.0101454413899233,0.00362735238257873,0.003035830720069,0.0172550520597776,0.00516781978245901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.0164849319556914,0.00590440980281747,-0.0280575751692137,-0.0049122887421692,0.00524615328760275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.00799357504353248,0.00286610551507909,-0.0136111418530875,-0.00237600823397747,0.00529594801503743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0172962543286731,0.00620608182663371,-0.0294601747088752,-0.00513233394847105,0.00532752273531131
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0322329229788858,0.0115756727765976,-0.054921241621017,-0.00954460433675453,0.00536959814218974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42636,-0.0184277478075641,0.00662404534882534,-0.0314108766912618,-0.00544461892386642,0.00541090505549299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.0149774633574096,0.00539252840395247,-0.0255468190291564,-0.00440810768566272,0.00548655207335348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42676,0.02130871491651,0.00767646668153668,0.0062628402206981,0.0363545896123219,0.00551336187070699
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,40483,-0.0372064341780099,0.0134175504064755,-0.0635048329747019,-0.0109080353813179,0.00556387480298522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.00937023502626788,0.00339027691084256,-0.0160151777715193,-0.00272529228101646,0.00572001258482697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,40199,-0.0136433261222002,0.00494195732087041,-0.0233295624711062,-0.00395708977329417,0.00577708386363839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0166228810875517,0.006034133620311,-0.0284497829833612,-0.00479597919174213,0.00588206293237946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0152094009337721,0.00552234582906004,-0.0260331987587298,-0.00438560310881442,0.00589414194270794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.00889490553653675,0.00323104881730238,-0.0152277612184494,-0.00256204985462409,0.0059155885632121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0121026561178514,0.00439866879072769,-0.0207240469476776,-0.00348126528802511,0.00594157520543713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42636,0.0105523827643097,0.00383963624938693,0.0030266957155113,0.0180780698131081,0.00599893427428155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,40223,-0.0140458064578385,0.00511405886472512,-0.0240693618326997,-0.00402225108297723,0.00603310162064405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.010699889052418,0.00389829167409303,-0.0183405407336403,-0.00305923737119564,0.00606534621623241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42611,-0.0200536903636161,0.00730988932529545,-0.0343810734411952,-0.00572630728603706,0.00608939006669816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,40136,0.0250285323046993,0.00912434543653753,0.00714481524908573,0.0429122493603129,0.00609705588105647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42587,-0.0208973789840474,0.00762432090387782,-0.0358410479556479,-0.00595371001244684,0.00613553811093505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.0188128332618885,0.00687448002013305,-0.0322868141013493,-0.00533885242242776,0.00621554055391209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,0.00734121653429497,0.00268369010443801,0.00208118392959646,0.0126012491389935,0.00623837065250685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0111499135913288,0.00408276908948269,-0.0191521410067149,-0.00314768617594277,0.00632465744943287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42594,-0.00969431733894742,0.00355058916096188,-0.0166534720944327,-0.00273516258346213,0.00633516310270066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.0074283251451092,0.00272898833587807,-0.0127771422834302,-0.00207950800678817,0.00649863581859634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42636,0.012703731064612,0.00466743378698015,0.00355556084213095,0.0218519012870931,0.00650148674059476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.00968766707703518,0.00355988979934048,-0.0166650510837425,-0.00271028307032785,0.00651012854265484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.020216364137562,0.00744029844026328,-0.034799349080478,-0.00563337919464598,0.00659483049030757
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0128939207050395,0.00474614078476349,0.00359148476690302,0.0221963566431759,0.00660371729564801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.0128942076070574,0.0047465914014492,0.00359088846021697,0.0221975267538978,0.00660762088851384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0187693411995501,0.00692135631211664,-0.0323351995712987,-0.00520348282780144,0.00670200558538183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0212491826611238,0.00784257853090528,0.00587772874054947,0.0366206365816981,0.00674774725838697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0193430875278323,0.00714035472187184,-0.0333381827827011,-0.00534799227296347,0.00675778704175843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,40532,-0.00644054634932067,0.00238022948384155,-0.0111057961376501,-0.00177529656099123,0.00682314949220178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0110176037649325,0.00407697809846951,0.0030267266919323,0.0190084808379328,0.00689274324181164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0248466795532072,0.00919500317309084,-0.0428688857724653,-0.00682447333394917,0.00689696794873606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,40136,0.0133529805567039,0.00494240771973686,0.00366586142601967,0.0230400996873882,0.00690890338525233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0191054670420854,0.00707267665531729,-0.0329679132865072,-0.00524302079766348,0.0069156013244858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0065387573499444,0.0024233563849564,-0.0112885358644589,-0.00178897883542986,0.00697980198160081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.00712817902826167,0.00264259669347125,-0.0123076685474653,-0.00194868950905802,0.00699675222870105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,40532,-0.0242849450743438,0.00901816458186884,-0.0419605476548067,-0.00660934249388084,0.00709392955456804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0107172791538377,0.00399415888720561,0.00288872773491473,0.0185458305727607,0.00730229107135589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.00758831330967482,0.00283329934211305,-0.0131415800202164,-0.00203504659913325,0.00741125517143071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.0338107090295119,0.0126254803844899,-0.0585566505831121,-0.0090647674759117,0.00741584783937239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0174254322857198,0.006515348352634,-0.0301955150568824,-0.00465534951455715,0.00749457840478595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.0057476606456202,0.00214960305206606,-0.00996088262766968,-0.00153443866357073,0.00751024740384747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.0222738230097719,0.00833248041744085,-0.038605484627956,-0.00594216139158787,0.00752393412289123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00859688446197948,0.00322365565440542,-0.0149152495446141,-0.00227851937934485,0.0076666277603571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0162556541306511,0.00612056881265421,-0.0282519690034534,-0.00425933925784888,0.00791887408808241
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.0102921329972002,0.00388166029730823,0.00268407881447604,0.0179001871799243,0.00802562671821773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0112569696841369,0.00424926859665685,-0.0195855361335843,-0.00292840323468947,0.00807898298647696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0177033790153635,0.00669250726321795,-0.0308206932512707,-0.00458606477945632,0.00817243755891572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,40539,0.00605598728989014,0.00228931787559051,0.00156892425373274,0.0105430503260475,0.00817252440884925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0124894708070011,0.00472628435357103,0.00322595347400184,0.0217529881400003,0.00824006261777408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0127043407296647,0.00480909690901268,-0.0221301706713295,-0.00327851078799981,0.00825813715561794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0309575226637515,0.0117223524899209,-0.0539333335439966,-0.00798171178350648,0.00827823259944133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.019680484196019,0.0074584584365617,-0.03429906273168,-0.00506190566035808,0.00833275182511398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.00842853099734501,0.00319640418273995,-0.0146934831955153,-0.0021635787991747,0.00837872619349092
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.00995310302526924,0.00378222104067292,-0.0173662562649882,-0.00253994978555031,0.00851122979114593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42721,-0.00773723005808352,0.00294546201232389,-0.0135103356022383,-0.00196412451392871,0.0086281360272863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,42357,-0.0148122923507561,0.00563959387247895,-0.0258658963408148,-0.0037586883606973,0.00863724326123297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42676,-0.0237379711572749,0.00904843640158507,-0.0414729065043816,-0.00600303581016813,0.00871464454530035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.0170853478677192,0.00651868490631213,-0.029861970284091,-0.0043087254513474,0.00877778772767985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0229261300084684,0.00874746306667552,-0.0400711576191524,-0.00578110239778437,0.0087799992726086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0144673980956709,0.00553020616492468,-0.0253066021789233,-0.00362819401241855,0.00890699209962079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0110901112138136,0.00425245659017532,-0.0194249261305572,-0.00275529629706993,0.00912146638991921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0212550878269809,0.00815112236463696,-0.0372312876616694,-0.00527888799229249,0.00912925342432135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.0102614882991627,0.00393560746076388,0.00254769767606554,0.01797527892226,0.00913701140760847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.00432994675379138,0.00166304845032409,-0.0075895217164266,-0.00107037179115617,0.00923650183230263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0127842671449922,0.00491764466316675,-0.022422850684799,-0.00314568360518538,0.00934370190692434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.0102374612264617,0.0039384486230915,0.00251810192520234,0.017956820527721,0.00935210995092073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,40182,-0.0107705554304531,0.00414776646368398,-0.0189001776992737,-0.00264093316163252,0.00942461451709446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,42370,-0.0290231183813491,0.0111869664788727,-0.0509495726799397,-0.00709666408275864,0.00948696618767249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2,Prothrombin,40539,0.00383249510054837,0.00147739191787172,0.000936806941519801,0.00672818325957695,0.00949621728745128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.0160754161573326,0.00621831601441658,-0.0282633155455891,-0.00388751676907615,0.0097456323019276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0117217278526156,0.00454103309421251,-0.0206221527172721,-0.00282130298795906,0.00985607142753761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0134034100948638,0.00519706173902751,-0.0235896511033577,-0.00321716908636985,0.00991808494707386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42611,0.0168114189031286,0.00653510275090873,0.00400261751134749,0.0296202202949097,0.0101079422418464
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.026001828382193,0.0101153813588892,-0.0458279758456158,-0.0061756809187702,0.0101674325295159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0155387980181545,0.00604783849318237,-0.027392561464792,-0.0036850345715171,0.0102007163690261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0110031606027432,0.00428414039833577,-0.0194000757834813,-0.00260624542200514,0.0102291390408697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.00995713450184021,0.00388646219249778,-0.0175746003991359,-0.00233966860454456,0.0104202852386744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,40511,0.0068183199806112,0.0026653000038798,0.00159433197300678,0.0120423079882156,0.0105350334165661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.0183014698008977,0.00715432893205581,-0.0323239545077271,-0.0042789850940683,0.0105354333608221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0116759898322753,0.0045651316273508,-0.0206236478218829,-0.00272833184266777,0.0105513220357021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.00963181294586203,0.00377060827496544,-0.0170222051647943,-0.00224142072692977,0.010648719253435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.0134120508711078,0.00525660599037749,-0.0237149986122477,-0.00310910312996795,0.0107381880940473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.00703937637897697,0.0027593738289732,-0.0124477490837644,-0.0016310036741895,0.010752473322585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0142513832179153,0.00559371116072872,-0.0252150570929436,-0.00328770934288697,0.0108532383360913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,40223,-0.00770124234269722,0.00302414259767202,-0.0136285618341344,-0.00177392285126007,0.0108916785042246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0145932130180953,0.00573423098248243,-0.0258323057437609,-0.00335412029242976,0.0109411579478841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00733700125420843,0.00288345098504427,0.00168543732352165,0.0129885651848952,0.0109563957520229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.00794618188393961,0.00312301002745979,-0.0140672815377608,-0.00182508223011841,0.0109579456095886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0215613728799674,0.00847574805837916,-0.0381738390743906,-0.00494890668554428,0.0109736331840293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.014873703310952,0.00584714673210048,-0.026334110905869,-0.00341329571603507,0.010980079479651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42710,0.0112119009564621,0.00441372244235799,0.00256100496944045,0.0198627969434838,0.0110888324948993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00901341239000805,0.00355614889032037,0.00204336056498012,0.015983464215036,0.0112688854130042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00875076956264805,0.00345354932725687,-0.0155197262440715,-0.00198181288122458,0.011292989226884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.0090118655279898,0.0035686163707444,0.00201737744133078,0.0160063536146488,0.0115709555754937
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,40199,-0.0103081001306095,0.00408195903177368,-0.0183087398328859,-0.00230746042833306,0.011574454263231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0122799891064287,0.00486665682231605,-0.0218186364781681,-0.00274134173468921,0.0116400665899058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42543,-0.00817194862211989,0.00324346483683058,-0.0145291397023078,-0.00181475754193195,0.011763339007012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0428555961777984,0.0170449268752332,0.00944753950234132,0.0762636528532555,0.011939579907328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0208435249679828,0.00830058525984177,-0.0371126720772726,-0.00457437785869291,0.012050099595976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0290770798239856,0.011584256906918,-0.051782223361545,-0.00637193628642621,0.0120852774675104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.00707643163945026,0.00281951826049439,-0.0126026874300193,-0.00155017584888125,0.0120914486673495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.0185487683980636,0.00740340973565625,-0.0330594514799498,-0.00403808531617732,0.0122418019069623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0165744813387701,0.0066235191130454,-0.0295565788003391,-0.00359238387720108,0.0123483839567531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,40223,0.0134556585226635,0.00538284156315245,0.00290528905888466,0.0240060279864423,0.0124431587089125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.0141197584613611,0.0056618158776241,-0.0252169175815044,-0.00302259934121791,0.0126509112842389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.00921219289748649,0.00369697729176001,-0.0164582683893361,-0.00196611740563688,0.0127235992709293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.00825076759621884,0.00331250600972279,-0.0147432793752755,-0.00175825581716218,0.0127604745927431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.00989535793387249,0.00397518663312398,-0.0176867237347955,-0.00210399213294949,0.0128148189477959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.0103973516988053,0.00418051588771598,0.00220354055888194,0.0185911628387286,0.0128937858839209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.0155163156809014,0.00624015778353211,0.00328560642517845,0.0277470249366243,0.0129117751253941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0228696277748372,0.00920297589862804,-0.0409074605361482,-0.00483179501352627,0.0129664213726815
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.00827743985600336,0.00333243765748587,-0.0148090176646757,-0.00174586204733106,0.0130099861632387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0215830596009285,0.00870318359901912,-0.0386412994550059,-0.00452481974685099,0.0131563121839305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.00675096372532731,0.00272264605901534,0.00141457744965723,0.0120873500009974,0.0131690052295779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0118248030445677,0.00476918202270907,0.00247720628005791,0.0211723998090775,0.0131746133313585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.00921091793766039,0.00371672291053194,-0.016495694842303,-0.00192614103301778,0.013218359677434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.0196719598395395,0.00797324984710212,-0.0352995295398596,-0.0040443901392193,0.0136308297013824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0205282410044025,0.00832490636352442,-0.0368450574769103,-0.0042114245318946,0.0136799300123189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42594,-0.00763832666292565,0.0030980350337106,-0.0137104753289984,-0.00156617799685286,0.0136931592907887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42794,0.00763163780496509,0.00309586042680632,0.0015637513684247,0.0136995242415055,0.0137093644306312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,42370,-0.0116878790664861,0.00474569108197604,-0.0209894335871591,-0.00238632454581308,0.0137968260883994
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42587,-0.0133711253150154,0.00543249161974482,-0.0240188088897152,-0.00272344174031551,0.01385502095861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.017462423084725,0.00709908481205078,-0.0313766293163445,-0.00354821685310544,0.0139133913653154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0079745470412771,0.003244266261174,-0.0143333089131781,-0.00161578516937606,0.0139824096079986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.00829874954627828,0.00338031391298275,0.00167333427683209,0.0149241648157245,0.0141029941921053
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.014207794075931,0.0057894027939463,-0.0255550235520657,-0.00286056459979622,0.0141386684436629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.00940399442033842,0.00383861893029528,-0.0169276875237172,-0.00188030131695967,0.0143049944686033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,0.00531955523167757,0.00217239842810161,0.00106165431259841,0.00957745615075672,0.0143498679043801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0205465344922291,0.00840454615422836,-0.0370194449545166,-0.00407362402994147,0.014513009931199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,40419,0.00828190980972686,0.00338882256892361,0.00163981757463659,0.0149240020448171,0.014545140155352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0133616478260526,0.00547884481547335,-0.0241001836643804,-0.00262311198772481,0.0147504400103089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00632119733767654,0.00259304561901667,0.00123882792440387,0.0114035667509492,0.0147919019134012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.00793409423246181,0.00326024636914144,0.00154401134894458,0.014324177115979,0.0149653783605539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0122011140918645,0.00501872304374692,-0.0220378112576085,-0.00236441692612055,0.0150655651419793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0132609936893944,0.00545456886709514,-0.0239519486689008,-0.0025700387098879,0.0150660568471945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.00619341045136695,0.00255132271133042,0.00119281793715933,0.0111940029655746,0.0152151237075471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.0117778494697243,0.00485414781163214,0.00226371975892535,0.0212919791805233,0.0152647656252853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00546449174170889,0.00225466343291128,0.00104535141320279,0.009883632070215,0.0153788017410787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,40116,0.0137434123527778,0.00567251590136248,0.00262528118610737,0.0248615435194483,0.015417252129005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0138222239186225,0.0057104956198704,0.00262965250367653,0.0250147953335685,0.0155128637493799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.0135188712325709,0.00559068263864101,0.00256113326083454,0.0244766092043073,0.0156150027495376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0142258619764332,0.00588352538819124,0.0026941522155784,0.0257575717372881,0.0156259670003641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0134789120320669,0.00559618030450909,-0.0244474254289047,-0.00251039863522905,0.0160304198291234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,40483,-0.019882562272851,0.00825918537653088,-0.0360705656108515,-0.00369455893485049,0.0160857063865941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.00820375182519678,0.00341145324527734,-0.0148902001859404,-0.00151730346445319,0.0161988013818497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0277265262992292,0.011545158466738,-0.0503550368940357,-0.0050980157044226,0.0163408718687945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0167655568637019,0.00698132840780418,0.00308215318440573,0.0304489605429981,0.016342573294362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.00698450423628316,0.00290989378982262,-0.0126878960643355,-0.00128111240823082,0.0163994817802984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0162969401490569,0.00680298673159492,-0.0296307941429829,-0.00296308615513085,0.0166115990239713
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0254796559148381,0.0106405552600865,-0.0463351442246076,-0.00462416760506852,0.0166556414251268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42721,0.00589277520725693,0.002465782975739,0.00105984057480849,0.0107257098397054,0.0168702800390663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0180593191801394,0.00755882672154518,-0.032874619554368,-0.00324401880591088,0.0169030868612006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0128162999132834,0.00536634695749867,-0.0233343399499808,-0.00229825987658601,0.0169441115091144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,42346,0.0127608890746023,0.00534549225095514,0.00228372426273019,0.0232380538864743,0.0169901692830122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,42346,-0.0136284089893846,0.00571753262582747,-0.0248347729360065,-0.00242204504276279,0.0171575288063251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0121933231239305,0.00511831796766893,-0.0222252263405616,-0.00216141990729942,0.0172217976874443
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42689,0.00712781822237793,0.00299598655909101,0.00125568456655954,0.0129999518781963,0.0173677424751333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0161829041880181,0.00680571758509914,-0.0295221106548124,-0.00284369772122378,0.0174314064562232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.016260369414217,0.00685042083602992,-0.0296871942528357,-0.0028335445755984,0.0176313517606233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0164420137743642,0.00692957340564366,-0.0300239776494257,-0.0028600498993026,0.0176740434038867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42705,0.00650395791844755,0.00274671762099483,0.00112039138129769,0.0118875244555974,0.0179032761803013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,40283,-0.0127262179550447,0.00538363034797527,-0.0232781334370763,-0.00217430247301321,0.0181021560258408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42611,0.00472401795025143,0.00200101407863597,0.000802030356124923,0.00864600554437793,0.0182491939160914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0341606030887173,0.0144810815261249,0.00577768329751249,0.0625435228799222,0.0183420349909905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0186352490328017,0.00790949870316772,-0.0341378664910104,-0.00313263157459292,0.0184873990083041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,0.0067506868995962,0.00286899284989091,0.00112746091381001,0.0123739128853824,0.0186378924352202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.00691575723271994,0.00294049322873953,-0.0126791239610494,-0.00115239050439046,0.0186951286404743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,40199,0.00405487323859628,0.0017267214400053,0.000670499216185902,0.00743924726100667,0.0188765355264373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.0186379366598174,0.00794158688163246,-0.034203446947817,-0.00307242637181774,0.0189492687542085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPART,Spartin,40283,-0.0177674476536146,0.00759616884748369,-0.0326559385946827,-0.00287895671254659,0.0193530365525111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.00885993256952458,0.00379208637353193,-0.0162924218616472,-0.001427443277402,0.0194864064618755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0087447164350112,0.00374617101278688,0.00140222124994892,0.0160872116200735,0.0195970537950542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.0103833339967966,0.00445004243034158,0.00166125083332713,0.0191054171602661,0.0196492845815621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.013912352630607,0.00596415373165511,-0.0256020939446511,-0.00222261131656303,0.0196839786051724
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42594,-0.0214028070914272,0.00920666258659489,-0.0394478657611532,-0.00335774842170123,0.0201024148077703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.0192011869371314,0.00826518606328859,0.00300142225308577,0.0354009516211771,0.0201896112611503
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.0079231956924862,0.00341220882107603,0.00123526640317718,0.0146111249817952,0.020247089063971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,42370,0.0320562527926722,0.0138170729535395,0.00497478980373487,0.0591377157816095,0.0203535571561419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0180275799204332,0.00778011516429868,-0.0332766056424586,-0.00277855419840774,0.0205114668884621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.0134442941564357,0.00580300498034351,-0.024818183917909,-0.00207040439496241,0.0205307935460952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,40384,-0.0102525345549967,0.00442917139172855,-0.0189337104827847,-0.00157135862720879,0.020643263627755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,42357,-0.017829353062685,0.00770912616932309,-0.0329392403545582,-0.00271946577081174,0.0207512209710427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0120159367611494,0.00519568701936191,-0.0221994833190987,-0.00183239020320001,0.0207583930341052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42794,-0.0164469027945247,0.0071191818687689,-0.0304004992573118,-0.00249330633173766,0.02089066501539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,40527,-0.0189281050798928,0.00819896047820433,-0.0349980676171733,-0.00285814254261232,0.0209837963746334
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42636,0.00599972717914646,0.00259999467618993,0.000903737613814205,0.0110957167444787,0.0210369481568323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0121883093284115,0.00528359415061029,0.00183246479321531,0.0225441538636076,0.0210802673964668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0112529844095041,0.00488251526550216,-0.0208227143298883,-0.00168325448911985,0.0211959789478888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0120328658783597,0.00522905710138427,-0.0222818177970728,-0.0017839139596465,0.021401482392861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0248724027207246,0.0108405074832309,-0.0461197973878572,-0.00362500805359199,0.0217835055889616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.0127824263682641,0.00557135864176427,-0.0237022893061221,-0.00186256343040616,0.0217914706118817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.00786419521701324,0.00343164303592633,-0.0145902155674288,-0.00113817486659763,0.0219404325573917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,40199,0.00667757599914216,0.00291479006358502,0.000964587474515526,0.0123905645237688,0.0219863549292001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0129516986437344,0.0056568020769393,-0.0240390307145354,-0.00186436657293337,0.0220643150051883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0204326178739578,0.00893118676530719,-0.0379377439339599,-0.00292749181395572,0.0221690365350266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00562983689634883,0.00246434875728228,0.000799713332075554,0.0104599604606221,0.0223571220172011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.015505000496768,0.00678920916378096,-0.0288118504577787,-0.00219815053575733,0.0224005620689929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.00929938202513717,0.00407532711329285,-0.0172870231671911,-0.00131174088308319,0.0225153724133377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0157952855410931,0.00694756126065584,0.00217806547020764,0.0294125056119785,0.0230150247451157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,40527,0.0221554883248429,0.00974796652635851,0.00304947393318017,0.0412615027165056,0.0230549562315049
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,42292,-0.00825343418891027,0.00363502353406404,-0.0153780803156758,-0.00112878806214475,0.0231915423204114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0187762509537446,0.00827245497195496,-0.0349902626987764,-0.00256223920871292,0.023242660193101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0150547606587592,0.00664232844696241,-0.0280737244148055,-0.00203579690271284,0.0234403366304808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.0071124819044626,0.00314176280100095,0.000954626814500744,0.0132703369944244,0.0236027118564652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0124803615429049,0.00552013832251021,-0.0232998326550249,-0.00166089043078488,0.0237830282512534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0105626816231288,0.00467411698648712,-0.0197239509166435,-0.001401412329614,0.0238483024310449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0193807792878557,0.00859353329022802,-0.0362241045367026,-0.00253745403900875,0.0241352116222866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0146721135467926,0.00650783654620709,-0.0274274731773585,-0.00191675391622666,0.0241821160557314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42679,-0.0128619041320312,0.00571427869043558,-0.0240618903652849,-0.00166191789877742,0.0244119673357191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0185277186752304,0.00823778990332889,-0.034673786885755,-0.00238165046470574,0.0245213902966992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.0115684098064649,0.00514462573913637,-0.0216518762551722,-0.00148494335775758,0.0245519116619268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00706836994886716,0.00314507203463462,0.000904028760983298,0.013232711136751,0.0246315729988856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,42346,-0.0146844692681976,0.00653777911757456,-0.0274985163386437,-0.00187042219775143,0.0247144892653393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,0.00703950387017343,0.00314144383041096,0.000882273962567952,0.0131967337777789,0.0250520662816563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,42370,-0.0188000849591054,0.00841848240307275,-0.035300310469128,-0.00229985944908285,0.0255530298454281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00807909641137785,0.00362048304814958,0.000982949637004667,0.015175243185751,0.0256683275637149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42679,-0.00761656813674888,0.00342202519118496,-0.0143237375114714,-0.000909398762026365,0.0260474852522966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0190847536280368,0.00858776706020468,-0.035916777066038,-0.00225273019003566,0.0262818500592024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0190180186729674,0.00855835850102287,0.00224363601096258,0.0357924013349722,0.0262893404846184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0137270672863905,0.00617809674277574,-0.0258361369022309,-0.00161799767055002,0.0263108242787448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.00654457625221797,0.00294879533689288,-0.012324215112528,-0.00076493739190792,0.0264789237327904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.0098271025962357,0.00443016822491312,-0.0185102323170654,-0.00114397287540598,0.0265599414976478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,0.00902710356105633,0.00407022841435343,0.0010494558689236,0.0170047512531891,0.0265857720778499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00457564087470097,0.00206758221828696,0.000523179726858534,0.00862810202254341,0.0269155271916282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,40463,-0.0215114614133715,0.00973176144312587,-0.0405857138418982,-0.0024372089848448,0.0270947501160164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.00583395343291175,0.00264121607824461,-0.0110107369462712,-0.000657169919552314,0.0272046335795179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0105799800794322,0.00479214349205375,-0.0199725813238576,-0.00118737883500689,0.0272800557846237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,0.0133197210143903,0.00603523390990206,0.00149066255098225,0.0251487794777983,0.027331256226546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0106345881847699,0.00482739965838136,-0.0200962915151973,-0.00117288485434239,0.0276142363948865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,40116,-0.00876142703413378,0.00398531734725723,-0.016572649034758,-0.000950205033509617,0.027939630835768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00615650805938667,0.00280803239073234,-0.0116602515452221,-0.000652764573551284,0.0283664071102895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.00659935777931845,0.00301020066402015,-0.0124993510807979,-0.000699364477838965,0.0283758694449339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.00719771786699731,0.00328327053501935,-0.0136329281156352,-0.000762507618359386,0.0283793100797781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0115135575661326,0.00525618306095942,-0.021815676365613,-0.00121143876665212,0.0285104678367155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,40451,-0.0152445253804217,0.00696135767474592,-0.0288887864229237,-0.00160026433791969,0.0285535205920297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,40302,0.00771810499159091,0.00352471929835302,0.000809655166818998,0.0146265548163628,0.028566168842565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.0128385124169254,0.00586334321917064,-0.0243306651264998,-0.00134635970735091,0.0285690807347047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,40182,0.0151314172251377,0.00694128256817559,0.00152650339151352,0.0287363310587618,0.0292847957560292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0191371023054054,0.0087823684101123,-0.0363505443892255,-0.00192366022158528,0.0293496170869862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,40449,0.0143262800366361,0.00658069495871305,0.00142811791755853,0.0272244421557137,0.0295000617429101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.006836827470605,0.00314430182571044,0.000673995892212529,0.0129996590489975,0.0296962588102908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0117436820356729,0.00540494481826359,-0.0223373738794695,-0.00114999019187627,0.0298153832236527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0114466394366859,0.0052681669251097,-0.0217722466099009,-0.00112103226347086,0.0298166431474293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42721,-0.0233812030714018,0.010762421293623,-0.0444755488069029,-0.00228685733590075,0.0298363750807902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.00651528545717842,0.00300431221055932,-0.0124037373898747,-0.000626833524482154,0.0301309785665119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,40449,-0.0218623997219725,0.0100876632004856,-0.0416342195949242,-0.00209057984902079,0.0302373664650562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCN,Decorin,42357,0.00517735607075293,0.00238905102193717,0.000494816067756086,0.00985989607374978,0.030243712968311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42587,0.00610143643471811,0.00281808668800737,0.00057798652622367,0.0116248863432126,0.0303977117528064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42613,-0.00834566197696073,0.00385569355724269,-0.0159028213491564,-0.000788502604765063,0.030443309252017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0154339114247187,0.0071324636214367,0.00145428272670275,0.0294135401227346,0.0304939188980175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.00875959633961932,0.00405010793540975,-0.0166978078930224,-0.000821384786216201,0.0305769666728384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0193540015277014,0.00895084693321362,-0.0368976615168001,-0.00181034153860273,0.0306195151402643
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.00630859205216208,0.00292046856322788,-0.0120327104360887,-0.000584473668235431,0.0307805736778859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.00947154589686421,0.00438758623210222,-0.0180712149117846,-0.000871876881943857,0.0308900317444527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0124514240104984,0.00578632797030701,-0.0237926268323002,-0.00111022118869669,0.0314288202844784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.00442491461991563,0.00205948573828171,-0.00846150666694778,-0.000388322572883479,0.0316915893890183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00695054789173224,0.00324145303230362,0.000597299948417155,0.0133037958350473,0.032033327174855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0143734640163558,0.00670377677110199,-0.0275128664877157,-0.00123406154499585,0.0320474069594471
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0187226848350636,0.00873363601442193,-0.0358406114233306,-0.00160475824679666,0.0320754759786124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.00996454068021617,0.00465650201852917,-0.0190912846365333,-0.000837796723899002,0.0323796725677722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0103248490192227,0.00482660191191248,-0.0197849887665712,-0.000864709271874275,0.0324450189296559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,40449,-0.0160001137903581,0.00748699530018788,-0.0306746245787264,-0.00132560300198987,0.0326150867338345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0127149366335037,0.00595568825475268,-0.024388085612819,-0.00104178765418846,0.0327888233484057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42794,-0.00534572256040416,0.00250462886452803,-0.0102547951348791,-0.000436649985929218,0.0328330182802303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.00607412167441761,0.00284930145694327,0.0004894908188088,0.0116587525300264,0.0330421464676033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,0.010004874662695,0.00469528301486167,0.000802119953566105,0.0192076293718239,0.033121003543874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.00735542743166998,0.00346294599040949,-0.0141428015728726,-0.000568053290467376,0.0336890324847101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0241920938837158,0.0113965692966764,-0.0465293697052016,-0.00185481806223001,0.0337929055483473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0223942180016459,0.0105543588117918,-0.0430807612727579,-0.00170767473053387,0.0338763672761442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,40285,-0.00451667708362892,0.00212888269372832,-0.00868928716333644,-0.000344067003921408,0.0338918928805288
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,40511,-0.0113259414909397,0.00535564476269692,-0.0218230052258257,-0.000828877756053737,0.0344716006576925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0104078618691795,0.00492340353355342,-0.0200577327949442,-0.000757990943414793,0.0345377381521449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.00828616302001934,0.00392221706112237,0.000598617580219493,0.0159737084598192,0.0346549544026367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.00951288483425833,0.00451690088738531,-0.0183660105735335,-0.000659759094983127,0.0352207651466374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42638,0.00713611738470114,0.00338927653120698,0.000493135383535454,0.0137790993858668,0.0352664176105295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.00980189451098774,0.00465535977936982,-0.0189263996785526,-0.000677389343422898,0.0352691074494319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0167624997778669,0.00797255255767008,-0.0323887027909002,-0.00113629676483351,0.0355261738220432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.00755528584608043,0.00360393530614474,-0.0146189990461241,-0.000491572646036727,0.0360659307858195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.0124056534368319,0.00591875238405342,0.000804898764087245,0.0240064081095766,0.0361059185669864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.00794143838158258,0.00379048723580456,-0.0153707933637595,-0.000512083399405647,0.0361849592880642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,0.00982768483000652,0.00469771592739687,0.00062016161230866,0.0190352080477044,0.0364603034001122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,40383,0.00624493068854824,0.00299081065844032,0.000382941798005214,0.0121069195790913,0.0368168312400048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.0135516754918529,0.00649808200992567,-0.0262879162313072,-0.000815434752398581,0.0370482116412198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0101002194048554,0.00484605723656098,-0.0195984915885149,-0.000601947221195855,0.037163765184545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.00413508475353497,0.00198427173398293,0.000245912154928418,0.00802425735214152,0.0371853811067825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00845091554278786,0.00405868871727786,0.000495885656923246,0.0164059454286525,0.0373486093102422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.014934922712029,0.00717856769257293,-0.029004915389472,-0.000864930034586099,0.0374998125096621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,40136,0.0196146386636572,0.00942983999611804,0.00113215227126585,0.0380971250560486,0.0375431923842343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.00656524179255706,0.00316368178695723,0.000364425490120878,0.0127660580949932,0.037992252941597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALLD,Palladin,40199,0.00804554517997541,0.00387704047544373,0.000446545848105686,0.0156445445118451,0.0379933113018944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.0127025651953448,0.00612221284009223,0.000703028028763998,0.0247021023619255,0.0380253929493892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,42311,-0.0142321720281922,0.00686856585147277,-0.0276945610970788,-0.000769782959305548,0.0382780980373153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.011572725034052,0.00559692241176652,-0.0225426929611144,-0.000602757106989642,0.0386923422578245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0130357288167727,0.00632244045885027,-0.0254277121161192,-0.000643745517426126,0.0392482373180493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0169036300216267,0.00820067097019148,-0.032976945123202,-0.000830314920051416,0.0392984182135866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42611,-0.0183483094509238,0.00891055071083259,-0.0358129888441557,-0.000883630057691941,0.0394975252814932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0135051607907876,0.00656677932903627,-0.0263760482756987,-0.000634273305876504,0.0397487886541015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0176022032821781,0.00857953530910808,-0.0344180924880299,-0.000786314076326216,0.0402273066681782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.013178093887273,0.00643302467473607,-0.0257868222497557,-0.000569365524790279,0.0405297596845339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00623447766573689,0.00305225945340242,0.000252049137068157,0.0122169061944056,0.041114122409868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,40516,-0.00298477332269994,0.0014618225201854,-0.00584994546226333,-0.000119601183136551,0.0411928649111802
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42608,-0.0118623492155387,0.00582070699750489,-0.0232709349306482,-0.000453763500429076,0.041573833700214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0180009082483054,0.0088365429916789,0.000681283984614742,0.035320532511996,0.0416602847369636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.00381256752899819,0.00187725682133295,-0.00749199089881078,-0.000133144159185607,0.0422823315147811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.0107860537912388,0.00531231985509079,0.000373906875260874,0.0211982007072168,0.0423416157293277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCT,Secretin,40182,-0.0100597180128808,0.00495837087858962,-0.0197781249349164,-0.000341311090845091,0.0424991290992681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.00921669501482852,0.00454558162354768,-0.018126034996982,-0.00030735503267508,0.0426236634484259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.00442287491734449,0.00218261636310644,-0.00870080298903312,-0.000144946845655857,0.0427424310246023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0175302828188773,0.00867157674469529,-0.03452657323848,-0.000533992399274485,0.043239647393621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0150749056377151,0.00745720015576711,-0.0296910179430187,-0.000458793332411569,0.0432491489001346
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0117501854141547,0.00581709254493694,-0.0231516868022311,-0.000348684026078301,0.0434094871665456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00726669037795161,0.00360725444012516,-0.0143369090805969,-0.000196471675306285,0.0439805767521693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.00860830550307632,0.00427535757630769,-0.0169880063526394,-0.000228604653513242,0.0440854705135828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,42311,-0.0148841444032079,0.00740897617571488,-0.0294057377076091,-0.000362551098806735,0.0445645816711584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0114229911333598,0.0056865112077323,-0.0225685531005151,-0.000277429166204476,0.0445801019245024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.00479946611183562,0.00238948980282797,-0.00948286612537845,-0.000116066098292799,0.0446023994367048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.01393208334292,0.00694269531246688,-0.0275397661553551,-0.000324400530484886,0.0448027737649949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,40283,0.0184642859097641,0.00921792844252806,0.000397146162409073,0.0365314256571191,0.0451925549523307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.00903537094164634,0.00451458044985772,-0.0178839486233675,-0.000186793259925216,0.045372070971191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0138986012022609,0.0069536091072386,-0.0275276750524485,-0.00026952735207322,0.045658118174202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),40324,0.0361295190509391,0.0180835093831008,0.000685840660061457,0.0715731974418167,0.0457489413942066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.00715099543846973,0.00358425963387783,-0.0141761443208703,-0.000125846556069186,0.0460513455513055
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0176136744743047,0.00883423210371816,-0.0349287693975923,-0.000298579551017107,0.0461943763088664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,42370,0.0123804037428813,0.00621147482396123,0.000205913087917292,0.0245548943978453,0.0462655635968341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00696472080316087,0.00349499832130101,0.000114524093410883,0.0138149175129109,0.046311654415648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0102039201632025,0.00512452063802811,-0.0202479806137376,-0.00015985971266741,0.046483644798235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.00762770151586592,0.00383384691797882,-0.0151420414751044,-0.000113361556627427,0.0466633727071596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.00810104816967812,0.00407343358052856,-0.0160849779875141,-0.000117118351842135,0.04675261787884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.0166093018007571,0.00836586446027925,-0.0330063961429045,-0.000212207458609809,0.0471283720452395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42794,-0.0169954468837794,0.00856288507133542,-0.0337787016235968,-0.000212192143961943,0.0471889629281765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,40136,0.0100704401651624,0.00507921212650899,0.00011518439720482,0.0200256959331201,0.0474284198071593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0110860154840639,0.00559301248048329,-0.0220483199458112,-0.000123711022316666,0.0474867199466302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.0158120803334615,0.00798044110704994,0.000170415763643635,0.0314537449032794,0.0475766871626975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0148848266638661,0.00751915730597474,-0.0296223749835766,-0.000147278344155632,0.0477749655070928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0179635629180515,0.009077106433366,-0.0357546915274489,-0.00017243430865415,0.0478371728825781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.00908983607507649,0.00459699610853294,-0.018099948447801,-7.97237023519286e-05,0.0480272084118458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.00557576220229762,0.00282103342217164,-0.011104987709754,-4.65366948412139e-05,0.048122831665009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,40483,-0.00760090896067919,0.00385111735275084,-0.0151490989720708,-5.27189492875463e-05,0.0484414329520939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.00890551626896578,0.00451895119500448,-0.0177626606111746,-4.83719267569994e-05,0.0487782770516881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.00710646805448951,0.00360952037108464,-0.0141811279818154,-3.18081271636281e-05,0.0489953802393728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.00800714647591672,0.00407206665754655,2.58958271254738e-05,0.015988397124708,0.0492777317469442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,0.00876931604561963,0.00446591149058648,1.61295240701329e-05,0.0175225025671691,0.0495961748701298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0160283773503159,0.00816643948766039,-0.0320345987461303,-2.21559545015744e-05,0.0497044890554524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00906546849714819,0.00462393198400443,2.56180849950681e-06,0.0181283751857969,0.0499556981205368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.0046698811593063,0.00238847377204993,-1.15274339115568e-05,0.00935128975252416,0.0505830210322055
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0116370324137857,0.00595286056815228,-0.0233046391273641,3.05742997928037e-05,0.0506242212182246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERVV_1,,40116,0.0084808958051995,0.00434335537422461,-3.20807282807433e-05,0.0169938723386797,0.0508908784745161
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00829538458542117,0.0042548150922828,-4.40529954531116e-05,0.0166348221662955,0.051243690732672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,40293,0.00474876885184919,0.00243993012376213,-3.34941907245779e-05,0.00953103189442295,0.051647218525361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.00771109249782045,0.00397639289243351,-0.0155048225669901,8.26375713492292e-05,0.0525002750511885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.00914110157483623,0.0047177998541599,-0.0183879892889896,0.000105786139317166,0.0526996943556845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,40482,-0.00931641311287901,0.00481237230192753,-0.018748662824657,0.000115836598898954,0.0529012822981407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.00707164579504765,0.00365836096448032,-0.0142420332854291,9.87416953337657e-05,0.053256548024003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGN,Cingulin,40182,-0.00791198191020749,0.00409380727033723,-0.0159358441600685,0.000111880339653469,0.0533024276482894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,40116,-0.0111711777914674,0.00578479353574044,-0.0225093731215186,0.000167017538583898,0.0534930495487199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0174188707127709,0.00902405549191361,-0.0351060194769216,0.000268278051379769,0.0535989588568031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.00593597267739479,0.00307764393245392,-0.0119681547850045,9.62094302148879e-05,0.0537888716965324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42495,0.00228860757608738,0.00118834308989784,-4.05448801123879e-05,0.00461776003228715,0.0541405029562962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAX,Protein max,42311,-0.0199218085389219,0.0103737753261591,-0.0402544081781937,0.000410791100349923,0.0548289242485558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0105150153429588,0.00547631098678072,-0.021248584877049,0.000218554191131398,0.0548716484623351
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,42017,-0.00535663483137867,0.00279360262002554,-0.0108320959666287,0.000118826303871393,0.0552010937112728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.00518974299352261,0.00270984914020706,-0.0105010473083285,0.000121561321283232,0.0554955469659557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00528089042849457,0.00276277162818756,-0.000134141962753041,0.0106959228197422,0.0559726309561653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,42370,0.00651391818405939,0.00341223653485249,-0.000174065424251485,0.0132019017923703,0.0562853567438956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.00746276712492726,0.00391019325923768,-0.000201211663178594,0.0151267459130331,0.0563472604827355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.00972015741434028,0.0051115322028338,-0.0197387605318945,0.000298445703213969,0.0572436219358688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0101670137649187,0.00534833051854638,-0.0206497415812696,0.000315714051432183,0.0573274005911492
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.0212874626531164,0.0112101751330289,-0.0432594059138531,0.000684480607620299,0.0575976893927359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.00535232484279297,0.00281860067573448,-0.0108767821672326,0.00017213248164661,0.0575991131727857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42636,-0.00658708801999496,0.00347391109976298,-0.0133959537755304,0.000221777735540474,0.0579604377900206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIM,Vimentin,42357,-0.0217328152584478,0.0115134544798991,-0.0442991860390499,0.000833555522154392,0.0591014315222882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0135993972447502,0.007209937228382,-0.027730874212379,0.000532079722878489,0.0592933359309708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42689,-0.0089416725444287,0.00475156826022923,-0.018254746334478,0.000371401245620601,0.0598797792913301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00642336340559803,0.00341606080778163,-0.000272115777653974,0.01311884258885,0.0600881279801404
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0146926668437969,0.00782978509467014,-0.000653711941756625,0.0300390456293503,0.0606118202878754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.00661346515974769,0.0035266479529557,-0.0135256951475409,0.000298764828045491,0.0607758345417779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00658050958751643,0.00350930486112477,-0.013458747115321,0.000297727940288128,0.0607927967028787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,39042,-0.0204953010962381,0.0109568127627583,-0.0419706541112444,0.000980051918768161,0.0614366744632859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,0.0127545736702641,0.00682756220262755,-0.000627448246885858,0.0261365955874141,0.0617739458376382
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.0134600455442215,0.00721494796799077,-0.0276013435614834,0.000681252473040433,0.0621227877063881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.0066999537309378,0.0035960377155213,-0.0137481876533595,0.000348280191483943,0.0624631806455807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.00609882887028827,0.00327502228640332,-0.0125178725516388,0.000320214811062243,0.0625936038676384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.0238671146926444,0.0128717001020528,-0.0490956468926679,0.00136141750737912,0.0637278378125558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.00653601623435607,0.00352587582079867,-0.0134467328431215,0.000374700374409334,0.06380476396399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,42322,-0.0157289379740621,0.00850098287954568,-0.0323908644179716,0.000932988469847445,0.0643000741275338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.00512513015682803,0.00277108466805719,-0.0105564561062201,0.000306195792564075,0.0644070689689406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,0.013118594899676,0.00712528180545714,-0.000846957439020002,0.027084147238372,0.0656291040784348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00781590847424247,0.00424923163796953,-0.0161444024846628,0.00051258553617781,0.0658871270813892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,40136,-0.0116290445661591,0.00632304644730151,-0.0240222156028701,0.000764126470551829,0.0659198869833214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00550371497378006,0.00299906385126653,-0.000374450174702349,0.0113818801222625,0.0665114375573777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00591964465397223,0.00322598026735555,-0.000403276670044647,0.0122425659779891,0.0665341576547046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.0154195094681749,0.0084080471337025,-0.0318992818502318,0.00106026291388201,0.0666952950941583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,0.00869361700789654,0.00474697968478449,-0.000610463174281069,0.0179976971900742,0.0670631001168903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.00637793633219268,0.00348849551982024,-0.0132153875510404,0.000459514886654997,0.0675350607274015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7,Complement component C7,40251,-0.00597927535848384,0.00327083297475332,-0.0123901079890004,0.000431557272032677,0.0675676416352569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00686743469128985,0.00375714478340774,-0.000496569084189317,0.014231438466769,0.0676014156721016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.00654770617659244,0.00359166105831526,-0.0135873618508904,0.000491949497705481,0.0683252711369904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,40482,-0.0113236383260638,0.00622144714227095,-0.0235176747249148,0.000870398072787272,0.0687706792548118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.00605613310430205,0.00332918181751493,-0.0125813294666313,0.000469063258027218,0.0689180387234232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0193515752933701,0.0106600266168381,-0.0402452274623727,0.00154207687563251,0.0694982352187519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.0202421169394618,0.0111939417013947,-0.0421822426741955,0.00169800879527187,0.070580653244032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.00752457539140367,0.00416245050851604,-0.0156829783880951,0.000633827605287778,0.0706718517718733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.00770483445169267,0.00427005589569056,-0.0160741440072462,0.000664475103860826,0.0711935805460528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,40483,0.00547771725288949,0.00304174997109503,-0.000484112690456764,0.0114395471962357,0.0717541467099797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,40009,0.00701630961717993,0.00389704016527604,-0.000621889106761104,0.014654508341121,0.0718221750092604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0140278942445759,0.00779591149488211,-0.00125209228539303,0.0293078807745448,0.0719843671660075
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0172998315346583,0.00962571694407235,-0.0361662367450401,0.00156657367572349,0.0723223965622446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0160423329283328,0.00893083321360847,-0.0335467660270054,0.00146210017033984,0.0724756634502366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.0096321003900831,0.00536615716007398,-0.000885567643661907,0.0201497684238281,0.0726858432068128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.00670896380444009,0.00374262026680653,-0.0140444995273809,0.000626571918500705,0.0730661965420564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,40235,-0.00739406054293587,0.00413476812123728,-0.0154982060605609,0.000710084974689188,0.0737606970491086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0115904883797695,0.00648491353248654,-0.0243009189034431,0.00111994214390414,0.0739113732527591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.00740298881548556,0.00417180843215903,-0.000773755711546148,0.0155797333425173,0.0760029569575434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.00914100284554805,0.00515853369170058,-0.000969723190185085,0.0192517288812812,0.0764150939909596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,0.00508771895398406,0.00287257860225766,-0.000542535106440953,0.0107179730144091,0.0765614718197725
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.0081614424222529,0.00461218889174244,-0.00087844780556229,0.0172013326500681,0.0768271172205351
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,40136,-0.00778350196662022,0.0044011681821128,-0.0164097916035613,0.000842787670320868,0.0770038418059825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.00584195742873824,0.00330423350197103,-0.0123182550926015,0.00063434023512499,0.077079952964733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.00771636244401658,0.00437768457004446,-0.0162966242013037,0.000863899313270551,0.0779856181240616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.0117884017848061,0.00669000260880886,-0.00132400332845929,0.0249008068980714,0.0780815129654452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.0119507164168032,0.00678342900997318,-0.0252462372763507,0.00134480444274418,0.0781388391117131
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0114342716315627,0.00649622669856209,-0.0241668759607443,0.00129833269761904,0.0784111079810263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0119825666164105,0.00680947820651651,-0.0253291439011828,0.00136401066836186,0.0784883078067566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0168923085169519,0.00960052519392128,-0.0357093378970376,0.00192472086313384,0.0785164434545458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0106332231868463,0.00604685050542308,-0.0224850501774756,0.00121860380378289,0.0786949011508244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.0145824592135777,0.00830217020700928,-0.0308547128193159,0.0016897943921605,0.0790362982356691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.00971386742410751,0.00553278785279397,-0.0205581316155837,0.00113039676736867,0.0791686279180477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00617773872036685,0.00352142641894262,-0.000724257060760688,0.0130797345014944,0.079397061955383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,40421,0.0125423510402297,0.00715192066319917,-0.00147541345964066,0.0265601155401001,0.079508544597602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,0.0139161519695209,0.00794464421587616,-0.00165535069359642,0.0294876546326381,0.0798585612533877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.0148313260273925,0.00847939948880969,-0.00178829697067451,0.0314509490254595,0.0802968898855246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,42311,0.00576745007479424,0.00331587961764867,-0.000731673975797151,0.0122665741253856,0.081998008185969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0112412612443575,0.00646772467826535,-0.0239180016137575,0.00143547912504262,0.0822240219625386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.0137119711488564,0.00789566634298669,-0.00176353488339752,0.0291874771811103,0.0824781022945187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42587,-0.00513768456063342,0.00295898777511408,-0.010937300599857,0.000661931478590184,0.0825341518983469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.0154951676056584,0.00892712914461372,-0.0329923407291012,0.00200200551778453,0.0826373349352077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.0102402802826867,0.00593971114655858,-0.00140155356456813,0.0218821141299415,0.0847293365377532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.020161536687281,0.0117358257965438,-0.0431637552485068,0.00284068187394473,0.0858340447768351
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.00666098110051726,0.00388553971870686,-0.0142766389491827,0.000954676748148189,0.0865019969911887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,40516,0.0037769049867818,0.00220400984630938,-0.000542954311984584,0.00809676428554818,0.0866201050552623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,40136,0.0130782537804369,0.00765205396794826,-0.00191977199674169,0.0280762795576155,0.0874576780006883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,40483,0.017558843188363,0.0102772441845114,-0.00258455541327932,0.0377022417900052,0.0875680019267245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,40337,0.00581371025785871,0.00340665014983627,-0.000863324035820368,0.0124907445515378,0.0879285952295674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0144412943026351,0.00847562536479736,-0.031053520017638,0.00217093141236768,0.0884300216859855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00562729047363606,0.00330551238347995,-0.000851513797984637,0.0121060947452568,0.0887095963386541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0202875319294214,0.0119604951885758,-0.0437301024990299,0.00315503864018709,0.0898697442560335
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0105820610765561,0.00624329998980753,-0.0228189290565788,0.00165480690346669,0.0901138120651824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.00652768403040248,0.00385776992045959,-0.0140889130745033,0.00103354501369831,0.0906576119221653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0130731865514585,0.00774333362412774,-0.00210374735183187,0.0282501204547489,0.0913792672439734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42587,0.00324053097078609,0.00191948123859438,-0.000521652256858895,0.00700271419843108,0.0913898521980853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.0088456634264437,0.00524058789654899,-0.00142588885079232,0.0191172157036797,0.0914553757628315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.00840330257363584,0.00499391913821005,-0.00138477893725586,0.0181913840845275,0.0924599724375323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0123668616311165,0.00737263596512124,-0.0268172281227541,0.00208350486052116,0.0934923692952315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0101044341235208,0.00602490293214702,-0.021913243870529,0.00170437562348732,0.0935482928408909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,42370,0.0077661019958286,0.00463134878675124,-0.00131134162620384,0.016843545617861,0.0935944923371941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.00698298353050253,0.00416512428561858,-0.0151466271303149,0.00118066006930989,0.0936564615679534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.00528424991035804,0.00315592657483702,-0.000901366176322528,0.0114698659970386,0.094077876881192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0145894282091217,0.00871781024906058,-0.0316763362972805,0.002497479879037,0.094253428542868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0064432863976796,0.00385187819774825,-0.0139929676652662,0.00110639486990697,0.0944020240091001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00846271456352973,0.00506067352239286,-0.00145620554036028,0.0183816346674197,0.0945033782463825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.00872047365571133,0.00521670658164062,-0.0015042712443043,0.018945218555727,0.0946232874573545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.00845236768341582,0.00506575349153243,-0.0183812445268194,0.00147650915998773,0.0952334867205574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.00998352943676705,0.00598426223444247,-0.0217126834162743,0.00174562454274018,0.0952799098718337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,42434,-0.0124231966683695,0.00745547633597376,-0.0270359302868781,0.00218953695013907,0.0956736879358363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.00576398792951461,0.00346237226810722,-0.0125502375750048,0.00102226171597555,0.0959859828577693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,0.0047388174121003,0.00287323221482699,-0.00089271772896061,0.0103703525531612,0.0991098062441604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.00987046624366912,0.00599827626546287,-0.0216270877239764,0.0018861552366381,0.0998851209716961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,40182,-0.0123915735098798,0.00753597461529641,-0.0271620837558608,0.00237893673610115,0.100138186542014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0119626733126855,0.00731840700719954,-0.0263067510467966,0.00238140442142564,0.102161114502105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.00661774574005465,0.00405177488906709,-0.0145592245226262,0.00132373304251685,0.102430434965859
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,40449,0.0184255539881306,0.0112813752523484,-0.00368594150647223,0.0405370494827334,0.102439780364106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0120430825451583,0.00739154735461934,-0.0265305153602122,0.00244435026989562,0.103272615425163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0116988402699361,0.00718572060389861,-0.0257828526535774,0.0023851721137052,0.103534230255826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0143905964477574,0.00884489360479843,-0.0317265879131624,0.0029453950176475,0.103766028918952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,42370,0.00792691317429735,0.00487414320398314,-0.00162640750550961,0.0174802338541043,0.10390566157203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00453644464890099,0.00279532419746456,-0.000942390778129558,0.0100152800759315,0.104646245204851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.00770046312139148,0.00475105022258813,-0.0170125215576642,0.00161159531488126,0.105090234444828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.00893413241958539,0.00551665224420605,-0.0197467708182292,0.00187850597905846,0.105371701310915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.00841689933318357,0.00524529582445316,-0.00186388048274462,0.0186976791491118,0.108598373681775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0065862092229419,0.00410658069212547,-0.0146351073795078,0.00146268893362402,0.108782223213661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42495,-0.00693074538680747,0.00434096507973322,-0.0154390369430846,0.00157754616946965,0.110380682463731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0111798800260808,0.00701678190882599,-0.00257301251521811,0.0249327725673798,0.111119579495355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,40182,0.00767728971469541,0.00482018643152626,-0.00177027569109607,0.0171248551204869,0.111247947112453
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.00879222965421566,0.00552782817908909,-0.00204231357679896,0.0196267728852303,0.111741311030147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.0149238303213144,0.00939265904867439,-0.0333334420567162,0.00348578141408735,0.112115617208969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.0135560264803142,0.00854448487930815,-0.0303032168437581,0.00319116388312981,0.11264910691821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0112069690550462,0.00707354582176966,-0.0250711188657147,0.00265718075562232,0.113142139780057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.00546700170585504,0.00345166976144921,-0.0122322744382955,0.0012982710265854,0.113246941214519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.00653522534476549,0.00413119310306306,-0.0146323638267691,0.0015619131372381,0.113691110133657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,40479,0.00405719365819622,0.00257166684789938,-0.000983273363686557,0.00909766068007899,0.11467375897166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,0.00427973446383656,0.00271544092175991,-0.00104252974281287,0.009601998670486,0.11503681794582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.00706125078780503,0.00448971254320673,-0.00173858579688015,0.0158610873724902,0.115802606820057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.00907650525498513,0.00578176666297075,-0.0204087679144078,0.00225575740443754,0.116479121795177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_A,,40482,0.00516828201801225,0.00329739240312297,-0.00129460709210877,0.0116311711281333,0.117052855667557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,0.00350925064141456,0.00223916650364647,-0.000879515705732529,0.00789801698856165,0.117092945600821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.00813130378430628,0.00519003196121632,-0.0183037664282903,0.0020411588596777,0.117204550830945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00460432559849269,0.00293960880693155,-0.0103659588600785,0.00115730766309315,0.117305060794869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.00950799209512205,0.00609875903717438,-0.00244557561773973,0.0214615598079838,0.119019466894125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.00744283441653645,0.00477630782929096,-0.0168043977619467,0.00191872892887383,0.119190479991596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00745460704735731,0.00478482284968363,-0.00192364573802261,0.0168328598327372,0.119269449432792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.0113509648300508,0.00728874990336297,-0.00293498498054058,0.0256369146406422,0.119421860329004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00400404660807821,0.00257437786971636,-0.00104173401656586,0.00904982723272229,0.119892819948348
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.00804082186338408,0.00517696082066686,-0.0181876650718911,0.00210602134512295,0.120405715325714
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0117739039762917,0.00758401152874151,-0.00309075862004162,0.0266385665726251,0.120579961420657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42495,-0.00502033064583855,0.00324400466751254,-0.0113785797941631,0.00133791850248602,0.121749179034282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.0162997270918206,0.0105761800552953,-0.00442958581655811,0.0370290400001994,0.123304040804385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.00509992500313435,0.00333115403584551,-0.00142913690712285,0.0116289869133915,0.125803402274475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.00407489409471987,0.00266327188862208,-0.00929490699641915,0.00114511880697941,0.126037282698572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0116901875641623,0.00764944904117148,-0.0266831076848584,0.00330273255653374,0.126481847140155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.0137615244087108,0.00901055104953524,-0.00389915564837827,0.0314222044657999,0.126723173660923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00842361286576392,0.00552982340360546,-0.0192620667368306,0.00241484100530279,0.127711227948214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0166873356941111,0.0109552249984137,-0.038159576691002,0.00478490530277977,0.127724453029048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00897234214987712,0.00589030150227506,-0.002572648794582,0.0205173330943362,0.127727479960357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0107843269225146,0.0070892190238885,-0.024679196209336,0.00311054236430687,0.128225778970796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.0079721035687403,0.00524245819633931,-0.00230311449608474,0.0182473216335653,0.128364072241862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,40182,-0.00919183069523162,0.00604918189652053,-0.0210482272124118,0.00266456582194862,0.128661351854422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.00541442596100516,0.00357364193911067,-0.0124187641616621,0.00158991223965175,0.129775944684233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00553677319563333,0.00366062056238285,-0.0127115894979037,0.00163804310663706,0.130429866974897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,40136,0.00820894342015509,0.00543023303910053,-0.00243431333648194,0.0188522001767921,0.13063625873271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0127354909569726,0.00844008912434538,-0.0292780656406896,0.00380708372674432,0.131345930402206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0122541694012579,0.00812593961885206,-0.0281810110542079,0.00367267225169216,0.13157463867845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0398235162738565,0.0264289570239619,-0.0916242720408219,0.0119772394931089,0.131886465176177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0102317882272893,0.00680624211779482,-0.0235720227781671,0.00310844632358856,0.132791959016537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0128809292867169,0.00857297161259824,-0.0296839536474094,0.00392209507397568,0.132995577810599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.00669653661484055,0.00445788491862414,-0.0154339910553439,0.00204091782566276,0.13307962155086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42611,-0.00573903112780818,0.00382303655073056,-0.0132321827672401,0.00175412051162372,0.133334902591617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.00702614912034117,0.00468173441299436,-0.0162023485698101,0.00215005032912777,0.133441722021163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00382399280534425,0.00254927421876747,-0.00882057027412849,0.00117258466343999,0.133634747751801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,40451,0.00393526315661296,0.00262704493196393,-0.00121374491003634,0.00908427122326226,0.134166249494496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.0072448366493527,0.004838224741457,-0.002238083843903,0.0167277571426084,0.134308520135301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0091400412776778,0.00610451297293676,-0.0211048867046338,0.00282480414927824,0.134354688629046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0104920412457246,0.00700777144246671,-0.0242272732729594,0.00324319078151011,0.134369470254639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,40434,0.00886506889235317,0.00593148639040681,-0.00276064443284418,0.0204907822175505,0.135052691203455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.0067282852069625,0.00450377513633628,-0.0155556844741816,0.00209911406025662,0.13522519689914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00873425643926233,0.00584685387261394,-0.00272557715106098,0.0201940900295856,0.135246773347812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00566231607736201,0.00379547022768878,-0.00177680556890801,0.013101437723632,0.135763843676326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.00857474071365998,0.00574900797397861,-0.0198427963426581,0.0026933149153381,0.13584986153357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00580692454429475,0.0038980773772286,-0.00183330711507331,0.0134471562036628,0.136334798382093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,40136,0.00710785049870156,0.00477632636945511,-0.00225374918543046,0.0164694501828336,0.136742342646884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,0.00378231072534359,0.00254747999239094,-0.00121075005974266,0.00877537151042984,0.137644328220527
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0104368564001061,0.00703313072933327,-0.0242217926295993,0.00334807982938714,0.137848972636293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,40451,0.00527907570670169,0.00355994800964296,-0.00169842239219852,0.0122565738056019,0.138126825807458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.00637073398425711,0.00430927267551552,-0.0148169084282675,0.00207544045975331,0.139334605344417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0144791614634478,0.00979562514507446,-0.0336785867477937,0.00472026382089817,0.139403055385508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42587,0.00612978422632009,0.00415246095757449,-0.00200903925052592,0.0142686077031661,0.139918802090085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00544954184466039,0.00369404438558664,-0.00179078515108943,0.0126898688404102,0.140181062484646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.00791429297079819,0.00537262237983346,-0.0184446328352718,0.00261604689367539,0.140753610457672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00892618562655146,0.00606204539026265,-0.00295542333836332,0.0208077945914663,0.140922512821685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,40199,-0.00914135441754086,0.0062101962858122,-0.0213133391377328,0.00303063030265104,0.141051843497208
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,42346,0.0122729431790058,0.00834464475039853,-0.00408256053177533,0.0286284468897869,0.141380817062193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0105759485600355,0.00719978294654457,-0.0246875231352628,0.0035356260151919,0.141880720866337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42654,-0.00451784391041675,0.0030765155700547,-0.0105478144277239,0.00151212660689046,0.141993519046653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,40527,0.00698847236719799,0.00475967953148735,-0.00234049951451721,0.0163174442489132,0.142059921899133
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.00804254537179959,0.00548418174664718,-0.0187915415952281,0.00270645085162889,0.142535795004819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42594,0.00918254839158685,0.00626239031380254,-0.00309173662346614,0.0214568334066398,0.142589803071584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00610788803848844,0.00416587563739223,-0.00205722821080032,0.0142730042877772,0.14263031319283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.00363692385147726,0.00248374531809939,-0.00123121697199754,0.00850506467495207,0.143138153060295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0216726525649693,0.0148403811538476,-0.0507597996265107,0.0074144944965721,0.144208566604911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,-0.00954730848933616,0.00654382924962141,-0.0223732138185941,0.0032785968399218,0.144598630440267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.00647054512694801,0.00443564796018787,-0.0151644151289162,0.00222332487502022,0.144659757808547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42588,-0.0113757042872312,0.00779971180528804,-0.0266631394255958,0.00391173085113336,0.144732416555372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0048985716794832,0.00336492894853845,-0.00169668905965217,0.0114938324186186,0.145478673971336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.00629113907552302,0.00432912406839495,-0.00219394409853108,0.0147762222495771,0.146193156374834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.00780328703470335,0.00537705812783165,-0.0183423209652534,0.00273574689584668,0.146747224757448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00834791193582527,0.00576681182544697,-0.00295503924205079,0.0196508631137013,0.147763807030658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00756838216648025,0.00522954633764505,-0.00268152865530405,0.0178182929882646,0.147859929615051
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,42370,-0.00459008892529548,0.00318035060142445,-0.0108235761040874,0.00164339825349644,0.148969589573915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0141036303972132,0.00979294349418106,-0.033297799645808,0.00509053885138169,0.149844251782904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00374614163852891,0.00260645348578641,-0.00136250719361247,0.00885479047067028,0.150673928132394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0155637125076902,0.0108289647177827,-0.0367884833545442,0.0056610583391638,0.150675870214506
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.00619536741477047,0.00431089078610636,-0.002253978525998,0.0146447133555389,0.150705183616492
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,40482,-0.00367260279424899,0.00256343109007968,-0.00869692773080518,0.00135172214230719,0.151974062185667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.010922257653086,0.00765448383058844,-0.0259250459610394,0.00408053065486731,0.153634322532512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00575611111089508,0.00403741459399688,-0.0021572214933388,0.013669443715129,0.153985690998078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00698467023867758,0.00490440980869042,-0.00262797298635565,0.0165973134637108,0.154423597158045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.00990547435373853,0.006961504520922,-0.0235500232147457,0.00373907450726859,0.154795807338086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42721,-0.00418967629885816,0.0029618179560397,-0.00999483949269597,0.00161548689497966,0.157219858335331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00680526874982405,0.00481737669639936,-0.00263678957511869,0.0162473270747668,0.157787058295777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.00606831690241898,0.00430898776388343,-0.0145139329196305,0.00237729911479253,0.159072818907449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.00903620925286155,0.00643661154010411,-0.0216519678714656,0.00357954936574251,0.160383712344627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42594,-0.0092163969681883,0.00656810008947454,-0.0220898731435584,0.00365707920718181,0.160578611575397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,40116,0.0102612907548706,0.00732831691565333,-0.00410221039980988,0.0246247919095512,0.161474430840394
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,42247,0.00927114875281795,0.00663266453714726,-0.00372887373999068,0.0222711712456266,0.162196422826461
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.00907151058412636,0.00649595441316985,-0.0218035812339393,0.00366056006568654,0.162596610052332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00639993329570224,0.00459205536127965,-0.0154003618038104,0.00260049521240587,0.163437510933574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.0103199406601062,0.00741399743699193,-0.00421149431639802,0.0248513756366103,0.163964782461459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00704304780936026,0.0050663663992893,-0.00288703033324676,0.0169731259519673,0.164509351189984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00825895656398188,0.00595272471159307,-0.00340838387074053,0.0199262969987043,0.165335823184607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.00826404682067713,0.00596221309848776,-0.00342189085235887,0.0199499844937131,0.165753718212104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.00414613562915488,0.0029958751032702,-0.0100180508315645,0.0017257795732547,0.166402415890633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0124748645173087,0.00901831353691529,-0.0301507590496627,0.00520103001504527,0.166606428484539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.016224405022033,0.0117546924572918,-0.0392636022383248,0.00681479219425889,0.167532921783386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42721,0.00867940091059166,0.0063009307979623,-0.00367042345341444,0.0210292252745978,0.168386941331614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0058850478540443,0.00428748484122448,-0.0142885181428443,0.00251842243475567,0.169896193422861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00468498127468683,0.00341555684314043,-0.00200951013786842,0.0113794726872421,0.170197560131722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,40116,0.00502877036260087,0.00366894614251024,-0.00216236407671919,0.0122199048019209,0.17051826224563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,40532,-0.0093670140411316,0.00684987975633598,-0.0227927783635501,0.00405875028128692,0.171504730415926
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.0079223365364136,0.00584009724159046,-0.0193689271299309,0.00352425405710371,0.174949641878242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.00509046423540731,0.00375277214806074,-0.0124458976456064,0.00226496917479174,0.174982254982838
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.00779259345384797,0.00574903762698445,-0.0190607072027375,0.00347552029504154,0.175298077455971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42587,-0.0108787641874614,0.00806222034999591,-0.0266807160734534,0.00492318769853055,0.177247096984516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,40136,0.00836182721083895,0.00619917346155577,-0.00378855277381036,0.0205122071954882,0.177409328866982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0087721772392404,0.00650985410339716,-0.0215314912818988,0.00398713680341803,0.177835065237558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.0154057969105203,0.0114382261628105,-0.0378247201896288,0.0070131263685883,0.178045001894061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0149903791387204,0.0111411997057613,-0.0368271305620126,0.00684637228457171,0.178493969922536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.00709738511065079,0.00527567852862573,-0.0174377150267572,0.00324294480545565,0.178554567496147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00531870669544939,0.0039627980636305,-0.0130857909001652,0.00244837750926638,0.179572213812722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.00596651410409233,0.00445029518409849,-0.0146890926649254,0.00275606445674071,0.180045513613629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.0085584593436279,0.00639185187625943,-0.00396957033384059,0.0210864890210964,0.180605502666009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,40199,0.00447357000448639,0.0033422415580421,-0.00207722344927613,0.0110243634582489,0.180763131992384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00652546116647797,0.00488774328617781,-0.00305451567443053,0.0161054380073865,0.181882485633225
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.0049174939606679,0.00368653410372647,-0.00230811288263599,0.0121431008039718,0.182261853093079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.00434786883600192,0.00326469111878862,-0.00205092575682378,0.0107466634288276,0.182953300234684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.00531320629584299,0.00399157643335015,-0.0025102835135233,0.0131366961052093,0.183181508131626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,40080,0.00879758477193601,0.0066113553929748,-0.00416067179829459,0.0217558413421666,0.183322876398488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,40483,0.0055936835726219,0.00420620608750034,-0.00265048035887876,0.0138378475041226,0.18358983369279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00647007430583438,0.00487385803465154,-0.00308268744208263,0.0160228360537514,0.184369035950698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42689,0.00654821028503042,0.00493706550977977,-0.00312843811413792,0.0162248586841988,0.184750701089372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0113838400347472,0.0085858882644397,-0.028212181033049,0.00544450096355461,0.184902731283195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.008702943994327,0.00656518252017718,-0.0215707017338743,0.00416481374522027,0.184988282394635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.00686502979664411,0.00518453346608849,-0.0170267153901776,0.00329665579688934,0.185484613071683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00320123557604067,0.00242034387947281,-0.00794510957980737,0.00154263842772603,0.185983716589865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00342098152593481,0.00259031080113274,-0.00165602764428536,0.00849799069615497,0.186629419520596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.00575692294074059,0.00436402299790838,-0.014310408016641,0.00279656213515984,0.187132129864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.00828139905607637,0.00630313078701643,-0.0206355353986286,0.00407273728647583,0.188922644876056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.00369840585107423,0.0028157593566967,-0.0018204824880513,0.00921729419019975,0.189048046314639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.00574954406258128,0.00438381067222607,-0.0143418129801444,0.00284272485498181,0.189702879605144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.00433374980716515,0.00330632784213651,-0.00214665276342241,0.0108141523777527,0.189970822008716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.00608836094076447,0.00464497176707784,-0.015192505604237,0.00301578372270811,0.189971584506934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00984171102096151,0.00751433424343231,-0.00488638409616581,0.0245698061380888,0.190316398432947
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,42460,0.00735965418178717,0.00562387788589183,-0.00366314647456081,0.0183824548381351,0.19067763152231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.00461072703294955,0.00352456512982426,-0.0115188746874051,0.00229742062150599,0.190842691095509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSG,Basigin,42746,-0.00281619953500529,0.00215285766452505,-0.00703580055747439,0.00140340148746381,0.190854267373993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0119307230815039,0.00915881116283771,-0.0298819929606659,0.00602054679765797,0.192720936739899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,40539,-0.00659923469772374,0.00506827009597469,-0.0165330440858341,0.00333457469038666,0.192919414416698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0127245872745116,0.00979469653451908,-0.031922192482169,0.00647301793314579,0.193925740052369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.0104772661477694,0.00806613220740977,-0.0262868852742926,0.00533235297875371,0.193997752139487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00690310441193774,0.00532563209191762,-0.00353513448822079,0.0173413433120963,0.194932627903192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,40116,0.00778188986172418,0.0060115477723063,-0.00400074377199616,0.0195645234954445,0.195523508799117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00661691301699578,0.00511451747188495,-0.00340754122789874,0.0166413672618903,0.195778738705279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.0107467410502429,0.00831962580812246,-0.0270532076341629,0.0055597255336771,0.196472061616427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.00717011102551736,0.00555164198753104,-0.0180513293210782,0.00371110727004349,0.196542319580776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,40302,0.0221734286856041,0.0171843126188407,-0.0115078240473236,0.0558546814185319,0.196963073039611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,40511,0.0123327194880871,0.00958416846423668,-0.00645225070181676,0.031117689677991,0.198197183710952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.00937577064104822,0.00729560278523584,-0.0236751521001105,0.00492361081801402,0.198770800899414
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.0075646394441098,0.00588925713378764,-0.00397830453811398,0.0191075834263336,0.199000461428852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.00777028587748785,0.00606164067453583,-0.0196511015995781,0.00411052984460238,0.199907297731219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0119357641663868,0.00932661878481365,-0.0302159369846216,0.00634440865184791,0.2006589502029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00372989557320918,0.00291603857350114,-0.00198554003085305,0.0094453311772714,0.200889943930422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42706,0.00763219293003805,0.0059788880662497,-0.00408642767981137,0.0193508135398875,0.201792356876445
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0106438647741291,0.00838322297599622,-0.0270749818070817,0.00578725225882345,0.204227282135789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00831097302192352,0.00654650354582493,-0.00452017392789334,0.0211421199717404,0.204279218155432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.0084815837604142,0.00668854494087316,-0.0215911318445256,0.00462796432369719,0.204793061762801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,0.00343580175639339,0.00270964238097564,-0.00187509731031886,0.00874670082310565,0.204827366998277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.00505491215726109,0.00400110948517221,-0.0128970867481986,0.00278726243367644,0.206480268632529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00683863378530388,0.00541463460173395,-0.00377405003409466,0.0174513176047024,0.206618989801148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.00760924729677782,0.00602926953608373,-0.0194266155875019,0.00420812099394628,0.206957124136772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.00445065060684116,0.0035307486612446,-0.0113709179828806,0.00246961676919826,0.207496901219064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,40460,-0.0114951550309116,0.00912267647902876,-0.029375600929808,0.00638529086798475,0.207672422378335
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00875385273245471,0.00695821688492334,-0.0223919578269044,0.00488425236199503,0.208397035667298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00498857706473713,0.00397272194136864,-0.00279795794034541,0.0127751120698197,0.209248421327313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,40283,0.00713184432387736,0.0056836855865868,-0.00400817942583277,0.0182718680735875,0.209580650972181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,40283,0.00504950519990233,0.00402454365305112,-0.00283860036007787,0.0129376107598825,0.209622225317469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00324988258631973,0.00259387126255175,-0.00833387026092117,0.00183410508828171,0.210265066799615
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.00856859053277465,0.00684397642654785,-0.0219827843288084,0.00484560326325914,0.210600199260698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.0106145589773888,0.00849282147357068,-0.0272604890655873,0.00603137111080973,0.211389146140155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00449841327620143,0.00360407138581444,-0.00256556663999488,0.0115623931923977,0.212003581859646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.00626083594662471,0.00502342894006449,-0.00358508477590169,0.0161067566691511,0.21267087880472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.00359815056642849,0.00289039215745887,-0.00926331919504787,0.00206701806219089,0.213202824728454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.0131382397799541,0.0105662959425422,-0.00757170026742866,0.0338481798273368,0.213738871466704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.00950814001666351,0.0076569026894316,-0.00549938925462242,0.0245156692879494,0.214341832119147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.0077373601789913,0.00623200230757516,-0.00447736434385601,0.0199520847018386,0.214427993391439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00391206726246792,0.00315122530075967,-0.0100884688519569,0.00226433432702102,0.214468523216665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.00914350713802109,0.00737231396620476,-0.0235932425117824,0.00530622823574024,0.214905112755207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.00231019264024464,0.00186361870337725,-0.00596288529886404,0.00134250001837476,0.215138915622109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00467032826181719,0.00377013007276682,-0.0120597832044401,0.00271912668080578,0.215456844120857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.0107646474718958,0.00869425588084177,-0.0278053889983456,0.00627609405455411,0.215688730826908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.0196681060976941,0.0158968016428292,-0.0114896251222511,0.0508258373176394,0.216024964377896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.00742848489170341,0.00600411775694183,-0.0191965556953094,0.00433958591190258,0.216027670810395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.0053842087901202,0.00436213441602114,-0.00316557466528123,0.0139339922455216,0.217115448196166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,0.00490391477951465,0.00397766372528123,-0.00289230612203656,0.0127001356810659,0.217653127017186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00550421161044912,0.00446558144608525,-0.00324832802387797,0.0142567512447762,0.217756134865358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0114634437320603,0.00932005433230153,-0.0297307502233713,0.00680386275925068,0.218731772719076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,42370,-0.00630185405869869,0.00513945699854222,-0.0163751897758414,0.00377148165844407,0.220156176964584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.00582339955913044,0.00475517487616723,-0.0151435423164182,0.00349674319815733,0.220735343319825
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.00706999757199455,0.00577787758512572,-0.018394637638841,0.00425464249485187,0.221112876502635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,0.00338671892866684,0.00277918465537385,-0.00206048299586591,0.00883392085319959,0.223020799031146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42611,0.00405245757671714,0.00333215920645218,-0.00247857446792914,0.0105834896213634,0.223943220421219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.0133397129482399,0.0109719146294161,-0.00816523972541555,0.0348446656218954,0.224085342297249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.0062766507332782,0.00517306453171847,-0.00386255574889,0.0164158572154464,0.225028708943981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00336652764255037,0.00278975028414964,-0.00883443819948366,0.00210138291438291,0.227550684428542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00689997151921485,0.00571871985913267,-0.00430871940468518,0.0181086624431149,0.227628203528181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.0036782012005634,0.00305008614707203,-0.00229996764769778,0.00965637004882458,0.22786932434152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0218427336106429,0.0181720376099775,-0.013774460104913,0.0574599273261988,0.229385992758607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.00347366245410307,0.00290401388561124,-0.00916552966990111,0.00221820476169497,0.231660077903413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.00482984575358129,0.00405255081170613,-0.00311315383736273,0.0127728453445253,0.233364052188926
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C5,Complement C5,40539,0.00178379068996736,0.00149676866653539,-0.001149875896442,0.00471745727637672,0.233379857396775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.0047126380584307,0.00395557041897543,-0.00304027996276114,0.0124655560796225,0.233520459345353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.00554230386112902,0.00465491566357449,-0.014665938561735,0.00358133083947697,0.233822079588541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,0.010945654412075,0.00921177351876898,-0.0071094216847122,0.0290007305088622,0.234766016224545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.00280114337456126,0.00236019353154699,-0.00742712269639336,0.00182483594727083,0.235321100935438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.00445153834335601,0.00375445791080539,-0.0118102758485346,0.00290719916182255,0.235774575354951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0168655861330546,0.0142716629512378,-0.0448380455174807,0.0111068732513716,0.237329379476857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00320753042033335,0.00271688689553737,-0.00211756789491988,0.00853262873558659,0.237786150622962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.00634171757934117,0.0053755980315197,-0.0168778897211198,0.00419445456243743,0.238135834513787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,42311,0.00448723272075815,0.00381221026547817,-0.00298469939957905,0.0119591648410954,0.239189513952267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,40136,0.00764933546082897,0.00652190532872582,-0.00513359898347363,0.0204322699051316,0.240874189716345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00387357403737632,0.00330607739415206,-0.00260633765516171,0.0103534857299144,0.241357784279414
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0106677998631058,0.00914326323614317,-0.0285885958059464,0.00725299607973479,0.243337010497701
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,42311,0.00519960511025326,0.0044653531719566,-0.00355248710678167,0.0139516973272882,0.244269711152068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.00620673511989756,0.00533771828675564,-0.0166686629619386,0.00425519272214351,0.24493311137722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00572703456048588,0.00493140663763242,-0.00393852244927367,0.0153925915702454,0.245529469109879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00407596747189366,0.00351117772231136,-0.00280594086383661,0.0109578758076239,0.245726137622864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,0.00394288893383452,0.00339771558276457,-0.00271663360838404,0.0106024114760531,0.245885314762029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.00741340310797786,0.0064067795124402,-0.0199706909523606,0.00514388473640492,0.24724906352298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.00353004379228833,0.00305491417677983,-0.00951767557877679,0.00245758799420014,0.247894071869764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.00497845918594864,0.0043106484486699,-0.00347041177344436,0.0134273301453416,0.24814797269407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.00526202286588845,0.00456279224184051,-0.0142050956598958,0.00368104992811895,0.248829733073895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,40302,0.00403244825979998,0.00350165647205981,-0.00283079842543726,0.0108956949450372,0.249517233023938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,40223,0.00981797803207097,0.00852621628703989,-0.00689340589052722,0.0265293619546692,0.249549629025719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,40302,0.00644034459481421,0.00559576034902423,-0.00452734568927328,0.0174080348789017,0.249784622264446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00308107181522118,0.00267878951655295,-0.00833149926766495,0.00216935563722259,0.250097822350529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42681,-0.0078842254010989,0.00686051040891158,-0.0213308258025656,0.0055623750003678,0.250486278529163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_DRA,,42549,-0.00419502834823327,0.00365529590401832,-0.0113594083201092,0.00296935162364264,0.251130473874008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.00950246755586338,0.00828268078319865,-0.0257365218909327,0.00673158677920599,0.251295170520768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.000925900881417785,0.000812299239875793,-0.000666205628738769,0.00251800739157434,0.254372504133559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.00910161876943655,0.00803198879224055,-0.024844316802228,0.00664107926335492,0.257162619542089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.00485146526690702,0.00428500803855939,-0.0132500810224834,0.00354715048866938,0.257573007520692
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.00822019616352744,0.00726448207792213,-0.0224585810362548,0.00601818870919994,0.25784396089662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.00484747867850926,0.00428837342622192,-0.0132526905939042,0.0035577332368857,0.258337678134156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00790641715022463,0.0070142591803516,-0.00584153084326452,0.0216543651437138,0.25968564125188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42674,0.00682148090972605,0.00605697333481734,-0.00505018682651593,0.018693148645968,0.260092710601065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00709368931075267,0.00633885444724898,-0.00533046540585534,0.0195178440273607,0.26313030253942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.00592061959399732,0.00529094599865536,-0.00444963456336719,0.0162908737513618,0.263160263683759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,40199,-0.00554568258483572,0.00495753457464949,-0.0152624503511487,0.00417108518147728,0.26331936408716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.00570289294534341,0.00509947743540075,-0.0156978687187289,0.00429208282804206,0.26344697801767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.00575459166978725,0.00516319057071316,-0.0158744451883851,0.00436526184881055,0.26507120309804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.00525217748204622,0.00472304991492075,-0.00400500035119846,0.0145093553152909,0.26614518805816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,40199,0.0116159647508199,0.0104507844388186,-0.00886757274926442,0.0320995022509043,0.266380853424054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42591,-0.00273492053385734,0.0024637064629162,-0.00756378520117308,0.0020939441334584,0.266982858869357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.00241283621795556,0.00217426315201182,-0.00667439199589873,0.00184871955998761,0.267136930485271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.00643244073340181,0.00579922364750184,-0.0177989190825054,0.0049340376157018,0.267368105081865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.00586894493047645,0.00529188991229064,-0.0162410491585661,0.00450315929761321,0.2674309596397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.00357161778759447,0.00322208840450449,-0.00988691106042327,0.00274367548523432,0.26767930625417
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.00402799943735231,0.00363534116469802,-0.0030972692454558,0.0111532681201604,0.267880926309546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.00275312525489802,0.00249180097052558,-0.00763705515712816,0.00213080464733212,0.269234055103609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0117411953159011,0.0106284192175381,-0.0325728969822758,0.00909050635047364,0.269314363159136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.00587391283752319,0.00532492060976226,-0.00456293155761084,0.0163107572326572,0.270008254887999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00672950898109685,0.0061036788583271,-0.018692719543418,0.00523370158122428,0.270253791380979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00989999807370708,0.00902813567898987,-0.00779514785711307,0.0275951440045272,0.272852797768068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,40527,0.00471828514337413,0.00430285583244462,-0.00371531228821732,0.0131518825749656,0.27286261527153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.00285013981428107,0.0026039018737311,-0.00795378748679403,0.00225350785823189,0.273731480286524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.00727915725079406,0.00666010693044103,-0.00577465233287036,0.0203329668344585,0.274436261720503
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.00569594833843871,0.005213979448735,-0.0159153480579593,0.00452345138108189,0.27466022063325
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39926,0.00756753360060973,0.00694658582679836,-0.00604777461991506,0.0211828418211345,0.276006878176767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.00716883804563765,0.00658251934107424,-0.0200705759541432,0.00573289986286786,0.276142137060991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.00562399537190207,0.00518708833750767,-0.00454269776961297,0.0157906885134171,0.278286886918149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.00807491571528203,0.00745394848660604,-0.0226846547490299,0.00653482331846581,0.278691970762324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00370974504715777,0.00343310511986259,-0.0030191409877729,0.0104386310820884,0.279907801464924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.00737629294144951,0.00682699027076628,-0.0207571938721514,0.0060046079892524,0.279956436426038
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.00658788272974498,0.00611452321117039,-0.0185723482236389,0.00539658276414899,0.281314175106306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,40482,0.00237345826574341,0.00220843669853237,-0.00195507766338004,0.00670199419486686,0.282521622888136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.00581491764147113,0.00541539290403234,-0.00479925245043226,0.0164290877333745,0.282946775490557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.00687648328625789,0.00640938765018987,-0.01943888308063,0.00568591650811426,0.283349959941797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42711,-0.00793390434553152,0.00741742456024597,-0.0224720564836136,0.00660424779255058,0.28480471198469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.00588773277917514,0.0055111942237722,-0.0166896734577686,0.00491420789941837,0.28539465490747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.00259439716132082,0.00243098892081057,-0.00735913544610953,0.00217034112346789,0.285892193343619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.00308824590771863,0.00289423348113304,-0.00258445171530212,0.00876094353073938,0.285975364574756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.00558014339665033,0.00523340658305765,-0.00467733350614266,0.0158376202994433,0.286327825393894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00288595722378907,0.00271531638981907,-0.00820797734783445,0.00243606290025631,0.287875423742552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.00528048694091269,0.00497074002328843,-0.015023137386558,0.00446216350473264,0.288115929296104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0075340800296655,0.00712354609879559,-0.0214962303833048,0.00642807032397385,0.290246480371284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00265105824442548,0.00250971708504286,-0.00757010373110948,0.00226798724225851,0.290845669439933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.00642564607034346,0.00611763866669787,-0.0184162178570713,0.00556492571638436,0.293581643901457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,0.00629223040305121,0.0060021719197888,-0.00547202655973483,0.0180564873658372,0.294511131343041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,0.00751816686353207,0.00719914688176853,-0.00659216102473426,0.0216284947517984,0.296359179702326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.00773752268247567,0.00741950597868948,-0.0222797544007071,0.00680470903575571,0.297034792021069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,42370,-0.00400130031398471,0.00384188515911986,-0.0115313952258596,0.00352879459789021,0.297665449268788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0126512015128022,0.0122296898220969,-0.0366213935641121,0.0113189905385077,0.300940972309518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,40136,0.00538390541925867,0.00520750765608771,-0.00482280958667324,0.0155906204251906,0.301218041825055
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.00380389200909806,0.0036797294537478,-0.0110161617384437,0.00340837772024762,0.301279365493555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42654,0.0111987253335422,0.0108688959397427,-0.0101043107083536,0.0325017613754379,0.30286604512371
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00377540781979282,0.00367502607237183,-0.0109784589216416,0.00342764328205596,0.304291223734148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.0068171817216372,0.00665491228922364,-0.0198608098085155,0.00622644636524114,0.305676903669308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.00762327252066759,0.00744573836177022,-0.0222169197097372,0.00697037466840204,0.305931033148008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,40223,-0.00746415976291003,0.00729524868322504,-0.0217628471820311,0.00683452765621105,0.306257680707879
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00365764369799593,0.00357575406464419,-0.00335083426870667,0.0106661216646985,0.306373300143341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,0.00853979204591919,0.00835382383653673,-0.00783370267369281,0.0249132867655312,0.306679774909361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,42292,0.0035540203535893,0.00348343849148319,-0.00327351908971776,0.0103815597968963,0.307623005417385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.0101831391722266,0.0100897190073147,-0.0299589884265634,0.00959271008211015,0.31287260461715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.00925119909961474,0.00919992975736062,-0.0272830614240416,0.00878066322481208,0.314639281974651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.00364765721130232,0.00363043531544819,-0.0107633104295808,0.00346799600697613,0.31503870433228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.0021971779487183,0.00218990910913561,-0.00648939980262409,0.00209504390518749,0.315728914372536
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.00511052617240814,0.00510604102866088,-0.0151183665885835,0.00489731424376719,0.316907774028061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,40302,-0.00826041111504018,0.0082632625340347,-0.0244564056817482,0.00793558345166782,0.317499306685727
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.00317190559663146,0.00317498968063068,-0.00305107417740468,0.0093948853706676,0.317798704995738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00395876923939042,0.00396497694237563,-0.0117301240464467,0.00381258556766582,0.318090895418978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42597,-0.00404770472852432,0.00406266035890264,-0.0120105190319735,0.00391510957492485,0.319113278413652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.00506644662946087,0.00508853105011305,-0.0150399674876824,0.0049070742287607,0.319437315197227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00286653036005526,0.00288066895595302,-0.00851264151372318,0.00277958079361266,0.319713685035914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.0029610225579379,0.00298393148612737,-0.00288748315487175,0.00880952827074755,0.321061383266388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.00478259159035975,0.00483705327995667,-0.0142632160190748,0.00469803283835532,0.322811260938309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,40116,-0.00703136777643045,0.00712135028978928,-0.0209892143444174,0.00692647879155653,0.323485900924261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.0079572411510071,0.0080709468610593,-0.00786181469666913,0.0237762969986833,0.324197906150353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.00548847859303794,0.00556733048031027,-0.00542348914837019,0.0164004463344461,0.324234936721888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,40116,0.00463577287450082,0.00471112272608628,-0.00459802766862829,0.0138695734176299,0.325134375781467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.00408114071919783,0.00414835614227863,-0.00404963731966827,0.0122119187580639,0.325236916056671
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.0109927710254523,0.0112044653812198,-0.0329535231726432,0.0109679811217385,0.326561436689526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,40302,-0.00432510467159189,0.0044282654332062,-0.013004504920676,0.00435429557749226,0.328736971821864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,42332,0.00720906482468689,0.00739457507590677,-0.00728430232409038,0.0217024319734642,0.329621537508182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.00698865003356947,0.00719462358685161,-0.0210901122637986,0.00711281219665969,0.331381336338675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00429339066018293,0.00442875110228943,-0.0129737428206702,0.00438696150030435,0.332348536412095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42711,0.00286252057756101,0.00295451414554712,-0.00292832714771134,0.00865336830283336,0.332630691165502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,0.0071355837788848,0.00736615564218593,-0.00730208127979961,0.0215732488375692,0.332717061731656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.007711278227589,0.00797262578363397,-0.0233376247635116,0.00791506830833357,0.33345509417094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.00835396049176977,0.00863748773645555,-0.0252834364552226,0.0085755154716831,0.333477713244076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.005444417668138,0.00563263110444809,-0.00559553929658026,0.0164843746328563,0.333769194126873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,0.00534735004481061,0.00553541861804028,-0.00550207044654835,0.0161967705361696,0.334053099386224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.00964472971698972,0.00999158574604776,-0.0292282377792433,0.00993877834526388,0.334423361189908
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00378304705796106,0.0039268065248748,-0.00391349373079354,0.0114795878467157,0.335372459848645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.00458067853627294,0.00475781218190161,-0.0139059904128001,0.00474463334025421,0.335684177013483
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0063168408620593,0.00656256851109798,-0.0191794751438113,0.00654579341969273,0.335787962524686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0054762471025774,0.00569211873147566,-0.0166327998162697,0.00568030561111489,0.336028966721093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,42357,0.00683296725790025,0.007108556175984,-0.00709980284702838,0.0207657373628289,0.336453498532261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,0.00401191609984076,0.00417489221963999,-0.00417087265065362,0.0121947048503351,0.336591514668593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,0.00323758264458937,0.00337693987398823,-0.00338121950842757,0.00985638479760631,0.337710739400668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00471246566285804,0.00494852778111169,-0.0144115801138369,0.00498664878812087,0.34096781882297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0104380852468392,0.0109689828685959,-0.0319372916692872,0.0110611211756087,0.341317362135758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,0.00127070666545657,0.00133945589929413,-0.00135462689715992,0.00389604022807307,0.342807173666431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.0042279078254149,0.0044569261397122,-0.0129634830592508,0.00450766740842101,0.34283376174717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00387543532806315,0.00408764285400223,-0.00413634466578122,0.0118872153219075,0.343106696258364
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.00828047070395826,0.00875756395880293,-0.00888435465529549,0.025445296063212,0.344413284538692
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,0.00939689127269117,0.00994824790673662,-0.0101016746245126,0.028895457169895,0.344895506110935
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.00312349559703463,0.00331147220643217,-0.00961398112164168,0.00336698992757243,0.345581558148485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,40116,-0.00793245090205925,0.00843466554875294,-0.024464395377615,0.00859949357349651,0.347003347968164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.0045470665578684,0.00484030148716596,-0.0140340574727137,0.00493992435697689,0.347533372757102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.00425810041384315,0.00453325838874679,-0.0131432868557869,0.00462708602810055,0.347595613015232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,0.00527659372181293,0.0056203922310514,-0.00573937505104781,0.0162925624946737,0.347834874412798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.00575268186330655,0.00615265897928984,-0.0178118934627146,0.00630652973610154,0.349813479421958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00664865334750015,0.00712418554656863,-0.00731475032377438,0.0206120570187747,0.35071089001281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00625933876693361,0.00672796101630206,-0.00692746482501843,0.0194461423588856,0.352211980271662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,42311,-0.00563280906699288,0.0060549632778354,-0.0175005370915503,0.00623491895756451,0.352243435884357
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.00514165635528909,0.00552835329396525,-0.015977228811461,0.00569391610088279,0.352360821170294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.00332677204120162,0.00357989063971095,-0.00368981361263184,0.0103433576950351,0.35275644905629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00346557974570334,0.0037363733298424,-0.0107888714721944,0.00385771198078777,0.353670692212448
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00557463464938707,0.00601787491723634,-0.0173696694871703,0.00622040018839615,0.354286603012789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.00716280983119698,0.00773333173016597,-0.0223201400223223,0.00799452035992832,0.354345431333669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42590,0.00667604589291606,0.0072154972032606,-0.00746632862547472,0.0208184204113068,0.354859242583602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00706053389021102,0.00765771847468812,-0.0220696621005997,0.0079485943201777,0.356541008408849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,42311,-0.00596401144855766,0.0064744447185626,-0.0186539230969404,0.00672590019982503,0.356982876078989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.00455882483603796,0.0049630599699824,-0.00516877270512754,0.0142864223772035,0.358350598687635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00427760130969557,0.00465873210523438,-0.00485351361656382,0.013408716235955,0.358539516952977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00546576015021495,0.00596852885638409,-0.0171640767087278,0.00623255640829787,0.359811233228871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.00954125616578001,0.0104299973495794,-0.0299840509709556,0.0109015386393956,0.360321479897997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,40482,-0.0033003925307863,0.00361613857061517,-0.010388024129192,0.00378723906761944,0.361428149023727
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42794,0.00177409323264396,0.00194757294692751,-0.00204314974333396,0.00559133620862187,0.362350943362475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.00472888423028816,0.00521222561887251,-0.0149448464432783,0.00548707798270197,0.364284645999233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.00290997387013701,0.00322908730507846,-0.0092389849880908,0.00341903724781678,0.367514323478609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42754,-0.00689383412164045,0.00766280262916098,-0.021912927274796,0.00812525903151506,0.368322950587214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESPL1,Separin,40080,0.0051491226695474,0.0057288515019145,-0.00607942627420502,0.0163776716132998,0.368776202563871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.0039673270527255,0.00443259242127558,-0.0126552081984256,0.00472055409297463,0.370787861843624
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00612782214198447,0.00687420229384021,-0.00734561435394233,0.0196012586379113,0.372721976635116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00364541105928148,0.00410521318852355,-0.00440080679022468,0.0116916289087876,0.374562789244207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,42346,0.00279564206096481,0.00315206589548167,-0.00338240709417927,0.00897369121610888,0.37513617897298
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.00240547232881445,0.00271296127563288,-0.00291193177142599,0.00772287642905488,0.375281305128567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.00285422769882875,0.00322181292432815,-0.00916898103051192,0.00346052563285441,0.375686240788999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.00456016931843146,0.00515766322067965,-0.0146691892309636,0.00554885059410066,0.376631790342562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.00770949999777067,0.00872180915042743,-0.00938524593706709,0.0248042459326084,0.376747935057443
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0033620270060714,0.00381117242282248,-0.00410787094266066,0.0108319249548035,0.377714880956675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.00338778080386397,0.00384123243072662,-0.0109165963680881,0.0041410347603602,0.37782231363858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00250306835148813,0.00284937178461898,-0.00808783704934133,0.00308170034636507,0.379711560570866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00401800921378875,0.00457878212182436,-0.00495640374498699,0.0129924221725645,0.380219139354045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,40199,0.00501563885558927,0.00572775005429249,-0.00621075125082402,0.0162420289620026,0.381226675183715
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,40182,-0.00525596612237985,0.00602854342191845,-0.01707191122934,0.0065599789845803,0.383311023982982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.00568153634995162,0.00652725952628858,-0.00711189232157399,0.0184749650214772,0.384079708055292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.00393194372098793,0.00452091853266613,-0.00492905660303768,0.0127929440450135,0.384467538494743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,40449,-0.00312304398391487,0.0035978219569857,-0.0101747750196068,0.0039286870517771,0.385392371370837
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,42346,0.0143341031407608,0.0165274299657853,-0.0180596595921785,0.0467278658737001,0.385798016068281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00396181483560149,0.00458780195435602,-0.00503027699493631,0.0129539066661393,0.387851749989755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00325247633607838,0.00377159905193658,-0.0106448104778741,0.00413985780571731,0.388508352666991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.0024788172503115,0.0028817104571353,-0.00316933524567369,0.00812696974629669,0.389703123287067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,42370,-0.00418325222408264,0.00487718493192413,-0.0137425346906539,0.00537603024248864,0.391063468736785
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.00193423978088548,0.00225532285793428,-0.00635467258243667,0.00248619302066571,0.391113238032553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.00457146497158824,0.00533978953429132,-0.0150374524587992,0.00589452251562275,0.391953321470693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARTN,Artemin,42370,0.00378512919838756,0.00443194021528591,-0.00490147362357281,0.0124717320203479,0.393088980353252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00290382190162257,0.0034030410896656,-0.00957378243736715,0.003766138634122,0.393510604068981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,42370,0.00510562784709699,0.00601657787826288,-0.00668686479429826,0.0168981204884922,0.396123036751149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42721,0.00613580677495193,0.00723243018520468,-0.00803975638804923,0.0203113699379531,0.396244648724817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,0.00295935559636784,0.00348924298806507,-0.00387956066023969,0.00979827185297537,0.396377177146435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,40136,0.00929208449550244,0.0109665172090989,-0.0122022892343314,0.0307864582253363,0.396838610121352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,42334,-0.00493802806324047,0.00583371632717971,-0.0163721120645127,0.00649605593803177,0.397309630652735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00765627666006509,0.00904756191479709,-0.0100769446929372,0.0253894980130674,0.397445523003576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.004887395665573,0.0057793092872961,-0.0162148418686733,0.00644005053752736,0.39775152685604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.00432973432689368,0.00512952589083064,-0.00572413641913437,0.0143836050729217,0.398642802980735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00407925265533159,0.00485463346578472,-0.0135943342482696,0.00543582893760645,0.400769020207205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.00522729978804343,0.00622351667575033,-0.0174253924725141,0.00697079289642721,0.40096714713263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NENF,Neudesin,40451,-0.00918996815197758,0.0109470279368369,-0.0306461429081779,0.0122662066042227,0.401209783479273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.00355557856229919,0.00423982925686059,-0.0118656439057459,0.00475448678114756,0.401704578497925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00587987679332143,0.0070421418230353,-0.0196824747664706,0.00792272117982775,0.403760581570878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00461598082906414,0.00553324807394691,-0.0062291853958718,0.0154611470540001,0.404171803010743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42594,0.00453603563665181,0.00545756748533,-0.00616079663459499,0.0152328679078986,0.405905939306284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.00513479481730719,0.00619985295777836,-0.00701691697993839,0.0172865066145528,0.407568072518608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00744096376751353,0.00901079953501042,-0.0251021308561339,0.0102202033211069,0.408944781633229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,0.0038487698348469,0.00466101360444785,-0.0052868168298709,0.0129843564995647,0.408968142668279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.00274475762491469,0.00332851356486693,-0.00377912896222448,0.00926864421205387,0.409605045484296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.00880320592776602,0.0106992558298903,-0.029773747354351,0.0121673354988189,0.410644239336304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00303244283987442,0.00368661785452118,-0.00419332815498709,0.0102582138347359,0.410779426957885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.00330637566616085,0.00402453569446507,-0.0111944656273124,0.00458171429499069,0.411345354472009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.00486420777419203,0.00592189895123867,-0.0164711297186198,0.00674271417023575,0.411439590572249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.0032556419083676,0.00396732898621074,-0.0110316067213406,0.00452032290460545,0.411884518266217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,40080,-0.00366591327942631,0.00446738200951475,-0.0124219820180752,0.00509015545922259,0.411894717485601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00550225479882589,0.00670531021870574,-0.0186446628274891,0.00764015322983737,0.411902381070344
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.00500115637558298,0.0061014422013018,-0.0169599830901345,0.00695767033896855,0.412423393739091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.00699470766399946,0.00854204420199189,-0.00974769897190465,0.0237371142999036,0.412883375800501
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00254331659970136,0.00310720186917478,-0.00863343226328392,0.00354679906388121,0.413076290637521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42594,0.00314127725418224,0.00385290344373257,-0.0044104134955336,0.0106929680038981,0.414914345339484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0046258306558738,0.00567783541047398,-0.0157543880604028,0.00650272674865519,0.415251394537355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00530728031471027,0.00652722042893172,-0.0181006323554164,0.00748607172599591,0.416175714097238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,42370,0.00750890657121066,0.00928547844170295,-0.0106906311745271,0.0257084443169484,0.418718429684963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,0.00265061138288846,0.00328131674190738,-0.00378076943125001,0.00908199219702692,0.419226343144997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00207624906110831,0.00257288221693914,-0.00711909820630903,0.00296660008409241,0.419698378115315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00357934718044068,0.00443688543582481,-0.00511694827377594,0.0122756426346573,0.419842108270155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.00546919755303687,0.00678952941436588,-0.018776675205194,0.00783828009912026,0.420528960391578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.00551926146062204,0.00687372445728007,-0.00795323847564691,0.018991761396891,0.422020566939451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,0.00477460239763094,0.00597316959694548,-0.0069328100123822,0.0164820148076441,0.424106690186697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.00582636470748268,0.00732529167313619,-0.0201839363868296,0.00853120697186424,0.426408890966157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,40269,0.00294786203526717,0.00371140420529796,-0.00432649020711684,0.0102222142776512,0.427054496728424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00584505427198411,0.00736749698198519,-0.00859523981270685,0.0202853483566751,0.427586883262802
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.00536519832101376,0.00677842427508682,-0.0079205132581564,0.0186509099001839,0.428659689740019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,42357,0.00485288700024453,0.00613121408933175,-0.0071642926148457,0.0168700666153348,0.428663584302103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0068349878485409,0.00863683776017309,-0.0237631898584802,0.0100932141613984,0.428741549508422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00379117094937083,0.00479983336072702,-0.00561650243765413,0.0131988443363958,0.429629775584552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,42370,0.00254937124998762,0.00324561497466258,-0.00381203410035103,0.00891077660032628,0.432185304765653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.00410302441139165,0.0052296738741022,-0.00614713638184866,0.014353185204632,0.432724791068198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.00277025011136132,0.00353379358194089,-0.00969648553196546,0.00415598530924282,0.433097133148773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,42357,-0.00369878282348291,0.00472875844532616,-0.0129671493763222,0.00556958372935637,0.434117580050247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,40080,0.00247293160568851,0.00316255927898359,-0.00372568458111934,0.00867154779249635,0.434266841949023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.00434834795597446,0.00557424467912874,-0.00657717161511787,0.0152738675270668,0.435361124652405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42656,-0.00244699889940535,0.00314336482292091,-0.00860799395233033,0.00371399615351963,0.436308726627375
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.00579314603338002,0.00744776890306717,-0.0203907730833917,0.00880448101663163,0.43668226147439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.00396632564442853,0.0051049436853306,-0.00603936397881944,0.0139720152676765,0.437200483713214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.00184589192596903,0.00237876040629949,-0.00281647847037798,0.00650826232231603,0.437771764558675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,40182,-0.00420404627714443,0.00542080345043735,-0.0148288210400016,0.00642072848571279,0.438037724946454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.00782784062605288,0.0100995121406063,-0.0119672031695355,0.0276228844216412,0.43831389321278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.00900420639776286,0.0116191029630541,-0.031777648205349,0.0137692354098233,0.438386706273227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.00362227341430683,0.00470113444997628,-0.0128364969362603,0.00559195010764669,0.441013259900057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,40182,0.00211337044293691,0.00275120230500401,-0.00327898607487096,0.00750572696074477,0.442407156618351
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,42154,-0.00283389462193559,0.00369685701609682,-0.0100797343734853,0.00441194512961417,0.443351994718504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.00263778356491093,0.00344136014165773,-0.00938284944256007,0.00410728231273821,0.443395618430131
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.00482991720051222,0.00631878248471086,-0.0172147308705455,0.00755489646952107,0.444659943156217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTTG1,Securin,40302,-0.00309699312061408,0.00407511467965895,-0.0110842178927456,0.00489023165151746,0.447284507342728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,40375,-0.00741555132064827,0.00976063389876164,-0.0265463937622211,0.0117152911209245,0.447425583307803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00347804966647984,0.00458001799647818,-0.0124548849395771,0.00549878560661738,0.447629013024024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.00294448568199658,0.00388864984871493,-0.0105662393854778,0.00467726802148468,0.448945896032917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,-0.00438028311259529,0.00582138481269528,-0.015790197345478,0.00702963112028746,0.451795459339224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00188374607024019,0.00251143846167958,-0.00303867331465178,0.00680616545513216,0.453230813369316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,42370,0.00375231336402517,0.00501039544357196,-0.00606806170537587,0.0135726884334262,0.453927454570566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.00699318917214695,0.00936747386027782,-0.0113670595939976,0.0253534379382915,0.455357624151246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.00347999066281095,0.00467290063576129,-0.00567889458328117,0.0126388759089031,0.456458047953262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00254475509034721,0.00341944733089725,-0.00415736167821141,0.00924687185890583,0.456771085008826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.00457210297827242,0.00614417677103693,-0.00747048349295997,0.0166146894495048,0.45681019594821
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00648281950563595,0.00871519255306094,-0.0105989578983635,0.0235645969096354,0.456978882550399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.00386889540013611,0.00520685662521474,-0.014074334385557,0.00633654358528477,0.457474031581171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.00537689616406466,0.00724363592467969,-0.0195744225764369,0.00882063024830753,0.457923464633524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.00171419758232166,0.00231350063042766,-0.00624865881795987,0.00282026365331655,0.458734421504718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,42357,0.00243320983439899,0.00329877099567778,-0.00403238131712945,0.00889880098592743,0.460764006013022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,0.00510074239302404,0.00692342741103254,-0.00846917533259974,0.0186706601186478,0.461298367203108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,40080,-0.00309964998967316,0.00421090616763781,-0.0113530260782433,0.00515372609889693,0.461685420257058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00237895980764047,0.00323254303790011,-0.00395682454664375,0.0087147441619247,0.461782624924543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.0040152280511943,0.00546917474606581,-0.00670435445109469,0.0147348105534833,0.462868891040818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.00465666537549163,0.0063499178415215,-0.0171025043448738,0.0077891735938905,0.463365108595193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.00395644657967925,0.0053971480741118,-0.0145348568049384,0.00662196364557988,0.463535563465984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00444546521400678,0.00610073108491108,-0.00751196771241893,0.0164028981404325,0.466214608723286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,42346,-0.0100585909823001,0.0138317370502372,-0.0371687956007649,0.0170516136361648,0.467109668178203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,40199,-0.00400986392323547,0.00551488199303807,-0.0148190326295901,0.00679930478311915,0.467180917586289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.00262176780622634,0.00360879259795032,-0.00445146568575629,0.00969500129820896,0.467551275396556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.00505381524585092,0.006964521898058,-0.00859664767434276,0.0187042781660446,0.468064972940255
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,42381,0.00331284588560535,0.00457039548759715,-0.00564512927008506,0.0122708210412958,0.468557627927413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.00656718569482918,0.00906452653433683,-0.0243336577021294,0.011199286312471,0.468775785067396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.00546890987361413,0.00755351922019372,-0.0202738075451938,0.00933598779796557,0.469067985837866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,40429,0.0038313814797401,0.00531011347925176,-0.00657644093959335,0.0142392038990736,0.470601365198488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.00617650752609033,0.00856264529471861,-0.0229592923037388,0.0106062772515581,0.470717963348391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,0.00630187828281299,0.00874416711724081,-0.010836689266979,0.023440445832605,0.471112606864632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.00310224761095316,0.00431014213309154,-0.0115501261918126,0.00534563096990627,0.471690764713594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,40483,0.00186346190623714,0.00259272455705555,-0.00321827822559174,0.00694520203806603,0.472323837991695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.00576148795725619,0.00805073455757825,-0.0215409276901096,0.0100179517755972,0.474221513128619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,0.00419567105206566,0.00588047415005797,-0.00733005828204795,0.0157214003861793,0.475556134520389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,40116,0.0035779218075134,0.00501641916545666,-0.00625425975678166,0.0134101033718085,0.475711140053154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.00494045028424348,0.00694523687335366,-0.0185531145560166,0.00867221398752969,0.476886340615804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00346537774697058,0.00487605545033076,-0.00609169093567772,0.0130224464296189,0.47728981647337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,0.0078210632830308,0.0110050999557891,-0.0137489326303158,0.0293910591963774,0.477299820117806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,42346,-0.00273651622781443,0.00386639998816128,-0.0103146602046106,0.00484162774898168,0.479101555327173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,-0.00214912162341152,0.00304282095125729,-0.0081130506878758,0.00381480744105277,0.480021068615507
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,0.00350011388298352,0.00495679343030143,-0.00621520124040728,0.0132154290063743,0.48012561261681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,0.00152022345524633,0.00215399093964039,-0.00270159878644883,0.00574204569694149,0.480343090161169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.00379571636450788,0.00537887408763852,-0.0143383095762794,0.00674687684726362,0.480405152864422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,40080,0.00266682859202174,0.00378624992668639,-0.00475422126428358,0.0100878784483271,0.48123262296093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.00823652534979226,0.0117660062937669,-0.0148248469859909,0.0312978976855754,0.483925228880841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,40451,0.00265415759624263,0.0038028800268855,-0.00479948725645295,0.0101078024489382,0.48523316084442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.00234413122579724,0.00336344858744436,-0.00424822800559371,0.00893649045718819,0.485850697137761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,40199,0.00508565027794925,0.00730250299601308,-0.00922725559423639,0.0193985561501349,0.48617702282882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00347934830278455,0.00499905941782907,-0.00631880815616043,0.0132775047617295,0.486443243067697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,40451,-0.00301168855435639,0.0043286830068708,-0.0114959072478232,0.00547253013911038,0.486598705938731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,0.0034044817680504,0.00490015239802867,-0.00619981693208578,0.0130087804681866,0.487211388498534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,40302,0.00161756639370004,0.0023297071347983,-0.00294865959050463,0.0061837923779047,0.487494958812531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00202052489786624,0.00291977392961812,-0.00370223200418528,0.00774328179991777,0.488941035399547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.00300035989649646,0.00434252319714679,-0.00551098556991124,0.0115117053629042,0.489624548553827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.0025995126800849,0.00376487175493512,-0.00477963595958794,0.00997866131975773,0.489916312715231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.00312169248448707,0.00453750117426321,-0.012015194786043,0.00577180981706882,0.491479577829688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00203960523158648,0.00298216750922116,-0.00788465354965995,0.00380544308648699,0.494031354178831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.00311936148577602,0.00456923886402454,-0.0120750696592641,0.00583634668771208,0.494818484907207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,40483,-0.00153005423816154,0.00224573493514749,-0.00593169471105063,0.00287158623472755,0.49568579170214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00264947291993236,0.00389181433263028,-0.004978483172023,0.0102774290118877,0.496022091306637
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.0033828202524659,0.00497200073102474,-0.00636230118034259,0.0131279416852744,0.496282072304278
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00248148031239329,0.003662290832479,-0.00469660971926556,0.00965957034405213,0.498054844095597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.00173628163438419,0.00256607511196431,-0.00329322558506586,0.00676578885383424,0.498652818188423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42679,0.00378630851490615,0.00559860605248287,-0.00718695934796027,0.0147595763777726,0.498865052228224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,40302,0.00412161220721385,0.00612974949393782,-0.00789269680090427,0.016135921215332,0.501346323908175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.00221942937185295,0.00332286728036758,-0.00873224924137341,0.00429339049766751,0.504192450803606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,42332,-0.00334840102647347,0.00502079932558242,-0.013189167704615,0.00649236565166807,0.504843911515914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.00645340503779034,0.00968979854331672,-0.0125386001071104,0.0254454101826911,0.505425192643861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.00250217654829365,0.00375791369776989,-0.00986768739592263,0.00486333429933533,0.505523811819176
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.00405035922847388,0.00611999144950014,-0.0160455424694942,0.00794482401254639,0.508097670051297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,0.0023515511036075,0.00355404969590049,-0.00461438630035746,0.00931748850757246,0.508206941193117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,0.00619729058659791,0.00938806158013285,-0.0122033101104625,0.0245978912836583,0.509187368940082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.00299565474972611,0.00454261655872418,-0.0118991832048255,0.00590787370537329,0.509616622736283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00321577411875002,0.00489463054739814,-0.0128092499916504,0.00637770175415035,0.511194433760332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00267271300423968,0.00406889854596366,-0.0053023281458491,0.0106477541543285,0.511279887246029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.00546997394776389,0.00832860447729512,-0.0217940387232623,0.0108540908277346,0.511340587406295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.00355789986416838,0.00541921671750011,-0.00706376490213183,0.0141795646304686,0.511494244234199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.00430757373546731,0.00657295586445011,-0.00857541975885491,0.0171905672297895,0.51225754621267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.00806949658186306,0.0123384162732976,-0.0322527924775264,0.0161137993138003,0.513116369113309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.00561715534330541,0.00862197563728623,-0.0225162275923864,0.0112819169057756,0.514742154220221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42611,-0.00772088077694254,0.0118666160120041,-0.0309794481604706,0.0155376866065855,0.515290820570392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.00202752403874432,0.00316489825222386,-0.00823072461310308,0.00417567653561445,0.521777384173182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00517846758970948,0.00810701128064063,-0.0210682096997651,0.0107112745203462,0.522989378811422
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42711,-0.0018734150009808,0.00293333665716215,-0.00762275484901862,0.00387592484705702,0.523052695392728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,40451,0.00215948506739698,0.00339354846819863,-0.00449186993027234,0.0088108400650663,0.524561164634791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,0.00331932382205482,0.00521900228809776,-0.00690992066261679,0.0135485683067264,0.524784468160806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.00157376880057154,0.00248435856533001,-0.00644311158861837,0.00329557398747528,0.526436948847309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,40116,0.00285858395112945,0.00451372077938449,-0.00598830877646414,0.011705476678723,0.526544565067314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,0.00467813083626948,0.00739138839109738,-0.00980899041028139,0.0191652520828204,0.526801472486799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.00381571240370822,0.00603643583548732,-0.0156471266412634,0.00801570183384693,0.52732583651755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00304812194287331,0.00484103131996153,-0.00644029944425129,0.0125365433299979,0.528941291842741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.00272365704100383,0.00432935703753292,-0.0112091968345684,0.0057618827525607,0.529285667094965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.00351418791983045,0.00559306120349457,-0.0144765878786798,0.0074482120390189,0.529810409960939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.00740716344655872,0.0117934211315939,-0.0305222688644827,0.0157079419713652,0.529964931610515
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00262061347761278,0.00417323940038627,-0.0108001627023699,0.0055589357471443,0.530043214823778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,40080,0.00255673163876133,0.00407779246921193,-0.00543574160089405,0.0105492048784167,0.53067949547868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00304008173602084,0.00487074760529248,-0.00650658357035243,0.0125867470423941,0.532541395014588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00403717050487331,0.00647923604799591,-0.00866213214919867,0.0167364731589453,0.533233800746758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,0.00252382493549997,0.00406035934105591,-0.00543447937296961,0.0104821292439696,0.534233190572777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.00562745048464806,0.0090745104352308,-0.0234134909377004,0.0121585899684043,0.535179622830193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00258808520170586,0.00417535690553695,-0.00559561433314656,0.0107717847365583,0.535370941572377
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.00280642183166342,0.00453198215227707,-0.00607626318679964,0.0116891068501265,0.535765648170971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.00353899441875447,0.00576780822846274,-0.00776590970903249,0.0148438985465414,0.539507646315736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.00227900160372432,0.00372957346557519,-0.00958896559625168,0.00503096238880305,0.541168693719143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,40199,-0.00247190814772328,0.00405186218820635,-0.0104135580366077,0.00546974174116117,0.541829901660284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.00634753167229777,0.0104197301905034,-0.0267702028456845,0.014075139501089,0.542415022230954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0057559407496846,0.00945856093250399,-0.0242947201773924,0.0127828386780232,0.542837721578486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,40482,-0.00459499858309738,0.00755667577921285,-0.0194060831103546,0.0102160859441598,0.543152339369982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00311251182762597,0.00513430527070003,-0.00695072650294608,0.013175750158198,0.544382461084352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.0019089748554722,0.00314991003507592,-0.00426484881327661,0.00808279852422101,0.544499998520594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.00269683806409208,0.00446692400568054,-0.0114520091152259,0.00605833298704178,0.546030033053698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00202151161211973,0.00335006367356861,-0.00858763641231422,0.00454461318807475,0.546238637191475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,42346,0.00469030945624866,0.00779199315051384,-0.0105819971187585,0.0199626160312558,0.547224701065001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.00710104263061014,0.0118151169444489,-0.03025867184173,0.0160565865805097,0.547841282128183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,0.00147533660502753,0.0024610475774438,-0.00334831664676232,0.00629898985681737,0.548868394702601
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00414972646826966,0.00697373994093435,-0.017818256752501,0.00951880381596166,0.551822113298718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.00252686853996838,0.00424760307961433,-0.0057984334960757,0.0108521705760125,0.551927487053669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00155163612367545,0.00261123695868147,-0.00666966056269114,0.00356638831534023,0.552380547772554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00139713755094851,0.00235945701861412,-0.00602167330743219,0.00322739820553517,0.553766242423369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00249962715950018,0.00422441569952378,-0.00578022761156643,0.0107794819305668,0.554057247482698
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,40269,0.00239537975485012,0.00406088066425213,-0.00556394634708405,0.0103547058567843,0.555291810514795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42754,0.00254374873458452,0.0043135795831517,-0.0059108672483928,0.0109983647175618,0.555396824279175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.00459915188498258,0.00780025693232345,-0.0198876554723365,0.0106893517023714,0.555460513773951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,0.00288269113971205,0.00488946161266965,-0.00670065362112045,0.0124660359005446,0.555487328609642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,0.00115653018668198,0.00196707164113991,-0.00269893022995225,0.00501199060331621,0.556580827460557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00158813334017479,0.00270148194206247,-0.00370677126626765,0.00688303794661724,0.556628046674056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00492600958380534,0.00842376858980181,-0.0115845768522062,0.0214365960198169,0.558711111248105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,40080,0.00268288333195245,0.00460066133954999,-0.00633441289356554,0.0117001795574704,0.559803284540509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,40198,0.00400891869090498,0.00693040672477046,-0.00957467848964511,0.0175925158714551,0.562969756299832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00211905718197269,0.00366529721850523,-0.00506492536629756,0.00930303973024294,0.563180909196796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.00508725769155273,0.00881738470675477,-0.0223693317167921,0.0121948163336866,0.563979855933283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.00565827401281379,0.00982486287317972,-0.024915005244246,0.0135984572186185,0.564684935500604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,42311,0.00260841652745961,0.00453080057295008,-0.00627195259552256,0.0114887856504418,0.564822683366462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,0.00358578325228481,0.00622924113610333,-0.00862352937447771,0.0157950958790473,0.564872294426505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00381636809995227,0.00664856084504326,-0.00921481115633252,0.0168475473562371,0.565968058458026
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,40116,-0.00218666201454596,0.00382434134375737,-0.0096823710483104,0.00530904701921848,0.567486317020851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.00434740306626627,0.00765217927713081,-0.0106508683169101,0.0193456744494426,0.569959019022044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.00213800109596936,0.00377939626189357,-0.00954561776928075,0.00526961557734204,0.571607835396534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.00647989019822141,0.0114567610300613,-0.0289351418171416,0.0159753614206988,0.571680165057586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.00187578812906301,0.00332540860083871,-0.00464201272858085,0.00839358898670687,0.572712910975827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0134136599786651,0.023788999936571,-0.0600400998543442,0.033212779897014,0.572860773082011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42618,-0.0020445895334916,0.00364046227608565,-0.00917989559461948,0.00509071652763628,0.574378128870917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.00292059786009597,0.0052192067807186,-0.0131502431503044,0.00730904743011249,0.575772621926968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,0.00261422135271705,0.00470250500339332,-0.00660268845393385,0.0118311311593679,0.578274308374005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,0.00240857299094488,0.00437154089150134,-0.00615964715639774,0.0109767931382875,0.581665856173873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,40482,0.00198723583486901,0.00361314130103496,-0.0050945211151595,0.00906899278489753,0.582328714368472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00423015006471597,0.00771294663755353,-0.0193475254743209,0.0108872253448889,0.583395209825059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.00127600071659959,0.00233154103496108,-0.00584582114512329,0.00329381971192412,0.584196929866564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,0.00226032632621618,0.00415079999515481,-0.00587524166428726,0.0103958943167196,0.586072848096992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00342710747566072,0.00630721064043246,-0.0089350253795869,0.0157892403309083,0.586890739827013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42603,0.00216578500012973,0.00399828695625266,-0.00567085743412548,0.0100024274343849,0.588049189672003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00221738641653402,0.00409433120175073,-0.00580750273889741,0.0102422755719655,0.588120421643326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.00418418900829789,0.00772868453723569,-0.0193324107012798,0.0109640326846841,0.588251840626695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,-0.0026011263572194,0.00480609247104352,-0.0120210676004647,0.0068188148860259,0.588370865331223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,40302,-0.00188732858475523,0.00350323666876972,-0.00875367245554389,0.00497901528603343,0.590078077386474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,40116,-0.00276194379751303,0.00513658215232894,-0.0128296448160777,0.00730575722105169,0.590794654082132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00291002593409324,0.00542520114172152,-0.0135434201718674,0.00772336830368094,0.591699490461076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42734,-0.00182571254293812,0.00341646568586826,-0.0085219852872399,0.00487056020136366,0.593083052072622
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPGN,Epigen,40451,-0.00237990702020921,0.00452653556508349,-0.0112519167277729,0.00649210268735442,0.599059848779151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,0.0015345749756275,0.00291878818453134,-0.00418624986605393,0.00725539981730892,0.599066947108518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,0.00376303928044381,0.0071624947859992,-0.0102754505001146,0.0178015290610022,0.599328573903014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.00501093922699475,0.00964865849271258,-0.0239223098727114,0.0139004314187219,0.603533489646118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.00161654518807542,0.00311614600133086,-0.00772419135068392,0.00449110097453307,0.603933581413228
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.00301013442635967,0.00581686369189007,-0.00839091840974486,0.0144111872624642,0.604828672023431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00288749915674601,0.00558468721511977,-0.00805848778488875,0.0138334860983808,0.605139626955224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.0017567386551319,0.00340492967800601,-0.00843040082402369,0.00491692351375988,0.605906577597251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,0.00552520157522562,0.0107594040696861,-0.0155632304013591,0.0266136335518104,0.607593979547673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.00206164304706656,0.00401922529520504,-0.00993932462566843,0.0058160385315353,0.607999902421997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,40080,0.00481195796939012,0.00943883310435159,-0.013688154915139,0.0233120708539192,0.61019888810153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00171236830866892,0.00336206603524232,-0.00830201773774386,0.00487728112040603,0.610537722260104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.00299568027498163,0.00589287668400271,-0.0145457185756269,0.00855435802566368,0.611213879498215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.00421801710786524,0.00831849375550453,-0.0205222648686541,0.0120862306529236,0.612119442943818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.00288809515880314,0.00569919305439524,-0.0140585135454178,0.00828232322781154,0.612334950046704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,40539,-0.00133832061085526,0.00264546625255603,-0.00652343446586508,0.00384679324415456,0.612942192419454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.00374426052790324,0.00740215600970506,-0.0182524863069251,0.0107639652511187,0.612983197207618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.00160929671109386,0.00321400672735498,-0.00790874989670962,0.0046901564745219,0.61658083915845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,40182,0.00171796185944164,0.00343487907880885,-0.0050144011350237,0.00845032485390699,0.616978025029064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.00446540972057532,0.00893126176061003,-0.0130398633302203,0.021970682771371,0.617100723461101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,40283,-0.00178829968627237,0.003591854869603,-0.00882833523069425,0.00525173585814951,0.618581052110291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.001142900073717,0.00230931159828445,-0.00566915080635453,0.00338335065892053,0.620673652219956
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.00215473391635327,0.00435755030727234,-0.0106955325186071,0.00638606468590051,0.620973307935363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,40384,0.00153578865824076,0.00312777030219744,-0.00459464113406624,0.00766621845054775,0.623423992590946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42711,-0.00311845938508254,0.00637098872837015,-0.015605597292688,0.00936867852252295,0.6245112063952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00183955681354948,0.00376083083860967,-0.00553167163012549,0.00921078525722444,0.624755054631753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00194802619154679,0.00399246405701701,-0.00977325574330013,0.00587720336020654,0.625612124486132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00199165789056231,0.00408536822083963,-0.00601566382228336,0.00999897960340798,0.625906737649234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,40527,-0.00449240393389545,0.00922985665419785,-0.0225829229761232,0.0135981151083323,0.626462488668737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.00188565409414745,0.00388268701021603,-0.00949572063417086,0.00572441244587597,0.627220155796009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42638,-0.00162924121226793,0.00336261046704822,-0.00821995772768245,0.00496147530314658,0.628027048459222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,0.00155844469373605,0.00321750795940823,-0.00474787090670409,0.00786476029417619,0.628135701505237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,40182,-0.00170368847278656,0.0035318118826826,-0.00862603976284445,0.00521866281727134,0.629543009265963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,40302,0.00134696624337346,0.00279607381622265,-0.00413333843642293,0.00682727092316985,0.630003795488933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.00243067700058501,0.00505051988717625,-0.00746834197828045,0.0123296959794505,0.630330773362291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.004594063028319,0.00958886320055595,-0.0142001088447707,0.0233882349014087,0.631874244534123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,40199,0.00126697826100932,0.00264538819728373,-0.00391798260566679,0.00645193912768543,0.631991894895673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,40302,0.00194853595597433,0.00407546093182927,-0.00603936747041104,0.00993643938235969,0.632578297532475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.00260815898491578,0.00546688525466926,-0.0133232540840675,0.00810693611423597,0.633312381902641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00263990617917474,0.00555887732757554,-0.0135353057412228,0.00825549338287333,0.634868288059578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,0.00499719277660011,0.0105702869044292,-0.0157205695560811,0.0257149551092813,0.636394615838243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00229518866289022,0.00488795534715875,-0.0118755811433214,0.00728520381754092,0.638676958999496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00281077083167487,0.00600273335225017,-0.00895458653873546,0.0145761282020852,0.639616226076931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42584,0.0033078376874506,0.0070690599469902,-0.0105475198086502,0.0171631951835514,0.639841003710577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00246158647607727,0.00528392165223602,-0.0128180729144599,0.00789489996230533,0.641322496676132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.00420349153146545,0.00909671321684795,-0.0136260663735565,0.0220330494364874,0.644026370874213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,40036,0.00160295719436992,0.00348190725188316,-0.00522158101932107,0.00842749540806092,0.645261638032791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.0014455298102929,0.00314162515537074,-0.00471205549423374,0.00760311511481955,0.645438080982203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,40080,0.00304460410338053,0.00663947629780875,-0.00996876944032462,0.0160579776470857,0.646558687824306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00183960884771075,0.00403141347983213,-0.00606196157276021,0.00974117926818172,0.648169831316927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.00673371320996266,0.0147568201787935,-0.0221896543404726,0.0356570807603979,0.648174485645687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.00284230128476969,0.00624086785620533,-0.0150744022829321,0.00938979971339274,0.648804640780777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.00213417208511635,0.00471775652806635,-0.0113809748801264,0.00711263070989369,0.651011062164405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00284046981647182,0.00628830597068383,-0.0151655495190121,0.00948460988606848,0.651489303924694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00170376301879343,0.0037927198135354,-0.00572996781573595,0.00913749385332281,0.653282215298192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.0011618419210351,0.00259514396850818,-0.00624832409931113,0.00392464025724093,0.654379391681489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.00225101673539533,0.00503998122339281,-0.0121293799332452,0.00762734646245458,0.655148157163845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00120885456208669,0.0027112849274002,-0.00410526389561769,0.00652297301979108,0.655706931975627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00330964855260994,0.00743925479163645,-0.0178905879442174,0.0112712908389975,0.656408241756861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.00532165636729284,0.012163752714354,-0.0185192989528411,0.0291626116874267,0.661755092377356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,40136,0.00247107973018226,0.00566665350782852,-0.00863556114516163,0.0135777206055261,0.662791711561056
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,42370,0.0020434687505751,0.00470716392287444,-0.0071825725382588,0.011269510039409,0.664209221115544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.00176393469632341,0.00406415291194873,-0.00972967440374292,0.00620180501109611,0.664280247284627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00228350840595035,0.0052615652928005,-0.0125961763798393,0.00802915956793864,0.66429708765776
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.00454025962462163,0.0104705566762072,-0.0250625507099877,0.0159820314607445,0.66457035286781
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,0.00343318572093072,0.00794924664522056,-0.0121473377037016,0.019013709145563,0.665831063623998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,40080,-0.00264355246277339,0.00615450062255687,-0.0147063736829849,0.00941926875743808,0.667544907789136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.00255863835016047,0.00597342654112191,-0.0142665543707594,0.00914927767043847,0.668412844218354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00407584105203491,0.0095210221918866,-0.0145853624440628,0.0227370445481326,0.668595057855923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.00188450319244466,0.00441436149088815,-0.00676764532969612,0.0105366517145854,0.669458304810214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00121005988539674,0.00284220938854089,-0.00678079028693689,0.0043606705161434,0.670300864637807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,40449,0.00130423109691213,0.00307583723518514,-0.00472440988405074,0.00733287207787501,0.671555871322238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.00182678440623271,0.0043087190463375,-0.00661830492458878,0.0102718737370542,0.671593136656735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00133793774555962,0.00315676638908836,-0.00752519986817281,0.00484932437705356,0.671696594363508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00119720052968482,0.00282678529564499,-0.00673769970914901,0.00434329864977936,0.671924077683772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00129190621430415,0.00307994779135426,-0.0073286038853585,0.00474479145675019,0.674890230371783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,0.00155718683582625,0.00371529319083028,-0.00572478781820111,0.0088391614898536,0.67512991065237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.00204638866476952,0.00488594918780452,-0.00753007174332734,0.0116228490728664,0.675347631851577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,40283,-0.004776513265302,0.0114307393954647,-0.0271807624804129,0.0176277359498089,0.676053444495229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.00443030792101329,0.0106717228430937,-0.0253468846934769,0.0164862688514504,0.67804417024728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.00178059356271444,0.00429354663139906,-0.0101959449602566,0.00663475783482772,0.678358013267898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.00320365820836795,0.00774008101265905,-0.0183742169931797,0.0119669005764438,0.678951838335315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42629,0.00758133543462529,0.0183891228910062,-0.0284613454317469,0.0436240163009975,0.68014605074426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.00155435670345776,0.003774941259422,-0.00895324157192488,0.00584452816500937,0.680525706177263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00182728647009917,0.0044381440359145,-0.0105260487804916,0.00687147584029325,0.680550401798249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.00115264112944894,0.0028095512405907,-0.00435407930210883,0.00665936156100671,0.681624600266868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.00196310106986042,0.00480403529231414,-0.0113790102427961,0.00745280810307531,0.682813594296065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,42357,-0.00196145255933376,0.00483885665393374,-0.0114456116010439,0.00752270648237637,0.685223502515961
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.00126426090841145,0.00313298651244814,-0.0074049144728098,0.00487639265598691,0.686564402571222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,40136,0.0014875365475651,0.00369811589603799,-0.00576077060866935,0.00873584370379956,0.687513988509676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,40302,-0.00163388062856446,0.00408622783406152,-0.00964288718332505,0.00637512592619613,0.689274251592621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.00177417724203626,0.00444546450197795,-0.00693893318184052,0.010487287665913,0.689828338523593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.00444536433860775,0.0112964795063778,-0.0265864641711083,0.0176957354938928,0.693943540210704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,42276,-0.00189201011952578,0.00482918078684147,-0.0113572044617351,0.00757318422268351,0.695222003356386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.00484358168187402,0.0124398841122882,-0.0292257545419588,0.0195385911782108,0.69701789184004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.00547653818711346,0.0141007590196567,-0.0331140258656407,0.0221609494914138,0.697737656876088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00275057856186829,0.00708529549368044,-0.0111366006057454,0.016637757729482,0.697868572127217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00198919878155251,0.005126820353171,-0.0120377666737677,0.00805936911066265,0.698024666230113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42652,-0.0014713601529754,0.00379716046516181,-0.00891379466469254,0.00597107435874174,0.698399917729006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00146361611077776,0.00378205495523139,-0.00594921160147576,0.00887644382303127,0.698771370638323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00101497918147815,0.00263724959387566,-0.00415403002251815,0.00618398838547445,0.700346624253974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.00392899834137403,0.0102216379580707,-0.0239634087391925,0.0161054120564445,0.700703887339988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.00460486853761041,0.0119956129111378,-0.0281162698434404,0.0189065327682196,0.701075303312724
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.00143299504256095,0.0037331530167466,-0.00874997495538428,0.00588398487026239,0.701090862526596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00255797145227135,0.00666911199483174,-0.0156294309621416,0.0105134880575989,0.701315616448755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,0.00141592321728682,0.00369757773347541,-0.00583132914032498,0.00866317557489861,0.70177715863332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,40199,0.0014254225845501,0.00372486963400662,-0.00587532189810287,0.00872616706720308,0.701966531538754
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,40136,0.00173098628937561,0.00454748987272695,-0.00718209386116922,0.0106440664399204,0.703472931149701
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00135450448587255,0.00356006162689163,-0.00833222527458014,0.00562321630283503,0.703602361270742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42721,0.00121996603360492,0.00322204335079712,-0.00509523893395743,0.00753517100116728,0.704967716748094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,40302,0.00266471379553056,0.00704785657660011,-0.0111490850946057,0.0164785126856668,0.705372046792268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,40199,0.00367401811350493,0.00973184441582577,-0.0154003969415136,0.0227484331685234,0.705790498400873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42595,0.00491481317818234,0.0130575867289415,-0.0206780568105429,0.0305076831669076,0.706629060808277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00239951990895215,0.00637544816836313,-0.0148953983189439,0.0100963585010396,0.706650057161329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00170452246571565,0.00453481452578597,-0.00718371400482486,0.0105927589362562,0.707016060389855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.00247177039367534,0.00660970509104178,-0.0104832515847665,0.0154267923721172,0.708439613422424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00325112441873389,0.0087190982580014,-0.0203405570044166,0.0138383081669489,0.709249458255148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,0.00136662992430397,0.00368964163908671,-0.00586506768830599,0.00859832753691393,0.711094116810657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.000979418507176361,0.00266129886880734,-0.00619556429003874,0.00423672727568602,0.712863301132894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.00215537388474728,0.00588445002312606,-0.0136888959300744,0.0093781481605798,0.714159632251308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00159873345198413,0.00436682282127198,-0.0101577061816772,0.00696023927770895,0.714290660288267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00178181628123444,0.00487208152653499,-0.00776746351077415,0.011331096073243,0.714581260434604
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,0.00117758921280973,0.00322103441111614,-0.0051356382329779,0.00749081665859736,0.714674328498759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00174758413279846,0.00478071566859815,-0.00762261857765392,0.0111177868432508,0.71470898116874
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,-0.00126013476836033,0.00345544848770681,-0.00803281380426567,0.00551254426754502,0.715356958207649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00204882926350227,0.0056183099025361,-0.00896305814546849,0.013060716672473,0.715364790000966
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.00199747679177528,0.00550480221244383,-0.0127868891281652,0.00879193554461462,0.716715869714586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00157367124576733,0.00436219431585604,-0.00697622961331051,0.0101235721048452,0.718291460527062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00160521714946271,0.00446551582242389,-0.0103576281614135,0.00714719386248811,0.719250771478974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42711,-0.00100735285359811,0.00282222947292042,-0.00653892262052213,0.00452421691332592,0.721145938902324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.00144050429599235,0.00403771932701841,-0.00935443417694843,0.00647342558496372,0.721275701399168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.0015522261914039,0.00436938094892304,-0.0101162128512931,0.00701176046848526,0.722407383016185
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.00110091877886628,0.0031021158973506,-0.00718106593767345,0.0049792283799409,0.722676607778969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,40532,-0.00173706672374272,0.00489680310922764,-0.0113348008178289,0.00786066737034346,0.722794836704982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,42370,-0.00100497656888067,0.00284009123327865,-0.00657155538610683,0.00456160224834548,0.723454247471696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,0.0010572404554313,0.00299145033453723,-0.00480600220026168,0.00692048311112428,0.723778629485011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42587,0.00258204414151621,0.0073070176388149,-0.011739710430561,0.0169037987135934,0.723820398142478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,40199,-0.00123746043868086,0.00353826771090598,-0.00817246515205657,0.00569754427469485,0.726543347347098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.00212690311310365,0.0060883315473475,-0.0140600329459048,0.00980622671969746,0.726840104372174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,40080,0.00108541029735385,0.00311245000446341,-0.00501499171139442,0.00718581230610213,0.727297411331132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0033832342603935,0.00976286762480837,-0.0225184548050179,0.0157519862842309,0.728941591474895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,0.00296396545733555,0.00855989026384041,-0.0138134194597917,0.0197413503744628,0.729152243418399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,40182,-0.00138378281288269,0.00403083425319712,-0.00928421794914904,0.00651665232338366,0.731379831289164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,0.00141016350637825,0.00414235139023272,-0.00670884521847788,0.00952917223123438,0.733541188438081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,40482,0.00229441223815888,0.00677206915652838,-0.0109788433086367,0.0155676677849545,0.734762786401217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.00219542248010427,0.00648250765031564,-0.0149011374747229,0.0105102925145144,0.734865718845976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00101127388686374,0.00299855109087301,-0.00486588625124737,0.00688843402497484,0.735930591267345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.00143311640988263,0.00425640396547534,-0.00977566818221429,0.00690943536244903,0.736352091918957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,40482,0.00155942544701982,0.00476337741494564,-0.00777679428627363,0.0108956451803133,0.74338799931783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42488,-0.00167103361839563,0.00512659296624681,-0.0117191558322394,0.00837708859544812,0.744464269276151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,40302,0.00176413446338384,0.00541314896557547,-0.00884563750914409,0.0123739064359118,0.744507662052121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.000770224417852498,0.00236388041430609,-0.00540343002989243,0.00386298119418744,0.744557594347316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00230588753863634,0.00708141021400329,-0.0115736764808101,0.0161854515580828,0.74471393869091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.00228643812186577,0.0070765181413846,-0.0115835374352481,0.0161564136789796,0.746624067291103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42594,0.00189672139640606,0.00588794672809891,-0.0096436541906678,0.0134370969834799,0.747354461667617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.00166130492973811,0.00518333795272786,-0.00849803745760849,0.0118206473170847,0.748587722030791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00181578667244559,0.00570421728791807,-0.00936447921187383,0.012996052556765,0.750245611951896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.00110319910878345,0.00348143153962805,-0.00572040670888752,0.00792680492645443,0.751338936196673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.00185974646185611,0.00589281754958384,-0.00969017593532821,0.0134096688590404,0.752315614437292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00195198516961378,0.00622168689096836,-0.0141464914759118,0.0102425211366842,0.753725337932005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,0.00071621533772551,0.00228656929560792,-0.00376546048166601,0.00519789115711703,0.75411297781558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00157396956043288,0.00503500901244057,-0.00829464810395065,0.0114425872248164,0.754586681112045
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,40199,0.000904681815208604,0.00289499047165703,-0.00476949950923918,0.00657886313965639,0.754667194610661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00103101419613802,0.00332587097972694,-0.00754972131640281,0.00548769292412677,0.756568198689452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00194412384751436,0.00630541345890684,-0.0143027342269718,0.010414486531943,0.757839952422949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,0.00147496579683585,0.00478508094210863,-0.00790379284969708,0.0108537244433688,0.75790262002428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00166963155732157,0.00545543845720058,-0.0123622909334347,0.00902302781879157,0.759573150326012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,40080,0.00142832641454519,0.00476159585879729,-0.00790440146869751,0.0107610542977879,0.764207287525479
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,42370,0.000879362984005756,0.00294254627622949,-0.00488802771740405,0.00664675368541556,0.765063612407066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEB,Nebulin,40116,0.0011411274817753,0.00382232540382981,-0.00635063030973113,0.00863288527328174,0.765294643561134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.00146627161397907,0.00491322431549883,-0.0110961912723568,0.00816364804439864,0.765377679595306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.00346472002137697,0.0116522262930197,-0.0263030835556956,0.0193736435129416,0.766208444572004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42636,0.00119113408283183,0.00403423857546368,-0.00671597352507699,0.00909824169074064,0.767802708416033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0029942754087063,0.0101878911353186,-0.0229625420339308,0.0169739912165182,0.768835751620191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.00146003780116772,0.00502549181319258,-0.0113100017550252,0.00838992615268974,0.771418090019594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.000854614424358141,0.00294967801189565,-0.00492675447895733,0.00663598332767361,0.772026238911764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00222784355274287,0.00780671637567467,-0.0130733205435795,0.0175290076490652,0.775362054314442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,40080,-0.00207533680846758,0.00727987849469612,-0.016343898658072,0.0121932250411368,0.775589428113136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.00172996980204471,0.00606966193138295,-0.0136265071875553,0.0101665675834659,0.77563484437252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,42293,0.00159587115805777,0.00563407329146479,-0.00944691249321322,0.0126386548093288,0.776986971592513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.00126007374582485,0.00444889073044359,-0.00997989957749429,0.00745975208584458,0.777003325683995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSND,Barttin,40080,-0.000962623818923069,0.00340028643049037,-0.00762718522268419,0.00570193758483805,0.777104949080852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,40199,0.00116403424923076,0.00412650484899375,-0.00692391525479698,0.00925198375325851,0.777881942833054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,0.00122745238008957,0.00441370383845876,-0.00742340714328961,0.00987831190346874,0.780940616816941
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0017376615178103,0.00626376547813713,-0.0105393188193385,0.0140146418549591,0.781466645487373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.000639919181657523,0.00230853772312349,-0.00516465311897957,0.00388481475566452,0.781633264709602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00118928191962356,0.0042976492204656,-0.00961267439173614,0.00723411055248902,0.781993831608336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42587,0.0052553568807907,0.019040591652615,-0.0320642027583348,0.0425749165199162,0.782546129443123
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.00156557313286613,0.00570006159447603,-0.0127376938580391,0.00960654759230688,0.783583352568153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,40080,-0.0011258495323159,0.00410891451131498,-0.00917932197449326,0.00692762290986147,0.784088519360413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.00192408903409006,0.00706431167227989,-0.0157701399117586,0.0119219618435785,0.785344555915217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.00229605772126774,0.00850733747703421,-0.0189704391762548,0.0143783237337193,0.787248848024965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,40136,-0.00128785088825922,0.00478351302475024,-0.0106635364167697,0.00808783464025126,0.787760076020521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.00232416817291066,0.00868953931603747,-0.0193556652323441,0.0147073288865228,0.789114239938091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.00334589332495163,0.0125696491677363,-0.0279824056937148,0.0212906190438116,0.790098379418887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.00108348960210557,0.00407229109966009,-0.00689820095322821,0.00906518015743936,0.790194998244321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,0.00194137154864458,0.00732424458434686,-0.0124141478366753,0.0162968909339644,0.790967439640219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42578,0.00287523307041339,0.0108985624511401,-0.0184859493338211,0.0242364154746479,0.791924499678661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,40539,0.0005494674434411,0.00208603375171057,-0.00353915870991162,0.00463809359679382,0.792244800935293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.00105550547416096,0.00400762288441452,-0.00891044632761342,0.0067994353792915,0.792266949662619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.00219372834149556,0.00835221446247047,-0.0185640686879377,0.0141766120049466,0.79282350912128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000763662595139644,0.00294985649490519,-0.00501805613487452,0.00654538132515381,0.795730894202858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,-0.00107919379739049,0.0042284894175953,-0.00936703305587728,0.0072086454610963,0.798558238466111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.00123249926066381,0.00484112647572187,-0.0107211071530787,0.00825610863175106,0.799045075870496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,42370,0.00190703541706248,0.00749246335388291,-0.012778192756548,0.016592263590673,0.799092296466307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,0.00157087123267672,0.00620834988012828,-0.0105974945323747,0.0137392369977282,0.800252405605932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.00159933850117967,0.00633824511265325,-0.0108236219196207,0.01402229892198,0.800789497291145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,0.00144088361113516,0.00578239150591018,-0.00989260374044879,0.0127743709627191,0.803221799602836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.00375265744490928,0.0152995924838712,-0.0337398587132969,0.0262345438234783,0.806244709509819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,42346,-0.0017901118576882,0.0073906591690495,-0.0162758038290252,0.0126955801136488,0.808619095193904
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,0.00083413618638245,0.00344509001188674,-0.00591824023691556,0.00758651260968046,0.80868926998851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,0.00179451578610376,0.00750127292813654,-0.0129079791530439,0.0164970107252514,0.81093300440567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.00139232585094812,0.00588342356264247,-0.0129238360337274,0.0101391843318311,0.812930978039689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.00227338894901643,0.00961111193151793,-0.0211111683347916,0.0165643904367587,0.813019870405871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.000812518477643243,0.00344023428273554,-0.00593034071651842,0.0075553776718049,0.813295680161403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.00193191109123392,0.00835018783015627,-0.0144344570558724,0.0182982792383402,0.817038363113751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,0.00103737426744091,0.00456965405894506,-0.00791914768809141,0.00999389622297323,0.820416495216588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.00204550474881668,0.00920252549073223,-0.0159914452130185,0.0200824547106518,0.824102849169635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.00121437600659184,0.00550352613153623,-0.0120012872244028,0.00957253521121917,0.825365150840005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,0.00183651324824584,0.00843346584610632,-0.0146930798101226,0.0183661063066142,0.827616285443283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42636,0.00162588059862411,0.00746837169796336,-0.0130121279293841,0.0162638891266323,0.827664490408414
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42570,-0.00141660484939526,0.00657290383332619,-0.0142994963627146,0.0114662866639241,0.829363710509141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42531,0.000971634083079232,0.00451809919499838,-0.00788384033911759,0.00982710850527605,0.829728716357702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.000622067761625103,0.00289456281678186,-0.00505127535926734,0.00629541088251754,0.829842212749948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,0.00179234512291666,0.00834265772583685,-0.0145592640197236,0.0181439542655569,0.829894538705125
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,0.000919053674286167,0.00428160795737726,-0.00747289792217326,0.0093110052707456,0.830042347512648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.001784067965552,0.00837828588426506,-0.0146373723676075,0.0182055082987115,0.83137746526889
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,0.000711893825506345,0.00337835755776368,-0.00590968698771046,0.00733347463872315,0.833108238241782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,-0.000906533594344076,0.00432068415768439,-0.00937507454340548,0.00756200735471732,0.833817855549221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,40223,0.000376724912729215,0.0018101955117513,-0.00317125829030333,0.00392470811576176,0.835144711547048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.00197993093315055,0.00961728563914322,-0.0208298107858713,0.0168699489195702,0.836894531519858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.00106804761124817,0.00542794131674463,-0.0117068125920676,0.0095707173695713,0.844012570528534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.000746331685224131,0.00386780127278286,-0.00683455880943027,0.00832722217987853,0.846993730323337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.00107872388745538,0.00560968131594547,-0.00991625149179774,0.0120736992667085,0.847512676810267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.00137979108947961,0.00723293605322642,-0.0155563457538034,0.0127967635748442,0.848713263679765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,42370,0.000955547148598937,0.00510397203370994,-0.00904823803747254,0.0109593323346704,0.851493868073365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42611,-0.000992592337245206,0.00530196368173539,-0.0113844411534466,0.00939925647895616,0.851497082805128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00086442123228694,0.00470998103507446,-0.0100959840610329,0.00836714159645901,0.854385827443022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.000506218056586745,0.00276761177846542,-0.00491830102920548,0.00593073714237897,0.854873561132595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.000529027459292553,0.00290919793920482,-0.00517300050154889,0.006231055420134,0.855705937809942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,0.000988855795165049,0.00545443704703756,-0.00970184081702857,0.0116795524073587,0.856140285631311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.000552111708418377,0.00306241751087987,-0.00655445002974292,0.00545022661290617,0.856931221089111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.00102424950529089,0.00571426189656835,-0.0122242028225649,0.0101757038119831,0.857748503817793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00101431428199776,0.00574387605482334,-0.010243682785456,0.0122723113494515,0.859833295575396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.000491935116317088,0.00282913112761762,-0.00603703212644762,0.00505316189381345,0.861961359062061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42594,-0.000936065959517685,0.0054694225859272,-0.011656134227935,0.00978400230889963,0.864112102582625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.00069236909439619,0.00407395398462403,-0.00729258071546691,0.00867731890425929,0.865051954018588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,40136,0.000842028080083791,0.00500154850884478,-0.00896100699725197,0.0106450631574196,0.866308317487736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.00109609370101928,0.00654273267868858,-0.0139198497512489,0.0117276623492103,0.866956854659542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,0.0012228870958248,0.0074650326586701,-0.0134085769151686,0.0158543511068182,0.869879471052652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.000683142390718665,0.00417358142600202,-0.0074970772042453,0.00886336198568263,0.869984077003759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.000992039284193687,0.0060676928644642,-0.0128847172985435,0.0109006387301561,0.870130980979306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,0.000639852722905211,0.00395583705839219,-0.00711358791154348,0.0083932933573539,0.871505966061706
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,40449,0.000548482508123935,0.00341642137325555,-0.00614770338345695,0.00724466839970482,0.872456239543262
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.000879055717937377,0.00547700863055685,-0.0116139926338288,0.00985588119795404,0.872490681528122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,40182,-0.000368761732336664,0.00230195977329144,-0.00488060288798789,0.00414307942331456,0.872730656791477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.000856469698362273,0.0053520660131276,-0.00963357968736783,0.0113465190840924,0.872863549531901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.000618534793869961,0.00386790909540886,-0.00819963662087132,0.0069625670331314,0.872950879346284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00122875860701996,0.00777610730913495,-0.0164699289329245,0.0140124117188846,0.874446171061613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.000353134551912788,0.00225173360725633,-0.00476653242213519,0.00406026331830962,0.875383389884864
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.000739038370823808,0.0047505120389729,-0.00857196522556307,0.0100500419672107,0.87637465669728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.000426838381132505,0.00275547447460469,-0.00497389158909269,0.0058275683513577,0.876898126903822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,0.000475408370893713,0.00308589384869501,-0.0055729435725485,0.00652376031433592,0.877565922131948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.000598088696093948,0.00392401622374718,-0.00828916049463843,0.00709298310245053,0.878860480091214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.000851669950478643,0.00559398525973346,-0.0101125411585989,0.0118158810595562,0.878994120270591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,0.000525986378502957,0.0034710196282971,-0.00627721209295935,0.00732918484996527,0.87955479439086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,40199,0.000478790802818357,0.00319315868095773,-0.0057798002118588,0.00673738181749552,0.880812578321291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00063370245041946,0.00425364971652677,-0.00770345099397302,0.00897085589481194,0.881573314279775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.000699220557965867,0.00469556249286093,-0.0099025230439733,0.00850408192804157,0.881626648283737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,0.00111087079246543,0.00760107039275819,-0.0137872271773406,0.0160089687622715,0.883808248930531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.000411733695933035,0.00285388683503539,-0.0060053518926024,0.00518188450073633,0.885288889858224
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42618,0.000341070594945337,0.00241516546437344,-0.00439265371522661,0.00507479490511728,0.887697962164718
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,0.000455455585708403,0.0032729559199441,-0.00595953801738203,0.00687044918879884,0.889327970747801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,-0.000972151191359014,0.00707147543187471,-0.0148322430378334,0.0128879406551154,0.890657387938602
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,0.000737258429208627,0.00536881848716779,-0.00978562580564025,0.0112601426640575,0.890778582022036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,40116,-0.000903828319898462,0.00660553097121973,-0.0138506690234891,0.0120430123836922,0.891168467841396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.000972396499905922,0.00716730347225225,-0.0150203113055203,0.0130755183057085,0.892083653401064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.00149032961583576,0.0111320848885,-0.0233092159972959,0.0203285567656243,0.893502336415451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.000617052803335782,0.00461336761827763,-0.00965925333515994,0.00842514772848837,0.893599761172799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.000306810436167328,0.00234612548388609,-0.00490521638458407,0.00429159551224942,0.895957075916998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.00118146973819421,0.00918813365287272,-0.0191902116978247,0.0168272722214363,0.897687234677099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,42249,0.00130181033585849,0.0102469401411821,-0.0187821923408584,0.0213858130125753,0.898907679179186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.000659823653976909,0.00521116514563859,-0.0108737073394285,0.00955406003147472,0.899245554115173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,0.000603236187131819,0.00484849383414208,-0.00889981172778665,0.0101062841020503,0.900986864936315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.0021457850018433,0.0173947694659137,-0.0319479631513475,0.0362395331550341,0.901825769925857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.000427954992358006,0.00353690593554742,-0.00736029062603095,0.00650438064131494,0.903695207544882
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,0.000693394411914453,0.00581145194189467,-0.0106970513941991,0.012083840218028,0.905027850980379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.000541439382316553,0.00461341948466166,-0.0095837415722534,0.0085008628076203,0.906575068953073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,40116,0.000498500712064218,0.00432395358592473,-0.00797644831634826,0.00897344974047669,0.908218831247249
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42721,-0.000687155157896655,0.0060055390071535,-0.0124580116119175,0.0110837012961242,0.908906375814812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.000335487641621763,0.00298828238828785,-0.00552154583942242,0.00619252112266595,0.910613188767319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,0.000325873201138383,0.00290339760632575,-0.00536478610726008,0.00601653250953685,0.910635963834496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.000808969401045542,0.00723768173859308,-0.0133768868065969,0.014994825608688,0.911006322818756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,-0.00117698622841595,0.0112232722424366,-0.0231745998235916,0.0208206273667597,0.916480822236957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.000397214282186414,0.00391780760695662,-0.00728168862744855,0.00807611719182138,0.919244898094843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,40199,-0.000419353756470638,0.00420302918866503,-0.0086572909662541,0.00781858345331283,0.920525430975207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42538,0.000570020248971817,0.00581136572113437,-0.0108202565644515,0.0119602970623952,0.921864571502434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.000279342589200203,0.00289418401183632,-0.00595194325239938,0.00539325807399898,0.923110459682355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,40286,0.000955821671889082,0.00992066087546481,-0.0184886736440219,0.0204003169878001,0.923247064226841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.000837313759739283,0.0087592552775317,-0.0180054541037014,0.0163308265842228,0.923846434510425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,0.000266813431400054,0.00291140156000221,-0.00543953362620427,0.00597316048900438,0.926982252200939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.000269606649690884,0.00294211213534043,-0.00549693313557637,0.00603614643495814,0.926988034840822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,40199,-0.000297426453276773,0.0032535961200165,-0.00667447484850911,0.00607962194195556,0.927164760184244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,42483,0.000928925872305716,0.0101791995880813,-0.0190223053203337,0.0208801570649451,0.927289552561985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.00043786233924225,0.00487098143877899,-0.00998498595924907,0.00910926128076457,0.928374365419996
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,40116,0.000300170987253604,0.00335559547860407,-0.00627679615081038,0.00687713812531758,0.92872285657689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42721,-0.000189691204985299,0.00214933032665217,-0.00440237864522356,0.00402299623525296,0.929674549951481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.000666827243096637,0.00768245511976178,-0.0157244392778297,0.0143907847916364,0.930832832835041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.000314786387977956,0.00376300490879943,-0.00706070323326893,0.00769027600922484,0.933333915025988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.000258403086565419,0.00308954112262221,-0.00579709751377412,0.00631390368690495,0.933345762499899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.000448994156918776,0.00540203719024413,-0.0110369870497973,0.0101389987359597,0.933761031891699
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42495,-0.000733185739006109,0.00891985030493918,-0.0182160923366869,0.0167497208586747,0.934491224214362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.00214343949386481,0.0269477018095408,-0.0549609350405648,0.0506740560528351,0.936603990667116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,0.000376325053257027,0.00482662181875595,-0.00908385371150463,0.00983650381801868,0.937854197910057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.000153377992706655,0.00196971820023906,-0.00401402566517521,0.0037072696797619,0.937934439773605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42636,0.000230728409239474,0.00299496295788067,-0.00563939898820664,0.00610085580668559,0.938593810190189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00034363235967736,0.00471033810553313,-0.00957589504652229,0.00888863032716757,0.941844990016328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,42311,-0.000384812333864989,0.00529384237532172,-0.0107607433894956,0.00999111872176558,0.942053473967057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,0.000562610371106263,0.00801648557250018,-0.0151497013509941,0.0162749220932066,0.944050324337427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.000345628797919514,0.00518499454529004,-0.010508218106688,0.00981696051084897,0.946854055824695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.000262385155754402,0.00401801772594448,-0.00813769989860559,0.00761292958709678,0.947934433726071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000335261703862842,0.00514676252416538,-0.010422916251227,0.00975239284350129,0.948063471225623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.000569242229979068,0.00875400327839834,-0.0177270886556398,0.0165886041956817,0.948153863382694
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000299993306463247,0.00473625030815763,-0.00898305729752571,0.0095830439104522,0.949497055883046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.000154498835793863,0.00244160235002759,-0.00494003944184793,0.00463104177026021,0.949546358223793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,40116,0.00066772719936975,0.0111386206829458,-0.0211639693392039,0.0224994237379434,0.952198921538047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00017726710875154,0.00299099893018517,-0.00603962501191448,0.0056850907944114,0.952740461057099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.000590159825309914,0.00999747361004133,-0.0201852081009909,0.0190048884503711,0.952928386665565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42636,0.00036990533496087,0.0066455235316248,-0.0126553207870237,0.0133951314569455,0.955611635189583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00030275887550676,0.00566073420218355,-0.0113977979117865,0.010792280160773,0.957347231372586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,42311,0.000251066377431541,0.00471771134845593,-0.00899564786554209,0.00949778062040517,0.957559157028608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.000332950839229921,0.00626103770853613,-0.0119386830695009,0.0126045847479607,0.957590865445293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,40060,0.000229521828993242,0.00440686814944448,-0.00840793974391794,0.00886698340190442,0.958463712148096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000187871656330323,0.00375613396082942,-0.00754989421955599,0.00717415090689535,0.960109521621037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.000271012257668934,0.00547181589418842,-0.0109957714102782,0.0104537468949404,0.960498796639434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.000330212123777472,0.00684532315955772,-0.0137470455165106,0.0130866212689557,0.961526558853681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00017087136435117,0.00364180148341246,-0.0073088022718396,0.00696705954313726,0.962578249476695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,40449,0.000277721389109678,0.00603438034759543,-0.0115496640921774,0.0121051068703967,0.963292588893696
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,40182,-0.000187800734544559,0.00415644242830113,-0.00833442789401477,0.00795882642492566,0.963962227859546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42553,0.000264159351322927,0.00591490975769974,-0.0113290637737686,0.0118573824764144,0.964379054609764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,40136,0.000319024632640123,0.00724737563974013,-0.0138858316212505,0.0145238808865308,0.964889797523621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00012261910021012,0.00280486495231315,-0.0056201544067439,0.00537491620632366,0.965131116869313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.000270783054552596,0.00655520231058673,-0.0131189795833026,0.0125774134741974,0.967050995899119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,40182,-0.000372260816790759,0.00903717676203016,-0.0180851272703699,0.0173406056367883,0.967143453456953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPL,Periplakin,40199,0.000135952534491501,0.00331158299754965,-0.00635475014070582,0.00662665520968882,0.967253878489434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.000146488614815428,0.00359685404078955,-0.00719632253476295,0.0069033453051321,0.967514378392935
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,40482,-0.00014685791983925,0.00381751137749424,-0.00762918021972796,0.00733546438004946,0.969313994593885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,0.000233849455676974,0.00638435802801799,-0.0122794922792383,0.0127471911905922,0.970781883700091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,8.89028518331174e-05,0.00253078567352947,-0.00487143706828464,0.00504924277195088,0.971977746371415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,6.6527895456224e-05,0.00199535767298082,-0.00384437314358619,0.00397742893449864,0.973402978219945
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,0.000155783808056352,0.00484021957899481,-0.00933104656677347,0.00964261418288618,0.97432488542685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.000243091025785087,0.00762198078624134,-0.0146959913152479,0.0151821733668181,0.974557612381741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,42353,-0.000264433958472751,0.00881040957415623,-0.017532836723819,0.0170039688068735,0.976056494557405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,42346,0.000233092319481828,0.00790334920346358,-0.0152574721193068,0.0157236567582704,0.976471966115395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.000172823904646,0.00633197031109958,-0.0122378379051092,0.0125834857144012,0.978225845185475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,40199,0.000155291466814867,0.00588081488150343,-0.0113711057009319,0.0116816886345616,0.978933625303605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,0.000145357421218272,0.00571768512800282,-0.0110613054296673,0.0113520202721038,0.979718490317112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.000256171032703367,0.010107793621888,-0.0200674465316038,0.0195551044661971,0.979781107919513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,40199,0.000126387135600929,0.00550309682400046,-0.01065968263944,0.0109124569106418,0.981677373375608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.000186933058067657,0.00919549921115873,-0.0178362453958034,0.0182101115119388,0.9837814179777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.000221688754287334,0.0109266668881886,-0.0216379558551369,0.0211945783465623,0.983813362761136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41779,-9.99087211841319e-05,0.00495828005817725,-0.00981813763521155,0.00961832019284329,0.983924133501312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.000160962017417333,0.00850517125292984,-0.0168310976731598,0.0165091736383252,0.984901068942058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,4.25978829908522e-05,0.0029226772899572,-0.00568584960532525,0.00577104537130696,0.988371497237909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42477,9.32927290440726e-05,0.00690181065505747,-0.0134342561548686,0.0136208416129567,0.989215415480868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,42357,-3.60368178842388e-05,0.00274343128614729,-0.00541316213873292,0.00534108850296444,0.989519749315209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,5.54955766882319e-05,0.00495007078164262,-0.00964664315533131,0.00975763430870777,0.991055254628936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,42311,6.36015119020599e-05,0.00579194456833274,-0.0112886098420301,0.0114158128658342,0.991238749490052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTN,Titin,40116,7.08843781877528e-05,0.00653301938966844,-0.0127338336255624,0.0128756023819379,0.991343184024612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,4.39707641835609e-05,0.00430584205214871,-0.00839547965802791,0.00848342118639503,0.991852417166182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,42262,4.49342681829051e-05,0.00459990676931285,-0.00897088299967029,0.0090607515360361,0.992206124050372
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,40511,-2.88830368423355e-05,0.00297232685541714,-0.00585464367345992,0.00579687759977525,0.99224699755235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-1.49856124965282e-05,0.00396388509961804,-0.00778420040774788,0.00775422918275482,0.996983642241058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,3.14459414366518e-05,0.0087713537564277,-0.0171604074211616,0.0172232993040349,0.9971395976127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-1.94987950896831e-05,0.00643656958919076,-0.0126351751899036,0.0125961775997242,0.997582965650416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42594,1.53862280116978e-05,0.00611023645953149,-0.01196067723267,0.0119914496886934,0.997990881064841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,1.35253505838553e-05,0.00804362387413411,-0.015751977442719,0.0157790281438867,0.998658388890307
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-7.74037004208384e-06,0.00471981508447357,-0.00925857793561028,0.00924309719552611,0.998691515525842
